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Abstract
Retroviral vectors are a promising tool for gene therapy. However, there are two 
major problems to overcome if a viable commercial production process is to be 
established. These are the instability of virus particles and the low virus titres. 
The characteristics of the producer cells were determined in batch culture, semi- 
continuous culture and semi-continuous culture at 32°C. Additionally, cell attachment, 
growth and virus production on various macroporous microcarriers was assessed 
under static and stirred conditions.
Alternative strategies for the cultivation of cells were also investigated. These 
included spinner basket, packed bed and spinner flask cultures with semi-continuous 
feeding and packed bed, fixed bed, fluidised bed and stirred tank cultures with 
continuous perfusion of culture medium. Of these the fixed bed bioreactor had the 
highest cell specific productivity and was capable of running for 28 days. The 
fluidised bed bioreactor had the highest reactor productivity, due to the higher cell 
number.
Optimisation of culture medium was performed with regard to serum concentration. 
The greatest production was observed at an initial serum concentration of 2.5% (v/v). 
The findings in this thesis will assist the development of an efficient method for the 
production of clinical grade retro viral vectors for gene therapy applications.
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Chapter 1: Introduction 
1.1 Gene Therapy
Gene therapy is one of the most significant breakthroughs in modem medicine. In 
principle, heterologous genetic information is inserted into damaged or defective 
tissue or cells, enabling them to function correctly and eliminate the disease 
symptoms. Gene therapy was initially developed to treat inherited monogenic 
disorders, such as cystic fibrosis and muscular dystrophy (Andreadis et al. 1999; Cruz 
et al. 2000; Johnson 2001) but it has the potential to treat several human diseases. 
These include cardiovascular disease, infectious diseases such as HIV, Herpes and 
Hepatitis, and degenerative disorders, particularly those that are neurological 
(Hiltunen et al. 2002; Islam et al. 1997; Kirn et al. 2000; Lauret et al 1993; Mautino 
and Morgan 2002; Palu et al. 1999).
The majority of clinical gene therapy trials are for the treatment of cancer 
(Marchisone et al. 2000). While cancer may be considered a genetic disorder due to 
the number of mutations in evolving clones of tumours, attempts to correct these 
mutations by gene therapy would be impossible in most cases, due to the huge range 
and complexity of mutations (McTaggart and Al Rubeai 2002). Instead, gene therapy 
is used to deliver cancer killing agents to the tumour cells.
Several strategies have been conceived for the treatment of diseases with an acquired 
genetic component. Thus, the original concept of gene therapy has evolved to include: 
1. The delivery of genes able to kill the targeted cell in a controlled manner 
(suicide-gene therapy).
2. The delivery of transdominant functions or sequences, like anti-sense 
molecules and ribosomes, capable of switching off a functional gene 
(suppressive gene therapy).
3. The delivery of immune functions capable of inducing the immune system to 
destroy cells expressing specific determinants (immune gene therapy). (Palu et 
al. 1999).
1.2 Gene delivery
The key to success for any gene therapy strategy is having a vector able to serve as a 
safe and efficient gene delivery vehicle (Friedmann 1997). Various kinds of synthetic 
vectors are currently being investigated as an alternative to viral vectors (Navarro et al. 
1998). They can be divided into two sub-groups; cationic lipids and molecular 
conjugates (Gao and Huang 1995; Michael and Curiel 1994). Simple mixing in vitro 
of the synthetic reagent with plasmid DNA leads to the spontaneous formation of 
DNA/vector aggregates via a self-assembly process. For efficient gene transfer these 
must survive in the extracellular medium and reach the target cells. Once the vectors 
have reached the target cell several steps, including binding, internalisation, 
endosomal release, uncoating, nuclear escape and expression, are required to achieve 
efficient gene delivery and expression. While non-viral methods are generally 
considered to be safer than viral transduction, they are less efficient, and no 
commercial processes have been developed to meet the potential market demand 
(Theodossiou et al. 1999). Viruses, however, have complex and precise structural 
features, adjusted through natural evolution for efficient transfection of host cells 
(Navarro et al. 1998).
A number of virus types are currently being investigated for use as gene delivery 
vectors. These include retroviruses, adenoviruses, adeno-associated viruses, 
poxviruses, rhabdoviruses, parviruses and alpha viruses (Palu et al. 1999). It is 
unlikely that any one of these vectors will emerge as a suitable vector for all 
applications. Instead, a range of vectors will be necessary to fulfil the objectives of 
each treatment (McTaggart and Al Rubeai 2002). Although vectors derived from 
adenovirus, adeno-associated virus and herpes virus are receiving more attention in 
the field of gene therapy (Benihoud et al. 1999; Parasrampuria 1998; Vos 1995), 
recombinant retroviruses are currently used in the majority of clinical trials (Kang S- 
H. et al. 2000; Wu and Ataai 2000; Wu et al. 2002).
1.3 The use ofretroviral vectors in gene therapy 
1.3.1 Retroviruses
Retroviruses have a number of advantages as gene therapy vectors and they are 
currently the only vectors capable of efficiently introducing genes into haemopoietic 
stem cells (Onions and Lees 1994). They are enveloped viruses that contain two 
identical copies of single stranded RNA, typically 7-10 kilo base pairs in length, as 
their viral genome. The diameter of retrovirus particles has been reported to be 90- 
147nm (Kafri et al. 1997). The structure of a retrovirus is illustrated in Figure 1.3.1. 
During the life cycle, the ssRNA is reverse transcribed to yield double stranded DNA 
that integrates into the host genome and is expressed over extended periods. As a 
result infected cells continuously produce virus particles with no apparent damage to 
the host cell (Smith 1995). However, for many types of retroviruses, mitosis and the 
breakdown of the nuclear envelope are required for the viral DNA to be transported to 
the nucleus. Thus, successful infection can only occur in actively dividing cells. A
notable exception to this are the lentiviruses, which include HIV, and can infect non- 
dividing cells (Lewis and Emerman 1994), a crucial asset in cells lines such as 
neurons and haematopoietic stem cells (Karri et al 1999; Klages et al. 2000). The 
permanent integration of the virus into the host cell genome allows the potential for 
stable gene expression, making this an attractive option for the treatment of genetic 
disorders. In reality, though, the frequent loss of gene expression in vivo has meant 
this has been difficult to achieve. An additional problem associated with retroviral 
vectors is the random insertion of the viral DNA into the host genome. This can lead 
to insertional mutagenesis or the activation of oncogenes. Random insertion can also 
result in varying levels of therapeutic expression, as this is reliant on the site of 
integration (Gordon and Anderson 1994).
Retroviruses can be divided into three subfamilies, Oncovirinae, Lentivirinae, and 
Spumavirinae, according to their pathogenicity and are further classified by their 
virion structure, cell receptors and oncogenicity (Kim et al 2000). The structure of 
the virus particle is extremely simple, comprising of three genes encoding gag, the 
core proteins; pol, the reverse transcriptase; and env, the viral envelope protein. At the 
ends of the RNA genome are the long terminal repeats (LTRs) which include 
promoter and enhancer activities and sequences involved in integration. The genome 
also includes a sequence required for packaging, termed psi (fy\ a tRNA binding site, 
and several additional sequences involved in reverse transcriptase.
Surface receptor;
Transmembrane protein 
TM
Envelope; EN 
Matrix; MA
RNA genome 
(2 copies) Reverse transriptase; RT 
Integrase; INT
Figure 1.3.1
Three-dimensional representation of 
a retrovirus particle.
1.3.2 Replication of retroviruses
In the natural life cycle of retroviruses, virus particles bind to a specific cell surface 
receptor through a direct interaction with the major viral envelope glycoprotein, 
termed SU. Entry into the cell is mediated by fusion of the envelope with the cell 
membrane, which is dependent on the activity of the minor transmembrane (TM) 
envelope protein. In some retrovirus infections this fusion may take place after 
endocytosis of the virus and activation in the low pH of the endosome (Onions and 
Lees 1994). The viral core is released into the cytoplasm and the genomic RNA is 
reverse transcribed into a double stranded DNA provirus and transported to the host 
cell nucleus. The nuclear proviral DNA then integrates into the host DNA using a 
virally encoded integrase (INT). Proviral DNA is transcribed by the cell, producing 
RNAs encoding gag, pol, and env proteins, allowing for the packaging of the full 
length unspliced viral RNA containing the ^ packaging site. Following virus 
assembly, the gag polyprotein is proteolytically cleaved by a viral protease into 
smaller polypeptides that include matrix (MA), capsid (CA), and nuleocapsid (NC). 
At least one of these binds to the ¥ site to facilitate packaging into the membrane 
associated virion. The assembled particles are released from the cell by budding from 
the env coated cell membrane. An important feature of retroviruses is that infected 
cells stably produce viruses for the duration of their life span without their growth 
properties being affected (Kim et al. 2000). The life cycle of a wild type retrovirus is 
illustrated in Figure 1.3.2.
Virus release 
by budding
Figure 1.3.2
The natural life cycle of a retrovirus (not to scale).
1.3.3 The design of safe retrovirus vector systems
There are two elements that make up retroviral vector systems; the vector particle and 
the packaging cell. The design and structure of packaging cells is discussed in detail 
in 1.4. Production of gene therapy vectors from wild type retroviruses is relatively 
straight forward, owing to their genetic simplicity and the fact that cells can 
incessantly produce virus proteins without suffering any detrimental consequences. 
Retroviral vectors need only contain the nucleic elements required in cis, which 
include the 5' and 3' LTR sequences and the ¥ packaging sequence that lies 
downstream of the 5' LTR (Smith 1995). Consequently, the helper genes gag, pol and 
env can be deleted from the virus genome and replaced by a therapeutic gene which 
can be up to lOkbp in size. Deletion of these genes also prevents the viruses from 
reproducing within the target cell, and avoids spreading of the virus in vivo (Pedersen 
and Duch 1999). Additionally, a selectable marker is usually inserted into the virus to 
allow the detection of successfully infected target cells. The viral helper genes are 
contained on plasmids present in the packaging cell line.
A problem encountered in first-generation vectors was a significantly reduced virus 
titre when compared to wild type viruses. To overcome this, modifications have been 
made in the packaging signal of currently used vectors, whereby the N-terminal gag 
sequences are inserted adjacent to the packaging sequence (called the ¥+ 
region)(Adam and Miller 1988; Armentano et al. 1987). This has led to vastly 
improved virus titres, such that levels are similar to those of the wild type virus, 
providing the ^ and gag sequences are kept together (Morgenstem and Land 1990). 
The potential expression of the initiation codon for gag synthesis rather than the gene 
of interest can be prevented by mutation of the AUG sequence or insertion of a
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downstream termination codon (Bender et al. 1987). To date, more than 100 genes 
have been expressed using the retroviral vector system (Morgan et al. 1993).
1.4 Packaging cell lines
The second element of a retroviral vector system is the packaging cell line. These 
cells contain the virus helper genes (gag, pol and env) that are absent from the vector 
genome. Producer cell lines are made by inserting the vector, which has had these 
genes replaced by a therapeutic gene, into the packaging cell on a separate plasmid 
(Pear et al. 1993). Hence, the structural and functional proteins required for the 
synthesis of new virus particles are produced by the cell. Recombinant viruses are 
released from the cell in a similar fashion to wild type viruses. Packaging cells are 
unable to produce their own virus particles as the ^ packaging sequence and the 
LTRs are only contained on the vector plasmid (Robbins et al. 1998). The mechanism 
of producing retroviral vectors from packaging cell lines is illustrated in Figure 1.4.1. 
Packaging and producer cell lines are able to continuously release vector particles, 
making them well suited to large-scale production systems. This gives them a 
significant advantage over transient transfection systems, such as baculovirus or 
adenovirus systems, where generation of large volumes of characterised supernatants 
is difficult (Rigg et al. 1996).
Many technological improvements are still required for vector design and production. 
These improvements include higher virus titres, human compliment-resistant vectors, 
and minimized potential for generation of replication-competent retroviruses (RCR) 
(Sheridan et al. 2000). Theoretical predictions have suggested that 108 virions ml" 1 of 
infusion product would be required to treat a tumour, based on the supposition that a 
typical tumour contains 109 cells g" 1 and a diseased organ may contain lOOg of tumour. 
This figure also assumes that the transduction efficiency would be 100%, no particles
are lost by compliment inactivation and that infection is not limited by cell replication. 
Therefore, it was recognised that the actual viral dose may be 10 -1000 times greater 
(Braas et al. 1996; Lyddiat and O'Sullivan 1998). It has subsequently been shown 
empirically that titres >5 x 107 virions ml" 1 of infusion product can efficiently obtain 
in vivo gene transfer in animal models of haemophilia, arthritis, cancer, chronic HB V 
infection, cystic fibrosis and other diseases (Ghivizzani et al. 1997; Karavodin et al. 
1998; Nemunaitis et al. 1999; Sallberg et al. 1998; VandenDriessche et al. 1999; 
Wang et al. 1998). Therefore, much attention has been focused on the development of 
high titre packaging cell lines. Calcium phosphate-mediated transfection was shown 
to be a reliable method for introducing vector genes into packaging cells. The 
resulting producer cells were capable of producing >106 virions ml" 1 (Pear et al. 1993). 
An alternative method for generation of producer cells is by retroviral infection. In 
comparison, this procedure was able to yield up to 5 x 107 virions ml" 1 more than 
transfected clones. The titre was increased by multiple rounds of infection (the "ping- 
pong" strategy) through long-term incubation of producer cells with ecotropic virus 
vectors, resulting in a 20-fold increase in vector titre (Kim et al. 1998). However, the 
ping-pong method suffers from the increased probability of recombination between 
retroviral components, leading to RCR (Muenchau et al. 1990). Sheridon et al. (2000) 
have shown that improved viral titres can be obtained by increasing the multiplicity of 
transduction, thus introducing multiple copies of the provector within vector 
producing lines. This has only been possible through the development of packaging 
cells with reduced homology between viral vector and packaging components. 
A major drawback to in vivo gene delivery is the inactivation of virus particles by 
human serum. The virus decay rate in vivo correlates with their in vitro resistance to 
serum complement. The sensitivity of retroviral vectors to human serum is dependent
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on the species of the packaging cell line and vectors produced from murine cell lines 
have been shown to have a half-life <1 minute following intravenous administration 
(Cometta et al. 1990). Viruses produced from non-primate cells are sensitive to 
human serum because they bear Gal(cd-3)galactosyl sugar on their envelope, which 
activates natural antibodies present in human serum (Takeuchi et al. 1996). Hence, 
human cell lines that do not express Gal, such as HT 1080 and TE671, have been used 
as packaging cells (Cosset et al. 1995; Higashikawa and Chang 2001). In addition to 
the packaging cell type, the type of envelope protein can also influence complement 
sensitivity of MLV vectors (Takeuchi et al. 1994).
Aside from the problems associated with the levels of expression and complement 
inactivation, there are concerns over the safety of using retroviral vectors, especially 
lentiviruses, which include HIV-1. Recombination between the vector and the helper 
genes can lead to the generation of wild type replication competent virus. The 
demonstration that producer cells do not release RCR is the most important criterion 
in using retroviral vectors (Onions and Lees 1994). The probability of producing RCR 
has been reduced by using separate plasmids for the gag-pol and env genomes, and by 
using genes from viruses with different host species. The possibility of formation of 
RCR can be further reduced by decreasing the viral sequences in the helper constructs 
(Cosset et al. 1995). However, RCR can still be produced through recombination with 
endogenous retroviral sequences. Early packaging cell lines were derived from 
NIH/3T3 cells, which express endogenous MLV virus sequences, and participate in 
recombination to form RCR, particularly in mass culture during large-scale clinical 
vector production (Rigg et al. 1996). For that reason, cell lines are now screened for 
endogenous viral sequences before being developed as packaging cells. An example 
of a cell line successfully created in this way is the ProPak packaging cell, which has
11
been derived from MLV-free HEK293 cells. Using a vector known to reproducibly 
give rise to RCR in PA317 cells, ProPak cells were shown to be RCR-free using 
conditions favourable to RCR formation e.g. the ping-pong method (Forestell et al. 
1997;Forestelletal. 1998).
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Figure 1.4.1
The principle mechanism of packaging cell lines and engineered retroviral vectors for 
gene therapy.
1.5 Complications in the production ofretroviral vectors
A number of breakthroughs have been made in the design and construction of gene 
therapy vectors and packaging cell lines. However, a number of biochemical 
engineering challenges remain in the production of clinical grade vectors. Unlike 
other biopharmaceutical products, viruses are particles, not molecules, and are rapidly 
denatured at 37°C. Although production at reduced temperatures (32°C) does result in 
an increased virus titre (Kaptein et al. 1991 \ Kotani et al. 1994), the supernatant 
contains higher levels of transduction inhibitors than at 37°C. Therefore, simply 
reducing the culture temperature reduces the potency of the vector stock (Le Doux et 
al. 1999).
The main problem, though, is the relatively low vector titres achieved from small 
scale production systems, such as roller bottles, that are currently in use. These titres 
seldom rise above 106 virions ml" 1 at 37°C (Merten et al. 2001). Additionally, scale-up 
of roller bottle production relies on an increase in unit numbers, which is 
uneconomical due to the extra space required and the added labour intensiveness. 
Therefore, there is a need to transpose vector production to a bioreactor system with 
an emphasis on process scale-up and intensification (McTaggart et al. 1999).
1.6 Overview of biopharmaceutical production systems
The production of biologies is the central core of animal cell biotechnology. It was 
estimated that the direct and indirect activities of the biotechnology industry 
contributed $47billion in revenues to the US economy in 1999 (Ernst & Young 2000). 
Immobilisation technologies have allowed for the production of large biomasses, 
which forms the substrate from which a wide range of products can be produced, as 
listed in Table 1.6.1. Animal cells are used for the production of these products to
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allow for the correct post-translational processing, including glycosylation, the 
formation of disulfide-bond, 7-carboxylation and other modifications to occur, which 
cannot be achieved using other eukaryotic or bacterial cells. However, the relatively 
low biomass productivity compared to bacterial cultures and the low product 
expression rate has meant it has become necessary to scale-up their production in 
order to meet the high demand for these products. Many biologies, such as viral 
vaccines, are produced from anchorage dependent cell lines. Although developmental 
work can be done in monolayer cultures, using either tissue culture flasks or roller 
bottles, it is not a desirable method for large scale manufacture. This is because scale- 
up is achieved by increasing the unit number of either flasks or bottles, which is 
extremely labour intensive and susceptible to contamination (Butler 1987). Modern 
facilities have overcome these problems by the use of expensive robots; however, it is 
still not possible to control environmental conditions such as pH or dissolved oxygen 
levels (Hu and Peshwa 1991). The most successful method for the scale-up of 
anchorage-dependent cells has been the use of microcarriers, first reported by (van 
Wezel 1967), which provide a high surface area to volume ratio and can be used in 
traditional stirred tank bioreactors.
The use of suspension cell lines, such as hybridomas, for the production of 
monoclonal antibodies has been widely used. Scale-up of these systems is relatively 
simple and the maximum cell densities achieved in fed-batch cultures is 
approximately 2 x 107cells ml" 1 . Therefore, in order to produce the required amount of 
product high volume bioreactors are necessary. Aside from this, the simple design and 
operation, along with flexibility and ease of licensing, these systems are the most 
popular for manufacturing. However, the immobilisation of cells allows for far greater 
cell densities to be achieved, whilst retaining these features. It also allows for long-
15
term perfusion cultures which are economically advantageous as time is saved in 
turnaround and seed build-up, and because of the higher densities it can reduce the 
capital equipment and plant costs as smaller vessels can be used (50-100 litres are 
equivalent to 4000 litres for suspension cultures). Immobilised cell cultures can also 
enhance cell specific productivity, thus giving even greater savings (Griffiths 1992). 
When developing a production process it is desirable to avoid nutrient limitation and 
accumulation of toxic metabolites such as lactate and ammonia. This problem can be 
overcome by the use of medium perfusion. While spin filters have offered limited 
success, immobilisation has been adopted as the best method (Griffiths 1992). 
The immobilization of cells for the production of biologies can be divided into three 
main areas. The first is cell retention within a compartment, allowing the free passage 
of medium. Examples of these systems include hollow-fibre and ceramic matrix 
bioreactors. While it is possible to achieve a 50-fold to 100-fold increase in unit cell 
biomass they are difficult to scale-up and are limited to 1-2 litres. The second method 
is cell encapsulation. This technique uses alginate or agarose beads to entrap the cells 
and allows the product to diffuse into the culture medium. Finally, the most common 
system is cell entrapment which uses macroporous microcarriers as a cell 
immobilisation substrate. The advantage of encapsulation and entrapment is that these 
processes allow cells to be grown in conventional bioreactors and the potential scale- 
up of these systems is far greater than with cell retention devices (Griffiths 1988).
16
Table 1.6.1
Biopharmaceutical products produced from animal cells
Viral Vaccines RotaShield™, RabAvert™, VAQTA™ 
Antibodies Monoclonal antibodies e.g. Capromab
pendetide/ProstaScint™
Interferons Human IFN-7 
Enzymes Fibrinolytic 
Whole cells Autologous cultured chondrocytes 
Insecticides Insect viruses 
Immunoregulators Human Interleukin-2 
Hormones Insulin 
Growth Factors Epidermal growth factor (EGF), nerve growth
factor (NGF)
(Chu and Robinson 2001; Griffiths 1985; Hu et al. 2000; Kratje and Wagner 1992; 
Wang et al 2002)
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1.7 Cell retention
As the potential of animal cells for the production of biologies became apparent, 
many investigators looked to develop new bioreactors in order to overcome the 
problems of hydrodynamic forces caused by mechanical agitation and bubble aeration 
that were believed to exist in the traditional stirred microcarrier or suspension cultures. 
One system that was developed by Knazek et al. (1972) was the use of ultrafiltration 
capillary fibres. In this bioreactor cells attach to the outer surface of semi-permeable 
fibres, growing in the extra-capillary space (ECS) while medium is circulated through 
the inter-capillary space (ICS) or lumen. Nutrients are able to diffuse through the 
fibres, usually made of cellulose acetate, while toxic metabolites diffuse out of the 
ECS and are carried away from the cells. A unit consists of thousands of fibres housed 
in a cylinder. A similar device is the ceramic matrix bioreactor. This is a cylinder of 
porous ceramic with square channels passing through the cylinder. Cells are 
inoculated into the channels and either attach to the surface or are immobilised in the 
ceramic pores. Medium is passed through the channels to provide nutrients and 
remove metabolites. In a ceramic system cells are directly bathed in the recirculating 
medium, whereas in a hollow-fibre bioreactor cells are only exposed to a slow stream 
of permeate (Hu and Peshwa 1991). The product accumulates within the ECS and is 
harvested intermittently.
There are numerous advantages to using hollow-fibre bioreactors (HFBR) and they 
have received much attention for the commercial production of monoclonal antibodies 
and recombinant proteins (Kessler et al 1997; Thelwell and Brindle 1999; Williams 
et al. 1997). The main advantage of HFBRs is the high cell densities that can be 
achieved. Numerous studies have reported near tissue densities of >108 cells ml" 1 
(Kessler et al. 1997; Koska et al. 1997). These high densities in turn lead to increased
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production and concentration of products and enhance the specific productivity in a 
relatively small bioreactor (Fassnacht and Former 1999; Glacken et al. 1983; Knight 
1989). Tzianbos and Smith (1995) reported that a flat HFBR was used to produce 
monoclonal antibodies from problematic cell lines and yielded a 200-300 fold 
increase in the concentration of antibody harvested when compared to levels obtained 
in static culture. Furthermore, it was possible to maintain antibody production over a 
two month period, demonstrating the long-term potential for HFBRs. This has been 
verified in studies conducted by Kessler et al. (1997) who consistently produced a 
MAb for 85 days and Fassnacht et al. (1999) that produced antibody for a 6 week 
period from two different murine hybridoma cell lines. Marx (1998) tested 31 
hybridoma cell lines of murine, human, and rat origin and found that the average 
culture times were 56 days, 84 days and 67 days, respectively, demonstrating that 
long term cultivation and production are possible in HFBR.
A further advantage of HFBRs is the total amount of serum used in production can be 
lower than that used in other types of bioreactor. The high molecular weight of serum 
makes it difficult to diffuse into the ECS and therefore only low concentrations are 
required in the culture medium, and in some cases it can be totally removed. Serum is 
the most expensive component in the production of biologies and may cause 
complications in the downstream processing of products. Therefore, removal of serum 
from any process is highly desirable not only for economical reasons but also removal 
of components of animal origin in the manufacture of therapeutic and diagnostic 
products are favoured by regulatory authorities. It has been shown that a reduction in 
serum concentration to 2.5% can also lead to an increase in antibody production in 
hybridoma cell lines, although productivity decreases at concentrations ^% (Kessler 
et al. 1997;Tzianbos and Smith 1995).
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Whilst HFBRs offer a number of advantages, these systems are associated with 
several disadvantages including poor cell viability, large diffusional gradients which 
limit scale-up and effect product quality, and difficulties in culturing anchorage 
dependent cell lines. As medium enters the lumen it encounters a positive 
transmembrane pressure and is able to permeate into the ECS. As this pressure 
decreases along the length of the fibre, it becomes negative towards the outlet, 
causing medium to flow back into the lumen ICS. This phenomenon is called Starling 
flow (Starling 1896). This results in a higher cell density at the inlet end compared to 
the outlet or, with suspension cells, a packed cell mass accumulating at the outlet end 
(Griffiths 1988). The resulting presence of large numbers of dead cells limits culture 
performance in two ways. Firstly, there is a need for high rates of cell proliferation to 
replace lost cells, which will reduce the specific productivity (Al Rubeai et al. 1992). 
Secondly, the release of proteases, DXA and other cellular components will lead to 
product degradation and will complicate downstream processing (Fassnacht et al. 
1999). Aside from the adverse effect on cell growth, these gradients also affect the 
quality of secreted products. Glucose concentration and culture pH have both been 
shown to affect the glycosylation patterns of secreted proteins (Borys et al. 1993; 
Hayter et al. 1992). The delivery of oxygen is a particular problem and is considered 
to be the main limiting factor in cell growth and protein production (Williams et al. 
1997). hi many HFBR systems high molecular weight proteins, either introduced with 
the cell inoculum (e.g. serum) or produced by the cells (e.g. protein products) are 
unable to permeate through the fibres and accumulate within the ECS, where product 
proteins are periodically harvested. The secondary flow within the ECS transports 
these proteins to the downstream end of the bioreactor where they accumulate and 
increase the local osmotic pressure. Downstream polarization of medium proteins can
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skew cell growth in this direction and cause a decrease in bioreactor productivity 
(Piret and Cooney 1990). However, this polarisation can concentrate the product 
proteins and harvesting from the downstream ECS port can facilitate product recovery 
and purification (Koska et al 1997). One way of overcoming these gradients is the 
use of flat-bed hollow-fibre bioreactors. An example of this system is the 
Tecnomouse (Integra Biosciences, St Albans, UK). This bioreactor incorporates 
traditional hollow fibre technology with a direct oxygenation technique across a 
silicone membrane and thereby separates the aeration from the medium supply, and 
was designed for the production of antibodies from hybridomas. Typical antibody 
yields in the Tecnomouse are -1.0-2.0 mg day" 1 (Fassnacht et al. 1999). The 
Tecnomouse has also been used to culture transformed B- and T-cell lines and CHO 
cells to produce cytokines (Tzianbos and Smith 1995) and primary rat hepatocytes for 
potential use as a component of a bioartificial liver system (Bratch and Al Rubeai 
2001). However, as with conventional HFBRs scale-up can only be achieved by 
increasing the number of units.
Hollow-fibre culture has mainly been used for the culture of suspension cells. This is 
due to the fact that anchorage-dependent cells do not readily attach to the cellulose 
acetate fibres. The cultivation of such cell lines can be achieved by coating the fibre 
walls with cell attachment material, such as poly-D-lysine (Hu and Peshwa 1991) or 
by using fibres made of polypropylene (Griffiths 1988). It may also be possible to use 
microcarrier beads as a cell substratum and load these into the ECS. Williams et al. 
(1997) successfully cultured CHO Kl cells on Cytodex™ 1 microcarriers in the ECS 
of a Setec Tricentric™ HFBR cartridge (Livermore, CA), and reached a final cell 
number of 1.4 x 10 .
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1.8 Cell encapsulation
The principle of cell encapsulation was originally developed by Nilsson and Mosbach 
(1980) and Lim and Sun (1980) and is used for the large-scale production of 
monoclonal antibodies (Rupp 1985). Although suspension cells can theoretically be 
immobilised in macroporous microcarriers, in practice the cell loading capacity is 
usually relatively low due to the non-adherent nature of the cells (Hu and Peshwa 
1991). Thus, for suspension cells, such as hybridomas, it is more manageable to 
entrap cells rather than allow them to attach to solid particles. Suspended cells are 
mixed with alginate or agarose before droplets are formed to produce spherical 
particles. Alginates are naturally occurring polysaccharides extracted from seaweed, 
which have been commonly used in the biotechnology industry for numerous 
applications. In the case of sodium alginate beads, the particles are coated with 
polylysine, which provides a semi-permeable layer, allowing the transport of nutrients 
into the bead and toxic metabolites out of the bead. The sodium alginate is then 
solubilised with sodium citrate, releasing the cells into suspension. During the course 
of the culture, cells will proliferate within the capsule and produce antibodies, which 
are also retained within the structure, and very high concentrations of both can be 
achieved. A similar method is the use of calcium alginate only. This allows antibodies 
to diffuse out of the bead into the culture medium while cells are maintained within 
the capsule. Agarose beads can also be used where cells are encapsulated within a 
honeycomb matrix within the gel. However, these tend to have a wide size 
distribution and a lower mechanical strength compared to alginate gels (Griffiths
1988).
The main advantages of using alginate beads are:
• Encapsulated cells can be cultivated in conventional fermenters. Consequently, 
volumetric scale-up has greater potential than in hollow-fibre systems. 
The technology permits the cost effective production of monoclonal antibodies 
that are functional and highly purified.
The process uses materials that are well established for use in the production of 
therapeutic agents.
O 1
Cell densities of >10 cells ml" have been reported using sodium alginate beads for 
microcapsule culture, which is significantly higher than the densities achieved in 
suspension culture (Rupp 1985). Calcium alginate beads can reach densities of ~7 x 
106 cells ml" 1 with a low viability of 56% through a 46 day run (Al Rubeai et al. 
1990a).
One problem of major importance in all immobilised systems is the limited mass 
transfer rates (Al Rubeai and Spier 1989). Significant gradients of oxygen, nutrients 
and metabolites exist, resulting in uneven distribution of cell viability, metabolic 
activity and growth rate in the beads. Another disadvantage of using sodium alginate 
gels is that it is limited to batch operation with a culture time of 10-15 days. After this 
the capsules are lysed to allow the release of the product. The other methods of cell 
encapsulation do offer longer culture periods as the product is able to diffuse out of 
the bead and into the culture medium. However, it is difficult to maintain cell viability 
above 50%. These beads tend to be relatively large (0.5-lmm) which causes severe 
nutrient limitation in the centre, resulting in a necrotic region within the particle. It 
has been recommended that the bead diameter should be <0.5mm to maintain uniform 
distribution of metabolically active cells (Al Rubeai et al. 1990b).
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1.9 Cell entrapment
Whilst cell immobilisation techniques such as hollow fibre bioreactors and gel 
encapsulation allow for high cell densities and increased product formation, the 
problems associated with their scale-up and the complexity of these systems has 
limited their suitability for industrial-scale processes (Wang et al. 1992; Yamaji et al. 
1989). Originally, the alternative to these high density/low volume cultures was low 
density/high volume cultures using either suspension cells or solid microcarriers 
grown in stirred tank bioreactors. The disadvantage of these systems is that they are 
not cost effective in terms of capital expenses, time required for inoculum preparation 
and low cell densities and product titres, and cells were exposed to hydrodynamic 
forces and mechanical stresses during production, which limited cell specific product 
formation. The development of macroporous microcarriers has given manufacturers 
the option of having medium volume/high density cultures with high specific 
productivities during long-term cultivation. This immobilisation technique is passive 
in nature; cells can be seeded into a culture and will attach to the external surface of 
the carriers and grow in to the internal pores, thus being protected from mechanical 
damage caused by bead-bead collisions, bead-impeller collisions or bead-eddy 
interactions. Suspension cells can also be immobilised on macroporous carriers by 
forming aggregates within the porous structure. Hence, macroporous carriers can be 
used for both suspension and anchorage-dependent cell lines. The main advantages of 
macroporous microcarriers are summarised in Table 1.9.1.
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Table 1.9.1
Advantages of macroporous microcarriers.
Unit cell density of 20- to 100-fold higher than solid microcarriers
Support both attached and suspension cells
in situ 100-250 seed expansion reducing scale-up steps
Suitable for stirred, fluidised or packed bed bioreactors
Short diffusion paths into a sphere
Good scale-up potential
Cells protected from hydrodynamic forces and mechanical stress
Capable of long-term continuous culture
Immobilisation in 3-D configuration, which is easily derivatised
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Despite these numerous advantages some possible limitations exist. Following the 
growth of cells to tissue-like densities, the glucose consumption rate has been seen to 
decrease as a result of necrotic cores forming (Kennard and Piret 1994). Cells initially 
penetrate relatively deeply into the porous matrix. However, over time an outer shell 
of highly dense cells forms, limiting transfer of oxygen and nutrients to the centre of 
the particle (Al Rubeai et al. 1990b; Yamaji and Fukuda 1992). In addition to this, 
toxic metabolites such as lactate and ammonia are unable to diffuse out of the particle 
and CO2 production will cause a drop in the pH. Consequently, this microenvironment 
induces cell death and a necrotic core develops, reducing the overall cell density and 
viability. This decreasing viability may therefore lead to unsatisfactory product yields. 
In a study by Preissmann et al. (1997) an assessment of limiting parameters for cells 
growing on macroporous microcarriers in a fluidised bed bioreactor was carried out. 
As no significant concentration gradients could be detected oxygen transfer to and 
into the carriers was examined. They found a significant transfer resistance within the 
laminar boundary film at the surface of the carrier and 40% air saturation in the bulk 
liquid could not provide efficient oxygenation during the exponential growth phase. 
A further limitation in the use of macroporous microcarriers is in the production of 
viral vaccines. Viral production relies on the ability of virus particles to infect cells, 
replicate, and then release their progeny, usually by cell lysis. However, the 
accessibility of cells to viral infection may be a limiting factor when using 
macroporous microcarriers. Berry et al. (1999) compared the production of reovirus 
type-1 and type-3 from Vero cells cultivated on solid and macroporous microcarriers. 
Overall, the productivity in macroporous carriers was significantly lower than that 
from solid microcarriers and was likely to be due to the inaccessibility of entrapped
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cells. They also concluded that the maximum cell yields were significantly lower 
when compared to values determined for solid microcarrier cultures. 
There are currently a large number of macroporous microcarriers available which 
have been developed for stirred tank, packed-bed and fluidised bed bioreactors. The 
production of biologies within these bioreactor systems is described in Table 1.9.2.
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Table 1.9.2
Characteristics of commercial macroporous microcarriers and their mode of use.
Microcarrier Manufacturer Matrix Cell lines used
Cultisphere G Percell Biolytica Gelatine
Cytoline
Cytopore
Fibra-cel
Immobasil
Siran
Amersham
Pharmacia Biotech
Amersham
Pharmacia Biotech
Bibby Sterilin
Polyethylene and silica
and polypropylene
Ashby Scientific Silicone rubber
Microsphere Verax Corp. Collagen
Schott Glasswerke Glass
CHO
CHO
Hybridoma
Cross-linked cotton cellulose CHO
BHK
Polyester non-woven fibre CHO
Hybridoma
BHK
Vero
FLYRD
CHO
HEK 293
BHK
Hybridoma
FLYRD
CHO
Hybridoma
CHO
Hybridoma
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1.9.1 Stirred Tank Bioreactors
Although many alternatives have been developed, the traditional stirred tank 
bioreactor has emerged as industry's technology of choice (Chu and Robinson 2001). 
The attractiveness of stirred tank bioreactors stems from their simplicity and ease of 
monitoring and controlling scale-up. Although they are commonly used for 
suspension cell culture, the use of macroporous microcarriers means that the same 
bioreactors can be used for immobilised anchorage-dependent cell lines. Suspension 
cells can also be entrapped within macroporous beads to increase the cell density. 
These cells are less dependent on attachment factors and Xiao et al. (1999) reported 
that the serum concentration could be reduced to as little as 0.1% to grow hybridomas, 
which are normally grown in 5-10% serum. This is an important consideration with 
respect to downstream processing and culture economics.
A typical characteristic of stirred tanks, and a major concern in animal cell technology, 
are the high mechanical forces that exist within the vessel. Not only are cells 
subjected to hydrodynamic forces from agitation when attached to solid microcarriers, 
but they are also vulnerable to high levels of energy released by bubble burst. 
Macroporous microcarriers may offer protection from these elements, provided that 
cells are able to migrate towards the centre of the particle. Many fibroblasts can move 
as fast as one centimetre a day on a smooth surface (Hu and Peshwa 1991) but the 
internal surface of these matrices is rarely flat or smooth and is quite tortuous for cells. 
However, once cells are protected from external forces the mixing of the stirred tank 
can be increased. This creates a completely homogeneous environment and allows for 
a greater oxygen and nutrient transfer rate to the immobilised cells (Xiao et al. 1999), 
resulting in high cell densities that range between 1 and 6 x 107 cells ml" 1 microcarrier 
(Hu et al. 2000; Kennard and Piret 1994; Yamaji and Fukuda 1994), depending on
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cell line and microcarrier used. Figure 1.9.1 shows CHO cells that have been grown to 
a high density on Immobasil FS microcarriers.
It has been observed that a decrease in specific growth rate occurs when immobilised 
suspension and anchorage dependent cells are grown in stirred tank perfusion cultures 
(Wagner et al. 1992; Yamaji and Fukuda 1994). Growth suppression has been proved 
to enhance antibody production in hybridoma cells. Therefore, immobilisation of cells 
may improve protein synthesis in stirred tank bioreactors. Certainly, the high cell 
densities can produce high yields of product. Stirred tanks have been used in the 
production of membrane anchored recombinant proteins, urokinase-type plasminogen 
activator, prourokinase, IgG and IgA monoclonal antibodies and vesicular stomatitis 
virus (Hu et al. 2000; Kennard and Piret 1995; Nikolai and Hu 1992; Schweikart et al. 
1999; Xiao et al. 1999; Yamaji and Fukuda 1997).
The most appealing aspect of stirred tank bioreactors is the ease at which they can be 
scaled up in excess of 4000 litres, and this is undoubtedly why they have been so 
extensively used in industry. However, the inoculum density required is relatively 
high (when compared to microbial cultures). This problem is further increased when 
anchorage dependent cells are used if they have to be trypsinised at each step of the 
scale-up process. It has been shown that bead to bead cell transfer is possible with 
cytopore microcarriers (Xiao et al. 1999). A scale-up ratio of more than 20 was 
achieved meaning that only three scale-up steps are necessary for a 1000 1 culture. 
This discovery has made the use of macroporous microcarriers a viable option for the 
commercial production of recombinant products from genetically engineered cells.
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Figure 1.9.1
Scanning electron micrograph of CHO cells immobilised on Immobasil FS
macroporous microcamers.
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1.9.2 Fluidised bed bioreactors
The most widely used culture system for porous microcarriers is the fluidised bed 
bioreactor (Kratje and Wagner 1992). The principle of their operation is that 
microcarriers of higher density than the culture medium are suspended by the upward 
flow of the medium, which is circulated through the bed. The height of the bed will 
increase as fluid flow increases. Medium circulation and fluid flow through the bed 
are achieved by using either a peristaltic pump or agitation. The advantage of this 
system is that carriers are separated from direct aeration and agitation, which avoids 
local high shear forces. In addition, fluidised bed bioreactors provide a very high mass 
transfer interface since both cells and fluid are moved (Preissmann et al. 1997) 
making it a suitable production system for larger scales.
Earlier studies into the potential of fluidised bed reactors for the production of 
biologies focussed on the use of porous glass beads. These studies conducted by 
Kratje and co-workers examined the potential of fluidised bed reactors as production 
systems using hybridomas suspension cells and anchorage dependent baby hamster 
kidney cells for the production of interleukin-2 (Kratje et al. 1994; Kratje and Wagner 
1992). In these studies, cell densities of 3.8 x 108 cells ml" 1 intrasphere volume were 
reached, whilst the IL-2 production rate was 0.75 mg I" 1 day" 1 . In spite of the cell 
density being over 18-fold higher, the productivity showed a 1.9 fold decrease when 
compared to a homogeneous stirred culture. The difference was assumed to be caused 
by cells changing their production characteristics during long-term cultivation. This 
phenomenon had previously been reported in hybridomas cells (Frame and Hu 1990). 
An alternative reason is that, unlike hybridoma cells, specific cell productivity is 
related to specific growth rate. . It has been shown by Leelavatcharamas et al. (1994) 
that there is a linear relationship between the production of interferon-7 and the
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specific growth rate of CHO cells. Therefore, in long-term cultures where the cells 
remain in the stationary phase over an extended period, productivity will be low as the 
specific growth rate is essentially zero.
Another substrate for the immobilisation of cells grown in fluidised bed bioreactors is 
polyethylene and silica microcarriers, such as Cytoline (Amersham Pharmacia 
Biotech, Sweden). These have been successfully used in the production of 
recombinant human proteins, especially human interferon-y, and erythropoietin 
(Goldman et al. 1998; Wang et al. 2002). These microcarriers have been specifically 
designed for use in the Cytopilot fluidised bed bioreactor and have proved to offer 
great potential for the production of biologies. Kong et al. (1999) compared CHO cell 
cultures in this system with solid microcarrier culture in a stirred tank bioreactor and 
reported that the product output rate was approximately three times higher in the 
fluidised bed, with the specific production rate being 5.5 times higher. The volumetric 
productivity of the stirred tank reached 5.6 mg I" 1 day" 1 during the growth period. 
However, after the maximum cell density was reached the volumetric productivity 
dropped and was maintained around 1.65 mg I" 1 day" 1 . In contrast, the Fluidised bed 
bioreactor maintained a consistent volumetric productivity of 22.8 mg I" 1 day" 1 . It was 
suggested that the isolated aeration and agitation in the fluidised bed bioreactor 
reduced the amount of hydrodynamic and mechanical stress imposed on the cells. 
Thus, more cellular energy was utilised in product formation, resulting in the higher 
and more consistent productivity. The total product yield was reported as 34.2 mg 
day" 1 and 13.2 mg day" 1 for the 2 litre fluidised bed bioreactor and the 10 litre stirred 
tank bioreactor, respectively.
When comparing the number of cells in each square meter of microcarrier surface 
area the Fluidised Bed Reactor was five times lower than the stirred tank reactor. This
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shows that there is further potential to increase the cell number and improve the 
productivity of the system. In order to unlock this potential it is necessary to ascertain 
the limiting factor for growth and how to overcome this limitation. Investigations 
carried out by Preissmann et al. (1997) determined that the transport of oxygen to 
cells within the macroporous matrix cultivated in a fluidised bed bioreactor was 
severely limited, leading to poor process performance. Although no limitations in 
nutrient concentration were detected, the beads were not believed to be an ideal 
substrate to grow cells to tissue like densities.
Efficient glycosylation is an important factor in the development of a bioprocess 
production method. The existence of gradients that cause decreases in dissolved 
oxygen, nutrients or pH may have implications for product quality, as well as cell 
densities. In a recent study, the relative proportion of glycosylation site occupancy for 
interferon-7 was not seen to change over time during a 500 hour culture. Hence, it was 
concluded that long-term perfusion cultures of CHO cells in a fluidised bed bioreactor 
could produce IFN-7 with a consistent and highly comparable degree of glycosylation 
(Goldman et al. 1998). Further studies, carried out by Wang et al (2002), have also 
examined the productivity and quality of erythropoietin (EPO) from a recombinant 
CHO cell line, cultured in a Cytopilot fluidised bed bioreactor. EPO is particularly 
vulnerable to a decline in sialylation due to the extensive level of glycosylation and 
heterogeneity. It was therefore important to show that the glycosylation profile of 
EPO in the Cytopilot did not differ from other culture systems. Results have shown 
that no difference was observed in electrophoretic product profiles between fluidised 
bed, stirred tank and stationary cultures. In addition, the significantly higher 
productivity rate in the fluidised bed bioreactor, when compared to stirred tank
34
reactors, makes it an attractive option for the large-scale production of recombinant 
proteins.
A potential problem that has been observed during the long-term cultivation of cells 
in medium containing 10% foetal calf serum is the clumping of carriers. This 
clumping causes a reduction in bed height, which requires increased agitation and 
fluid flow to maintain sufficient fluidisation. The reason for carriers clumping is not 
fully understood but it may be due to cell bridging. This is an incident usually 
associated with solid microcarriers, where cells become simultaneously attached to 
two beads, thus creating a bridge. A possible means of overcoming this problem is to 
reduce the concentration of serum used in the process. This could be done step wise 
during the course of the experiment if serum is necessary for cell attachment and 
growth in the initial stages. The clumping of carriers has not been observed to have an 
adverse effect on productivity. It does, however, limit the duration of the process as 
excessive clumping has an adverse effect on reactor performance.
1.9.3 Packed bed bioreactors
Packed bed bioreactors have been used for the cultivation and production of a wide 
range of cell lines and biologies. Some recent examples include monoclonal antibody, 
anti-leukaemic factor from stromal cells, recombinant proteins (e.g. recombinant Ca2+ 
binding receptor and HIV-1 gp!20), and retro virus vectors for use in gene therapy 
(Hu et al. 2000; Kadouri and Zipori 1989; Kang et al. 2000; Kaufman et al. 2000; 
Merten et al. 2001; Wang et al. 1992). Since the initial conception of packed-bed 
bioreactors for the production of biologies in the 1970's, they have grown in 
acceptance and their potential as a viable system for commercial manufacture of 
animal cell products. Stirred tank and fluidised bed bioreactor systems have been 
scaled up in excess of 1000 litres and have been widely used in industrial processes
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(Cong et al. 2001). However, at high cell densities, cells detach from the carriers and 
along with cell debris cause complications in product purification during downstream 
processing. Packed bed bioreactors have the advantage that they are capable of 
generating high cell densities with a low concentration of free cells in suspension. 
This is possible due to the low shear forces present in the system. Cells are 
immobilised within porous carriers that may be porous ceramic beads (Park and 
Stephanopoulos 1993), porous glass beads (Chiou et al. 1991), or polyester disks (Hu 
et al. 2000; Kang et al. 2000; Wang et al. 1992), which are packed and retained in a 
cylindrical vessel through which culture medium is re-circulated. As mentioned 
earlier, a characteristic problem in intensive production systems is the reduced 
transport rate of limiting nutrients, such as oxygen to immobilised cells, which 
restricts their final density. Packed bed technology has overcome this problem by the 
use of intraparticle convective flow. Through the development of a simple 
hydrodynamic model based on the Blake-Kozeny equation, Park and Stephanopoulos 
(1993) significantly enhanced the transport of oxygen in a packed bed, allowing the 
maintenance of cell viability and productivity whilst sustaining a low shear 
environment. In their evaluation of the model they achieved cell densities of 5.1 x 
108cells ml" 1 . They also calculated the specific insulin productivity to be 0.88 x 10"5 
uU cell" 1 hour" 1 . The model developed allows packed bed bioreactors to be scaled-up 
several-fold before oxygen becomes limiting. Any oxygen limitations that do occur 
primarily exist close to the bioreactor exit. Another recent development to overcome 
this problem has been to provide oxygenation to the bed through silicone tubing. This 
simple but effective method has been used for the successful culture of hepatocytes 
and the production of retrovirus particles from the human packaging cell lines, 
FLYRD18 and TEFLYRD (McTaggart and Al Rubeai 2000).
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An alternative system is the Celligen® packed-bed bioreactor, developed by New 
Brunswick Scientific Co. (New Jersey, USA). Conventional packed beds require a 
conditioning vessel to control culture parameters such as temperature, dissolved 
oxygen and pH. The culture medium is circulated through the packed bed and the 
product may be concentrated and continuously or periodically harvested from the 
conditioning vessel for prolonged periods. An important parameter in the optimisation 
of these arrangements is the circulation rate; if the rate is too low then gradients in pH, 
nutrients and metabolites will appear along the bed affecting cell viability, 
productivity and product quality, as can be seen in hollow fibre bioreactors (Thelwell 
and Brindle 1999). If the circulation rate is too high it may have an adverse affect on 
cell attachment or product formation. This problem is eliminated in the Celligen® 
packed bed bioreactor by the fact that the bed is contained in a basket within a stirred 
tank bioreactor. Mixing in the bioreactor is achieved with either a cell-lift impeller, 
which allows bubble-free medium to flow through the packed bed (Wang et al. 1992) 
or a double screen concentric cylindrical cage impeller. Shi et al. (1992) have shown 
that the latter impeller is able to increase convective mass transfer, cell concentration 
and MAb product concentration. The significant improvements in oxygen transfer rate, 
cell density and product concentration were attributed to the increased surface area 
allowing for convective oxygen transfer and protection of cells from hydrodynamic 
stresses. Both methods create a homogeneous environment for cells to grow and 
product can be directly removed from the culture vessel, which allows for easier 
downstream processing and product purification.
One drawback of large-scale packed bed bioreactors using anchorage-dependant cells 
is the generation of seed stock. Cultures are commonly inoculated at a density of 2 x 
105 cells ml" 1 of bed volume, which could be as high as 20 litres in a 100 litre vessel at
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commercial scale. Scale-up is typically done from monolayer cultures using either T- 
flasks or roller bottles due to difficulties in harvesting cells from macroporous 
microcarriers and low cell densities achieved from solid microcarrier culture. Thus, 
while the production culture may be simple and cost effective the scale-up steps may 
be less economical and susceptible to contamination. In a recent study, a method has 
been devised whereby cells are scaled-up on Cytopore macroporous microcarriers and 
the carriers are directly inoculated into the packed bed bioreactor, alleviating the need 
to detach cells from the carriers (Cong et al. 2001). Using this method, it was possible
*7 1
to achieve a cell density of 2 x 10 cells ml" bed volume and thrombopoietin 
production was 1.3-1.8 mg I" 1 day" 1 , compared to 0.76-1.1 mg I" 1 day" 1 for 
macroporous microcarrier perfusion culture. Cultures were maintained in excess of 30 
days.
A further disadvantage of packed bed bioreactors is the inaccessibility of carriers, 
making it difficult to monitor viable cell number. Cellular metabolism can be 
followed by online measurements of pH and dissolved oxygen and offline 
determinations of glucose, lactate, ammonia and glutamine. The substrate uptake rates 
and production rates are conventionally used as cell growth markers (Rodrigues et al. 
1999). As cell concentration generally has a linear correlation with glucose uptake 
rate at high cell densities it is possible to calculate the former from the latter (Former 
et al. 1994). However, the yield coefficient is not a true constant and will vary for 
each cell line and for each bioreactor system. Therefore, it should be determined 
before being used to estimate cell number. Alternatively, cell number can be 
determined through measuring the oxygen uptake rate (OUR). By placing oxygen 
probes upstream and downstream of the packed bed and measuring the percentages of 
dissolved oxygen, it is possible to determine the OUR, which can be directly
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correlated with cell number. The density of cells within an immobilised culture is an 
important parameter for many purposes including calculation of the specific 
productivity of a system.
1.10 Summary
Gene therapy has revolutionised the practice of medicine to treat patients with 
inherited or acquired diseases (Mountain 2000). The delivery of functional genes to 
host cells means it is now possible to correct dysfunctional genes or invoke an 
immune response. A number of gene delivery vehicles exist, either viral or non-viral. 
Non-viral vectors are considered safer than viral vectors but are susceptible to 
extracellular degradation and have very low transduction efficiencies. In contrast, 
viruses have evolved into extremely efficient vectors for gene transfer. Current 
research is investigating the use of retro-, adeno-, adeno-associated, herpes and alpha 
viruses as gene therapy vectors. Of these, retroviruses comprise >60% of the current 
clinical trials. Retroviruses are appealing because they are able to permanently insert 
their viral sequence into the cell genome without any adverse effect on cellular 
growth or function.
Retroviral vectors are generated by deleting the helper gene sequences from the viral 
genome and replacing them with a therapeutic gene and a selectable marker. The viral 
proteins, gag, pol and env are produced in packaging cells, which contain plasmids 
expressing their genes. Vector particles assemble within the producer cells and are 
continuously released into the supernatant through budding. Packaging cells are 
unable to produce viral particles unless they have been infected with the vector as 
they do not contain the ¥ packaging sequence or LTRs. Research into the molecular 
biology of retrovirus systems has largely overcome the problems associated with low 
viral titres, inactivation by complement in human serum and the generation of RCR
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through recombination. However a number of biochemical engineering challenges 
remain and there is an urgent need to transpose production of clinical grade vectors 
into bioreactor systems.
Traditional stirred tank reactors using suspension cells are still the preferred choice of 
biopharmaceutical production in the biotech industry. However, due to the relatively 
low cell densities, immobilised cell cultures are growing in interest for the production 
of high value biologies such as gene therapy products. Immobilised cultures offer 
many advantages such as near tissue cell densities leading to higher productivity, 
increased specific production rates, separation of products from cells, improving the 
efficiency of the downstream processing, serum concentration can be reduced making 
the process more economical and immobilisation techniques can be used for both 
suspension and anchorage-dependent cells.
A number of systems can be used in the production of biologies from immobilised 
cell cultures. The advantages and disadvantages of these systems are summarised in 
Table 1.10.1.
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Table 1.10.1
Advantages and disadvantages of cell immobilisation systems for the production of 
biopharmaceutical products from animal cells.
Production 
System
Advantages Disadvantages
Hollow Fibre 
Bioreactor
Alginate Beads
Stirred Tank 
Bioreactor
Fluidised Bed 
Bioreactor
Packed bed 
Bioreactor
>108 cellmr
200-300 fold increase in
product 
Reduced serum concentration
Uses conventional fermenters 
Cost effective 
Uses materials well
established in biotech
industry
Simple to operate 
Cells protected from
mechanical stresses 
Growth suppression leads to
enhanced productivity 
Scale-up >1000 litres 
Carriers separated from
agitation and aeration 
Consistent volumetric
productivity
Consistent product quality 
Good scale-up potential 
Generate and retain high cell
densities 
Intraparticle flow restricts C>2
limitations
Poor cell viability
Diffusion gradients exist
Limited scale-up
Difficult to culture anchorage- 
dependent cells
Limited mass transfer rates
Sodium alginate beads limited to 
batch culture
Cell viability <50%
Lower cell concentration 
compared to other systems
Unable to support high 
microcarrier density
Specific productivity reduced in
some cell lines
Oxygen limitations may occur 
Carriers clump at high serum
concentrations
Difficult to directly measure cell 
density
Difficult to generate anchorage- 
dependent cells for inoculation
41
1.11 Aims and objectives
To enable the optimisation of a bioreaction process in animal cell culture, the process 
has to be designed so as to fully exploit the biological potential of the cell. This is 
done through maximisation of viable cell number and improvement of the medium 
formulation. Manipulation of the physical environment, by altering the mode of 
bioreaction and/or the bioreactor system, is the basic method for improving cell 
number (Leelavatcharamas et al. 1994). In this study, retrovirus production was 
predominantly examined in semi-continuous and perfusion cultures. A selection of 
microcarriers was assessed with regard to their potential as a cell substrate for 
immobilised culture and a number of bioreactor systems were evaluated. These 
included stirred tank bioreactors, packed bed bioreactors and fluidised bed bioreactors. 
Finally, the composition of culture medium, and the initial concentration of serum 
was analysed, and growth and production kinetics were determined by mathematical 
modelling.
The overall objective of this thesis was to propose an economical, efficient and 
scalable process that could be implemented by Oxford BioMedica for the production 
of their MetXia® gene therapy product.
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CHAPTER 2: GENERAL MATERIALS AND METHODS
This chapter describes the materials and methods that were used throughout this 
research work. Details of specific protocols are given, where appropriate, in 
individual chapters.
2.1 Cell Lines
2.1.1 TEFLYRD/83
The TEFLYRD packaging cell line was constructed from the TE671 cell line 
(Takeuchi et al. 1994). The transfected cell line contained two plasmids; the first 
expresses the Moloney murine leukaemia virus (MoMLV) gag-pol gene and the 
second expresses the env gene originating from the cat endogenous virus, RD114. 
TEFLYRD cells were used by Oxford BioMedica to construct the TEFLYRD/83 cell 
line. In brief, the cells were transfected with a third plasmid containing the 
G418/neomycin resistance gene (as a selectable marker), the LacZ gene and the 
MetXia-P450 gene. The MetXia-P450 gene encodes the MetXia® therapeutic protein 
which is a potential treatment for a range of solid tumours. In recent phase I/II clinical 
trials it was shown that MetXia® was capable of reducing the size of tumours and that 
it may also elicit an anti-tumour immune response, destroying other tumours in the 
same patient (Kan et al. 2001).
2.1.2 HT1080
The human fibrosarcoma HT1080 cell line (ATCC CCL-121) was kindly donated by 
Oxford BioMedica (Oxford, UK). These was used as the target cells to measure
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retro virus particles with the LacZ titration assay (see 2.5 Measurement of Lac Z 
Containing Retroviral Vectors).
2.2 Recovery and Maintenance of Cells
2.2.1 Cell Freezing
A cell bank was created and stored in liquid nitrogen. The cells were passaged as 
described in 2.2.3. After the cells had been trypsinised they were centrifuged at 1000 
rpm for 5 minutes. The supernatant was discarded and the pellet was resuspended in 
70% Dulbecco's Modified Eagle Medium (DMEM) (Gibco Life Technologies, UK), 
20% Foetal Calf Serum (PCS) (PAA Laboratories, UK), and 10% Dimethyl 
sulphoxide (DMSO) (Sigma, UK). The cell suspension was alloquoted into 1 ml 
cryotubes. These were placed in a freezing container, containing iso-propanol, and 
stored in a freezer at -80°C. The iso-propanol allowed the temperature to drop by 1°C 
every minute, preventing the formation of crystals that would kill the cells. After a 
minimum of 90 minutes the cells were transferred from the -80°C freezer to liquid 
nitrogen.
2.2.2 Cell Revival
The cells were removed from liquid nitrogen and defrosted at room temperature. They 
were added to 10 ml of DMEM + 10% PCS in a sterile universal tube and centrifuged 
for 5 minutes at lOOOrpm. The supernatant was discarded and the pellet resuspended 
in 10 ml of DMEM + 10% PCS. Cells were counted by removing lOOjul of suspension 
and adding 0.5% trypan blue at a ratio of 1:1. The cells were counted under a 
microscope using a heamocytometer counting chamber. They were then inoculated 
into T-flasks at a concentration of 2 x 104 cells cm"2 . For 25 cm2 and 75 cm2 T-flasks
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the total volume of medium was made up to 10 ml and 20 ml, respectively. After 24 
hours the medium was removed and replaced with fresh medium.
2.2.3 Cell Maintenance
Cells were routinely maintained in 75 cm2 tissue culture flasks (T-flasks) with 20 ml 
of DMEM containing 4.5 g I" 1 of glucose, supplemented with 10% (v/v) PCS, and 100 
RJ ml"1 penicillin streptomycin (Gibco Life Technologies, UK) to prevent bacterial 
contamination. The cells were passaged twice weekly.
Cells were passaged using standard trypsinisation methods. In brief, medium was 
removed from T-flasks and the cells were washed with sterile phosphate buffered 
saline (PBS). Cells were detached by treating with trypsin-EDTA (Gibco Life 
Technologies, UK) for approximately 5 minutes. Once the cells had detached from the 
surface of the flask DMEM + 10% PCS was added to neutralise the trypsin. T-flasks 
were seeded with the cell solution at an appropriate density and the total amount of 
medium was made up to a suitable volume. The flasks were incubated at 37°C in a 5% 
COi atmosphere.
2.3 Preparation of Microcarriers
Cytoline 1 and Cytoline 2 microcarriers were supplied by Amersham Pharmacia 
Biotech (Upsala, Sweden), Fibra-Cel™ microcarriers were obtained from Bibby 
Sterilin (UK) and Immobasil-FS carriers were provided by Ashby Scientific Ltd. 
(UK). The specifications of these microcarriers are described in Table 2.1.
Table 2.1
Technical specifications of microcarriers.
Matrix
Cytoline 1
Polyethylene 
and silica
Cytoline 2
Polyethylene 
and silica
Fibra-Cel
Polyester non- 
woven fibre &
Immobasil-FS
Silicone 
rubber
Average particle Thickness: 
size (mm) 0.5-1
Length: 1.7-
2.5
Schematic 
representation
As Cytoline 1
polypropylene 
(50/50) 
Diameter: 6.0 Diameter: 0.8 
Depth: 0.25
Ba"B8
1.7-2.5mm 0.8mm
6mm
Anticipated 
fluid flow
Approximate 
surface area 
(m2 g- 1 ) 
Pore diameter
>0.3 0.12
10-400 10-400 50-150
* Fluid may enter the larger pores (>200um) where may be cells exposed to shear forces. Fluid is not 
expected to enter smaller pores, and a microenvironment is expected to form.
t Huid is not expected to penetrate the densely woven fibres. However, forced convection in a packed 
bed assists the transport to and from the disc.
# Fluid does not enter pores. A microenvironment forms and transport of virus particles into the 
medium may be hindered.
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2.3.1 Cytoline 1 & 2
The preparation of Cytoline 1 and Cytoline 2 microcarriers was identical. To the 
desired amount of microcarriers twice the volume of double distilled water was added 
and the mixture was autoclaved for 10 minutes at 121°C (1 bar). The distilled water 
was removed from the mixture and replaced with twice the amount of fresh double 
distilled water. The mixture was stirred for approximately 10 minutes. The double 
distilled water was removed and the process repeated three times. After the third wash 
and equal volume of 0.1 M NaOH was added to the microcarriers. The mixture was 
incubated overnight at room temperature. The mixture was washed 3-4 times with 
double distilled water to remove all the alkali. The microcarriers were transferred to 
the culture vessel and autoclaved in double distilled water for 30 minutes at 121°C (1 
bar). The double distilled water was removed aseptically, and replaced with culture 
medium. The mixture was incubated overnight under culture conditions to allow the 
microcarriers to equilibrate.
2.3.2 Fibra-Cel™
The desired amount of discs was placed in the culture vessel and PBS was added. The 
vessel was sealed and autoclaved at 121°C, 1 bar, for 30 minutes. The PBS was 
aspirated and growth medium was added to the vessel to cover the carriers. The 
carriers were incubated under culture conditions for a minimum of 24 hours to allow 
equilibration and to check for sterility. Immediately prior to inoculation the medium 
was removed.
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2.3.3 Immobasil-FS
Immobasil-FS carriers were supplied ready hydrated by the manufacturer. The 
required volume of beads was added to the culture vessel with an equal volume of 
double distilled water. The carriers were autoclaved at 121°C, 1 bar, for 30 minutes. 
Following sterilisation, the DD water was removed and the carriers were equilibrated 
for at least 24 hours in growth medium under culture conditions, and to verify 
sterility. Before inoculation the equilibration medium was removed and discarded.
2.4 Monitoring of Cell Growth and Cell Adhesion
2.4.1 Counting of Attached Cells in Tissue Culture Flasks
Cells were detached from the flask surface as described in 2.2.3 Cell Maintenance. A 
lOOjal cell suspension was removed and stained with an equal volume of trypan blue 
solution (0.5% w/v at 1:1 dilution). Viability was determined using the dye exclusion 
test. Viable cells (unstained) and non-viable cells (stained) were counted under a 
microscope using a heamocytometer chamber.
2.4.2 Measurement of metabolic parameters
The glucose consumption and lactate production were determined by measuring the 
concentration in fresh and exhausted medium. The concentration of glucose in the 
culture supernatant was determined using a GLUCOTREND® (Roche, France) test 
strip kit as per the manufacturer's instructions. Lactate was measured using the 
Biolyser Rapid Analysis System (Eastman Kodak Co., USA). A lOul sample was 
added to a slide containing the appropriate reagents and the relative concentration was 
determined as per the manufacturer's instructions.
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2.4.3 Estimation of cell number using an MTT Assay
The MTT assay (Mosmann 1983) is a sensitive, quantitative and reliable colorimetric 
method of estimating viable cell number. The assay is based on the capacity of 
mitochondrial dehydrogenase enzymes in living cells to convert the yellow water- 
soluble substrate 3-(4,5-dimethyliazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) 
into a dark blue formazan product, which is insoluble in water. The amount of 
formazan production is proportional to the number of cells in a variety of cell lines 
(Al Rubeai et al 1990; Mosmann 1983). As the assay does not require the cells to be 
in suspension it can be used to estimate cell number in microcarrier cultures where 
trypsinisation is not appropriate.
A stock solution of 5mg ml" 1 of MTT (Sigma, UK) in PBS was prepared and filtered 
through a 0.22jam filter to sterilise and remove the small amount of insoluble residue. 
This stock solution was stored at 4°C for a maximum of 1 month. A known number of 
microcarriers, typically 20-50, were suspended in 1ml of culture medium and 100 jal 
of MTT was added. The samples were incubated at 37°C for 3 hours to allow the 
MTT to diffuse through the matrices and react with the cells. The supernatant was 
removed and replaced with 1 ml of acidic iso-propanol. The samples were shaken at 
lOOOrpm for 20 minutes using a Vibramax shaker to release the formazan products 
from the microcarriers. 100 \\\ of the formazan solution was pipetted into individual 
wells of a 96 well plate and the absorbance was measured at 540nm using an Elisa 
plate reader (SLT Spectra, UK).
2.4.4 Observation of Cell Adhesion 
Fluorescence Microscopy
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Approximately 1 ml of microcarriers were placed into a 25 ml universal tube and the 
supernatant was removed. The carriers were washed once with PBS. The PBS was 
removed and replaced with acridine-orange solution (4 jig ml" 1 ). The DNA stained 
cells were observed under a fluorescent microscope.
2.5 Measurement of Lac Z Containing Retroviral Vectors
Active virus titres were assessed by either the LacZ titration assay or by real-time 
polymerase chain reaction (RT-PCR).
2.5.1 LacZ Titration Assay
The number of MetXia-P450 vector particles in a given preparation can be determined 
by their ability to transfer the lacZ gene to indicator cells, in a simple titration assay. 
Successful gene transfer and the subsequent expression of /3-galactosidase are 
assessed by X-Gal staining. At the end of the assay the number of particles in the 
preparation is expressed as lacZ transferring units per ml (LTU ml" 1 ).
Day 1: Plating HT1080 Indicator Cells
First, the number of 12 well plates required was calculated. Typically, 2-3 dilutions of
each sample were plated. Therefore:
no. of samples x no. of dilutions x no. of replicates = no. of plates
no. of wells
Each well of the 12 well tissue culture plates was seeded with 105 target cells. In order 
to ensure inter assay consistency, fresh HT1080 cells were revived from a working 
bank laid down specifically for this purpose. The cells were used within five passages 
of resuscitation. The plates were incubated at 37°C and 5% COz overnight.
Day 2: lOx Serial Dilution of Virus
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A 10-fold dilution series of the test article was made in DMEM supplemented with 
8(ig ml" 1 of polybrene (Sigma, UK) in a 24 well tissue culture plate. lOSOjal of the 
polybrene-supplemented medium was placed into each well of the plate. 120|ul of 
vector preparation was added to well Al and mixed thoroughly. 120jal was then 
transferred from well Al to well Bl; this process continued down the next 4 wells to 
create the dilution series. The diluted vector preparations were then used to transduce 
the indicator cells that were prepared on day 1. The culture medium was removed 
from the growing target cells and they were overlaid with 0.5ml of vector from the 
appropriate dilution wells. This process was carried out in duplicate. The plates were 
incubated at 37°C and 5% CC>2 for two hours before a further 1ml of fresh medium 
was added to each well. Incubation was continued for another 48 hours.
Day 4: X-Gal Staining
The medium was removed from each well and replaced with 0.5 ml of 4% neutral
buffered formalin solution (BDH Chemicals, UK). This was incubated at room
temperature for 5 minutes. The fixing solution was carefully removed and the cells
washed once with 1ml of PBS. 0.5ml of X-Gal stain was added to each well and
incubated at 37°C for 24 hours.
The X-Gal stain was prepared as required:
2ml potassium ferricyanide (Sigma, UK)
2ml potassium ferrocyanide (Sigma, UK)
lOOjil 1M magnesium chloride (Sigma, UK)
1ml 2% X-Gal solution (Alexis, UK)
It was made up to 50ml with sterile PBS.
The solutions were added in order to prevent a precipitation from occurring.
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Day 5: Cell Counting
On the fifth day the transduced cells were counted under a microscope. A single
transduction event was represented by a small cluster of blue cells, which were the 
progeny of a transduced cell that divided during the course of the assay. The value 
was obtained by counting the cell clusters in wells where the number of clusters was 
between 30 and 300.
The final titre was calculated by multiplying the mean number of clusters from 
duplicate wells by the dilution factor and then multiplying by 2 to convert to a ml, 
thus giving the number oflacZ transferring units per ml (LTU ml" 1 ).
2.5.2 Real Time PCR
Real time PCR is a reliable and rapid method for the enumeration of infectious virus 
particles. The reaction exploits the 5' nuclease activity of AmplTaq Gold® DNA 
polymerase to cleave a Taqman probe during PCR. The Taqman probe contains a 
reporter dye at the 5' end of the probe and a quencher dye at the 3' end of the probe. 
During the reaction, cleavage of the probe separates the reporter and the quencher 
dyes, resulting in increased fluorescence of the reporter. Accumulation of PCR 
products is detected directly by monitoring the increase in fluorescence of the reporter 
dye. When the probe is intact, the proximity of the reporter dye to the quencher dye 
results in suppression of the reporter fluorescence. During PCR, the probe specifically 
anneals between the forward and reverse primer sites if the target of interest is 
present. Cleavage of the probe between the reporter and quencher dyes only occurs 
when the probes hybridises to the target. The probe fragments are then displaced from 
the target, and polymerisation of the strand continues. The 3' end of the probe is
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blocked to prevent extension of the probe during PCR. This process occurs during 
every cycle and does not interfere with product accumulation.
In brief, supernatant containing retrovirus was boiled to rupture the viral envelope and 
release the RNA genome. Reverse transcriptase was added to the solution to generate 
DNA. The amount of DNA was measured by real time PCR using the Taqman probe. 
The results obtained from RT-PCR are expressed relative to some basis sample, such 
as a calibrator. Therefore, the virus titre in all experimental samples was determined 
from a standard curve, which was prepared from a known quantity of virus particles.
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Chapter 3: Fundamental characterisation of TEFLYRD cells 
and OB83 retroviral vector particles
3.1 Introduction
Preliminary experiments were conducted to determine the fundamental characteristics 
of the TEFLYRD/83 cell line and the vector particles produced before any bioreaction 
or medium modifications were performed. These studies included construction of an 
MTT calibration curve, characterisation of cells and vector production in batch culture 
and long-term semi-continuous culture at 37°C and 32°C, and the attachment and 
growth of cells on various microcarriers under static and stirred conditions. 
The results from these experiments provided a basic understanding of the packaging 
cells and the vectors they produced, which assisted in the planning of future 
experiments.
3.1.1 Microcarrier culture
Animal cells are widely used for the production of biologies including viral vaccines, 
recombinant proteins, monoclonal antibodies, hormones, interferons, and gene 
therapy vectors (Berry et al. 1999; Croughan et al. 1987; Forestell et al. 1992; Hu and 
Peshwa 1991; Nikolai and Hu 1992; Venkat et al. 1996; Yamaji et al. 1989; Zecchini 
and Smith 1999). A number of cell lines currently in use are anchorage dependent. 
One of the earliest technologies for the culture of these cells and the production of 
biologies was roller bottles (Schevitz et al. 1990). Whilst this method is fitting for 
developmental work it is not an attractive option for large-scale manufacture 
(Zecchini and Smith 1999). This is because scale-up can only be achieved by 
increasing the number of bottles, which is labour intensive and susceptible to
contamination (Butler 1 ()87). Modern facilities have overcome these problems by the
54
use of expensive robots; however, it is still not possible to control environmental 
conditions such as pH or dissolved oxygen levels (Hu and Peshwa 1991). 
Microcarriers were first described by van Wezel (1967) and offer a scalable 
alternative to roller bottles for the culture of anchorage dependent cells. They present 
a solid surface for cells to adhere to and can be easily suspended in liquid medium 
within a stirred tank reactor (Christi 1993).
The first microcarriers to be developed were solid spheres made up of cross-linked 
dextran. Others carriers have subsequently been developed using alternative materials 
such as polystyrene, cellulose, gelatine and glass (see review by Hu and Peshwa 
1991). The advantages of using microcarriers are that they offer growth-surface-to- 
reactor-volume ratios of over 100cm"1 , they allow for simple medium and cell 
separation and perfusion, they can support high cell densities (>106 cells ml" 1 ), and 
can be easily scaled-up (Croughan et al. 1987). Solid microcarriers do have some 
disadvantages, though. The spheres have a low surface-area to volume ratio, limiting 
the number of cells per bead and are vulnerable to hydrodynamic forces in the culture 
(Ng et al. 1996). The mechanisms of cell damage in microcarrier culture are primarily 
caused by collisions between beads and reactor parts, principally the impeller, 
collisions with other microcarriers and interactions with turbulent fluid eddies of the 
same size or smaller than the microcarrier diameter (Cherry and Papoutsakis 1988). In 
order to overcome these problems, macroporous microcarriers were developed. 
The concept of macroporous microcarriers was pioneered by the Verax Corporation 
and there are currently large numbers of carriers available for use in stirred tank, 
fluidised bed and fixed bed reactors (Griffiths 1992; Looby and Griffiths 1990). These 
beads have relatively large internal pores and are typically made of gelatine or 
collagen (Nikolai and Hu 1992). After inoculation, cells attach to the surface of the
carriers and then migrate inwards, eventually occupying the interior of the bead.
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Unlike solid carriers, the cells immobilised within the structure are not in direct 
contact with the fluid flow and are not thought to be prone to any mechanical damage 
caused by agitation, bead interactions, or turbulence (Hu and Peshwa 1991; Nikolai 
and Hu 1992). Due to the large internal matrix, macroporous microcarriers provide a 
greater surface area per carrier for cell expansion than solid carriers. The cell 
concentration is, therefore, potentially much higher than with conventional 
microcarriers (if a comparable amount of beads are used) or suspension cultures (Hu 
and Peshwa 1991; Nikolai and Hu 1992).
Virus productivity is dependent on several culture parameters, including the use of a 
suitable host cell and the type of microcarrier used (Berry et al. 1999). Varani et al. 
(1998) have shown that productivity is dependent upon the virus, host cell line and the 
microcarrier type. Therefore, the ideal microcarrier should i) support rapid cell 
attachment; ii) support rapid high-density cell growth; iii) not interfere with the 
secretion of products; and iv) allow cells to be easily detached if required (Varani et 
al. 1998). In this study, four microcarriers have been evaluated with regard to these 
criteria. The microcarriers used were Cytoline 1 and 2 (Amersham Pharmacia, 
Sweden), Immobasill FS (Ashby Scientific, UK) and Fibra-Cel™ (Bibby-Sterilin, 
UK).
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3.2 Materials and methods
3.2.1 MTT calibration curve
In order to determine the cell number from absorbance a calibration curve was 
constructed using TEFLYRD/83 cells. In brief, duplicate 1ml suspensions of known 
cell number, between 1 xlO6 cells ml" 1 and 1.25 x 105 cells ml" 1 , were added to 
eppendorf tubes and lOOjal of MTT was added. These were incubated at 37°C for 2 
hours. The cell suspension was then centrifuged at 10000 rpm for 2 minutes in an 
Eppendorf 5415C centrifuge. The supernatant was removed and the cells were 
resuspended in 1 ml of acidic iso-propanol. The tubes were shaken for 20 minutes at 
1000 rpm in a Vibramax shaker. 100 (J,l of the formazan solution was pipetted into 
individual wells of a 96 well plate and the absorbance was measured at 540nm using 
an SLT Spectra Elisa plate reader.
3.2.2 Batch culture of TEFLYRD/83
The typical behaviour of TEFLYRD/83 cells, with regard to cell growth and vector 
production, was assessed over a 10-day period. Monolayer cultures were established 
in several T-25 culture flasks using 10 ml DMEM supplemented with 10% PCS (as 
described in chapter 2) and were inoculated with ~6 x 105 cells. Flasks were incubated 
at 37°C with 5% CC>2. Cells were trypsinised from duplicate flasks at regular intervals 
and counted under a microscope with a heamocytometer. Viability was determined 
using the trypan blue exclusion test. The supernatant was collected and the 
concentration of glucose and lactate was measured. A 1ml sample was stored in liquid 
nitrogen for virus analysis using the LacZ titration assay at a later point. The number 
of cells per flask, glucose consumption, lactate production and virus production were
assumed to be constant under identical culture conditions.
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Data Analysis
Cell growth is a first order autocatalytic process i.e. rx = jux. Taking the time period of 
the early exponential growth phase, specific growth rate, ju, can be calculated given 
that:
dx
The specific growth rate changes in a hyperbolic fashion due to the change in glucose. 
A functional relationship between // and an essential compound's concentration, in 
this case glucose, was proposed by Monod in 1942, which states:
S
KS +S
Here famax is the maximum achievable growth rate when the substrate, S»Ks and the
concentrations of all other essential compounds are unchanged. KS is the value of the
limiting nutrient concentration when ^i = 1A jimax-
Defining a yield coefficient, YX/S , can link substrate utilisation and cell growth.
= Ax = ILK 
x/s AS AS
Af
where AS is the change in substrate concentration during cell growth and A/ is the 
time between to and t\ . However, Y, is not a true constant and must be characterisedx/7s
for different culture environments. It is useful in estimating cell number where direct 
counting is not possible (e.g. immobilised cell cultures) and in optimising cell growth.
3.2.3 Semi-continuous culture of TEFLYRD/83
The ability of TEFLYRD/83 cells to continuously produce retrovirus particles was 
assessed in a semi-continuous culture over a 21 day period. Cells were inoculated into
triplicate T-25 flasks at an initial density of 2 x 106 cells flask" 1 . Pre-warmed culture
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medium was added to each flask to give a final volume of 4.5ml. The cultures were 
inoculated at 37°C in a 5% CO2 atmosphere for 3 days. The culture medium was 
changed and the total volume was reduced to 3ml per flask. The cultures were 
incubated for a further 2 days. A complete medium change was performed and the 
total medium volume was reduced to 1.5ml per flask. The medium was subsequently 
harvested daily and 1ml of the supernatant was stored in liquid nitrogen for later virus 
titration using the LacZ titration assay. The residual glucose concentration was 
measured and the glucose uptake rate was calculated. The total medium volume was 
increased when necessary to reduce the potential for substrate limitation. At the end of 
the experiment cells were detached from the flasks by trypsin and counted as 
described in chapter 2.
3.2.4 Semi-continuous culture of TEFLYRD/83 at 32°C
The performance of TEFLYRD/83 cells with regards to cell growth and virus 
production at 32°C was assessed in a semi-continuous culture. 5 x 106cells were 
inoculated into T-75 culture flasks with 13.5ml of DMEM supplemented with 10% 
PCS. These were incubated at 37°C with 5% CC>2 for 3 days. The medium was 
removed and replaced with 9 ml of fresh medium and the temperature of the incubator 
was reduced to 32°C. The flasks were left for 2 days to adapt to the lower 
temperature. After this the media was completely removed and replaced with 4.5ml of 
fresh media. A complete medium change was performed every 24 hours for a period 
of 10 days. The glucose concentration was measured daily in order to monitor cell 
viability. A 1ml sample of the harvested supernatant was stored in liquid nitrogen and 
the virus titre was later measured using the LacZ titration assay. At the end of the 
experiment cells were detached from the flasks using trypsin and counted using a
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heamocytometer and microscope. Cell viability was determined using the trypan blue 
exclusion test.
3.2.5 Attachment and growth of TEFLYRD/83 on microcarriers
The attachment and growth of TEFLYRD/83 cells to different microcarriers was 
assessed and the final virus titre was measured. The microcarriers used were Cytoline 
1, Cytoline 2 (Amersham Pharmacia, Sweden), Immobasil FS™ (Ashby Scientific 
LTD., UK) and Fibra-Cel™ (Bibby-Sterilin, UK). 2ml of microcarriers (dry volume) 
were prepared as described in chapter 2 and placed into 100ml spinner flasks 
(Bellco™, USA). Prior to inoculation the equilibration medium was completely 
removed. 10ml of fresh culture medium was added containing exponentially growing 
cells at a concentration of 2 x 106cells ml"1 microcarrier volume. The flasks were 
placed in an incubator during the attachment phase and gently shaken every 30 
minutes to obtain uniform distribution on the carriers. A sample of supernatant was 
taken every hour and the number of cells in suspension was counted under a 
microscope using a heamocytometer. This was used to calculate the approximate 
number of attached cells. After 4 hours, culture media was added to give a final 
volume of 20 ml. A sample of microcarriers was taken and the cell density was 
determined using MTT (see chapter 2). The flasks remained under static conditions 
overnight. Agitation was started after 24 hours, for stirred cultures, at 40 rpm in a 
stirring incubator. Samples of microcarriers were taken every day and the cell density 
was estimated using MTT. Supernatant samples were taken daily and the 
concentration of glucose and lactate were measured. Cultures were run over 5 days. A 
1ml sample of supernatant was collected at the end of the culture and stored in liquid 
nitrogen for virus titration using RT-PCR.
60
3.3 Results and Discussion
3.3.1 MTT Calibration Curve
In order to evaluate viable cell numbers from the MTT assay the relationship between 
cell number and absorbance was determined. Figure 3.3.1.1 shows the calibration 
curve obtained from cell suspensions of known density.
The MTT assay is useful for estimating viable cell density in immobilised cell 
cultures where direct counting of cell numbers is not possible as trypsinisation is 
required to remove cells from the matrix. However, the assay is dependant on the 
ability of mitochondrial enzymes to convert MTT into blue formazan. Unless the 
activity of cells within the culture is constant, the amount of formazan produced per 
cell may be variable (Yamaji and Fukuda 1992). It should also be noted that the 
amount of metabolic activity varies throughout the cell cycle, which will affect the 
assay. Therefore, estimation of cell numbers from the MTT assay should only be used 
as an indication of a change in cell density or activity or as a comparison of cell 
numbers between cultures from the same batch of cells (McTaggart 2000).
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Figure 3.3.1.1
MTT calibration curve, showing the relationship between the TEFLYRD/83 cell 
number and the absorbance at 540nm. Known cell numbers were incubated with MTT 
for 2 hours before the formazan product was dissolved on acidic iso-propanol and the 
absorbance was measured at 540nm, using an SLT Spectra Elisa plate reader. Error 
bars represent standard deviation, n = 8.
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3.3.2 Batch Culture of TEFLYRD/83 cells
Batch culture of TEFLYRD/83 cells was necessary to determine how the cells 
respond to changes in nutrient concentration and metabolic by-product accumulation. 
The growth curve obtained from the batch culture of TEFLYRD/83 cells followed the 
typical trend for mammalian cells. During the first day after initiation of the culture 
there was no increase in cell number, indicating the lag phase. The cell number 
increased in an exponential fashion until day 8, representing the log or exponential 
growth phase. The mean cell number had decreased after 10 days, indicating the start 
of the death phase at which point the experiment was ended. These results are 
illustrated in Figure 3.3.2.1.
Glucose consumption of TEFLYRD/83 cells was consistent during the first 8 days of 
the batch culture. By this time the mean concentration of residual glucose had 
dropped from 22.5mM L' 1 to 0.65mM L" 1 . This depletion in glucose coincides with 
the cells entering the death phase which suggests that glucose is the principal limiting 
substrate. Lactate production was consistent with glucose utilisation. The mean 
glucose and lactate concentrations in the culture supernatant are shown in Figure 
3.3.2.2. 
The yield coefficient Yx/ was calculated over the initial 8 days of the batch culture.
'S
-iThis was deemed to be 2.18 x 10 cells g" glucose. This value is useful for estimating 
cell numbers in monolayer cultures where direct counting is not possible and the 
metabolic demand of the cells is assumed to be constant with batch cultures. 
The specific growth rate was calculated during the early exponential phase (after 1 
day, up to 6 days) for TEFLYRD/83 cells. This was calculated as 0.484 day" 1 which
corresponds to a doubling time of 2.07 days. The instant specific growth rate was
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determined and plotted against the glucose concentration, shown in Figure 3.3.2.3. 
The maximum specific growth rate was determined as 0.864 day" 1 achieved when 
glucose was >19mM L" 1 . The maximum specific growth rate was higher than values 
reported for CHO cells and PA317-RCM1 cells in batch culture (Leelavatcharamas et 
al. 1994;Wu et al 2002), but lower than values reported for the FLYRD18 human 
packaging cell line (McTaggart and Al Rubeai 2001).
The mean virus titre increased for 6 days before a sharp decrease was observed (see 
Figure 3.3.2.4). The maximum titre achieved was 3 x 105LTU ml" 1 . The virus titre 
reflects the changes in cell number, where a rapid increase in virus titre was seen 
during the exponential phase. The decrease in virus titre after 6 days may have been 
caused by two simultaneous events. Firstly, it has been previously reported that virus 
production is related to cell proliferation (Cruz et al. 2000; McTaggart and Al Rubeai 
2001). After 6 days in batch culture the increase in cell number was slight, revealing 
that cell proliferation was diminishing. This reduction would result in a loss of virus 
production by the cell population. Secondly, as virus particles are unstable they will 
decay over time(Higashikawa and Chang 2001; Kaptein et al. 1991 \ Le Doux et al. 
1999). The combination of reduced production and virus decay accounts for the 
dramatic decrease in virus titre during the closing 4 days of the batch culture. 
It may be possible to overcome the problem of the loss in infectious virus particles by 
harvesting the supernatant when the cells reach the end of the exponential phase, and 
the virus titre is at its maximum. Alternatively, in order to avoid down time between 
batch cultures and a break in production as cells reach their maximum number, a 
semi-continuous culture could be performed. This has the advantage that cells are 
maintained at a constant number and daily medium replacement reduces the risk of 
nutrient limitation or the build up of toxic metabolites. While the cells are kept in an
active metabolic state, virus particles can be produced and harvested daily, increasing
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the overall virus titre for the experiment. A semi-continuous culture could be 
performed over an extended period of time e.g. >2 weeks. Once virus is collected it 
can be stored at a reduced temperature where it will be more stable than at 37°C. In 
addition to producing the viral vectors in a semi-continuous culture, the temperature 
may be reduced to 32°C to increase the virus stability in the culture supernatant. The 
possible disadvantage of reducing the temperature may be that the metabolic activity 
of the cells would decrease and virus production would lessen. These methods for 
increasing the overall productivity of culture systems are examined in the subsequent 
sections.
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Figure 3.3.2.1
Mean viable cell number during a 10 day batch culture of TEFLYRD/83 cells in 
monolayer. Cells were inoculated into several 25cm2 T-flasks at a density of ~6 x 104 
cells ml" 1 in 10ml of culture medium, and incubated at 37°C in a 5% CC>2 atmosphere. 
Cells were detached from duplicate flasks at regular intervals and the viable cell 
number was counted using a haemocytometer under a microscope. Viability was 
determined by the trypan blue exclusion test. Error bars represent observed range, n = 
2.
66
•Glucose • Lactate
0
0 8
Time (days)
10
T 40
12
Figure 3.3.2.2
Mean residual glucose and lactate concentration during a 10 day batch culture of 
TEFLYRD/83 cells in monolayer. The supernatant was collected from duplicate 
flasks at regular intervals and the glucose was measured using the GLUCOTREND® 
glucose test kit (Roche, France) and lactate was measured using the Biolyser Rapid 
Analysis System (Eastman Kodak Co., USA). Error bars represent observed range, n 
= 2.
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Figure 3.3.2.3
Effect of glucose concentration on specific growth rate of TEFLYRD/83 cells in batch 
culture. The instant specific growth rate was calculated by fitting the Monod equation 
(page 58) to the experimental data presented in Figure 3.3.2.1. The glucose 
concentration for each respective point was obtained from Figure 3.3.2.2.
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Figure 3.3.2.4
Mean daily virus titres during a 10 day batch culture of TEFLYRD/83 cells in 
monolayer. Virus containing supernatant was collected from duplicate flasks at 
regular intervals and stored in liquid nitrogen. The virus titre was later measured using 
the LacZ titration assay. The model presented in chapter 5 was used to predict virus 
titres. The model underestimates the infectious virus titre while cells are in the growth 
phase. However, it should be noted that this model is unable to account for possible 
changes in specific production rate due to changes in specific growth rate. Error bars 
represent observed range, n = 2.
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3.3.3 Semi-continuous culture of TEFLYED/83
A semi-continuous culture of TEFLYRD/83 cells was performed in monolayer culture 
to determine its potential for virus production. Batch cultures have demonstrated that 
the cell line was capable of producing high virus titres but the number of infectious 
particles showed a dramatic decrease once cells entered the stationary growth phase. 
Daily harvesting of the supernatant with replacement of growth medium was thought 
to provide a means of overcoming the limitations observed in batch cultures. 
The experiment was run for a total of 21 days. The final cell number from triplicate 
flasks was determined as 9.94 ± 0.77 x 106 cells, which corresponds to a cell density 
of 3.97 x 106 cells ml" 1 (see Figure 3.3.3.1 ).
The glucose uptake rate (GUR) and the residual glucose concentration are shown in 
Figure 3.3.3.2. After 6 days the residual glucose was completely utilised by the cells. 
It was therefore decided to increase the medium volume to 2.0ml. However, this was 
insufficient and the volume was increased to 2.5ml after 9 days, where it stayed for 
the remainder of the experiment. The constant GUR from day 10 onwards shows that 
cells had reached a constant number and that there was no decline in the total viable 
cell number. This demonstrates the ability of TEFLYRD/83 cells to survive over long 
periods of time and their suitability for long term production of virus particles. 
The mean daily virus titres and the cumulative virus titre are recorded in Figure 
3.3.3.3. During the production phase, where the culture medium was replaced daily, 
the mean virus titre showed some variance, unlike the assumed cell number. The 
mean virus titre increased up to day 10, as did the GUR. After 10 days, though, the 
mean virus titre began to decrease, whereas the GUR remained constant, with the 
exception of the final day when the virus titre showed an increase. If the cell number 
is constant, as can be assumed from the GUR, and the rate of virus decay is also
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constant, as the culture conditions do not change, then the change in daily virus titre 
can be attributed to a change in cell specific virus productivity. The change in specific 
productivity is possibly due to the change in cell metabolism. After 10 days the cells 
reach the stationary phase, where the total cell number remains unchanged. Cells still 
proliferate but the number of cells produced is only equal to the number of cells that 
die so there is no net increase in cell number. As the cell population becomes 
established the amount of cell death may be reduced and therefore the cell 
proliferation will be reduced, leading to a decrease in virus production.. 
The cumulative virus titre was estimated to be 4.83 x 106 LTU. If it is assumed that 
during the same time period 3 batch cultures could be run then they would amass ~9 x 
106 LTU. This number is based on the ability of each batch culture to produce 3 x 106 
LTU (3 x 105 LTU ml" 1 ) over a six day period. The ability of batch cultures to produce 
a higher amount of vectors is due to the higher proliferative state of the cells as they 
are in the exponential growth phase during the initial six days of culture. In contrast, 
the maximum daily virus titre achieved in the semi-continuous culture was 1.62 x 105 
LTU ml" 1 . In addition to this, the batch cultures require a total of 30ml of culture 
medium compared to the semi-continuous cultures which utilised 45ml of culture 
medium. Although batch culture is more favourable for monolayer cultures this may 
not be true for larger scale cultures such as microcarrier cultures. In monolayer batch 
cultures a sufficient amount of medium is present to achieve a 10-fold increase in cell 
number. In microcarrier cultures a 100-fold increase in cell number may be required 
to maximise productivity and therefore medium replacement would be required. This 
experiment has shown the potential for long term cultivation of packaging cells and 
their ability to continually produce infectious virus particles.
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Figure 3.3.3.1
The initial and final viable cell number and cell density in a semi-continuous culture 
of TEFLYRD/83 cells in monolayer at 37°C. Cells were seeded into triplicate 25cm2 
T-flasks at a concentration of 2 x 106 cells flask" 1 . 4.5ml of medium was added to each 
flask before incubating at 37°C in a 5% CO2 atmosphere. After 3 days the medium 
volume was reduced to 3ml, and then to 1.5ml after 5 days. To reduce the chance of 
glucose limitation the volume of medium was increased to 2ml after 6 days and then 
to 2.5ml after 9 days. The cell number was determined at the end of the experiment by 
detaching the cells from the flask surface by trypsin digestion and counting viable 
using a haemocytometer under a microscope. Viable cell numbers were determined by 
the trypan blue exclusion test. Direct measurement of cells was not possible during 
the course of the experiment as cells were attached to the flask surface.
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Figure 3.3.3.2
The Glucose uptake rate (GUR) and residual glucose concentration in a semi- 
continuous culture of TEFLYRD/83 cells in monolayer at 37°C. The initial medium 
volume was 4.5ml. After 3 days this was reduced to 3ml and then to 1.5ml after 5 
days. The medium was changed daily from this point onwards. After 6 days the 
volume was increased to 2ml as all the glucose was fully utilised. Again, after 9 days 
the medium volume was increased to 2.5ml. The GUR was used as an indirect 
measurement of viable cell number and to monitor cell growth.
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Figure 3.3.3.3
Mean daily virus titre and cumulative virus titre for a semi-continuous culture of 
TEFLYRD/83 cells in monolayer at 37°C. From day 4 onwards the culture medium 
was changed every day and the virus titres measured 3 times per week. The 
cumulative virus titre was estimated from median values of the titres recorded from 
the day immediately before and after. Virus titres were measured using the LacZ 
titration assay. The model presented in chapter 5 was used to predict daily virus titres. 
The predicted titres were 10-fold higher than those obtained. This demonstrates that 
the mode of bioreaction will influence the specific productivity. Error bars represent 
observed range, n = 2.
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3.3.4 Semi-continuous culture of TEFLYRD/83 at 32°C
It is a well established fact that the virus decay rate is reduced at lower 
temperatures(Cruz et al 2000; Higashikawa and Chang 2001; Kaptein et al. 1997; Le 
Doux et al. 1999; McTaggart and Al Rubeai 2000; McTaggart and Al Rubeai 2002). 
In order to improve the overall productivity of semi-continuous cultures, the 
temperature was reduced from 37°C to 32°C for the production phase of the culture. 
The total viable cell number decreased over the 15 day culture. However, the cell 
density increased due to the fact that the volume of medium was reduced from 13.5ml 
to 4.5ml. The initial and final cell numbers and densities are shown in Figure 3.3.4.1. 
The glucose concentration was measured daily to monitor the cell growth and 
viability. The glucose concentration and the glucose uptake rate are shown in Figure 
3.3.4.2. There was no significant change in the daily glucose consumption rate during 
the 10 day production phase at 32°C. This suggests that the cell number was constant 
throughout. The glucose concentration did not fall below lOmM L" 1 during the 
experiment which shows that there was no glucose limitation. The final cell density 
reached was 7.6 x 105 cells ml" 1 compared to 3.98 x 106 cells ml" 1 at 37°C. Therefore, 
at 32°C growth was limited by some factor other than glucose depletion as was the 
case in all previous experiments. The change in temperature would have an effect on 
the rate of cell metabolism. More than a thousand independent enzyme-catalyzed 
metabolic reactions occur in living cells. The rate constants of many enzyme- 
catalyzed reactions are dependent on temperature (Bailey and Ollis 1986). A 
reduction in temperature from 37°C to 32°C will result in a lower enzyme rate 
constant and hence slower cell metabolism, which accounts for the reduction in cell 
density.
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The mean daily virus titres, like the glucose consumption, showed no significant 
variation over the course of the culture. The mean daily virus titre was 1.03 ±0.31 x 
106 LTU ml" 1 day" 1 , and was maintained for 10 days, as illustrated in Figure 3.3.4.3. 
The total cumulative virus titre was 4.64 x 107 LTU. The specific production rate, 
based on the final cell density and the virus titre recorded on day 15, was 0.71 LTU 
cell" 1 day"1 . The daily virus productivity showed a 10-fold increase compared to semi- 
continuous culture at 37°C.
As cell metabolism is slower at lower temperatures the virus production rate would 
also be expected to be lower. However, the reduction in temperature would increase 
the stability of virus particles, which explains the increased titres. The total amount of 
virus particles produced was significantly higher than all previous cultures, even when 
the difference in culture volume is taken into account. Therefore, a semi-continuous 
culture with a cell growth phase at 37°C and a vector production phase at 32°C 
appears to support the highest productivity for monolayer cultures. This mode of 
operation can be easily transferred to alternative methods of production.
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Figure 3.3.4.1
The initial and final viable cell number and density in a semi-continuous culture of 
TEFLYRD/83 cells in monolayer at 32°C. Cells were seeded into duplicate 75cm2 T- 
flasks at a concentration of 5 x 106 cells flask" 1 . 13.5ml of medium was added to each 
flask before incubating at 37°C in a 5% CC>2 atmosphere. After 3 days the medium 
volume was reduced to 9ml and the temperature lowered to 32°C. The medium 
volume was reduced to 1.5ml after 5 days and the medium was changed daily 
thereafter. The cell number was determined at the end of the experiment by detaching 
the cells from the flask surface by trypsin digestion and counting viable using a 
haemocytometer under a microscope. Viable cell numbers were determined by the 
trypan blue exclusion test. Direct measurement of cells was not possible during the 
course of the experiment as cells were attached to the flask surface. Error bars 
represent observed range, n = 2.
77
•Glucose uptake rate —a—Glucose concentration
0.01 -I 
0.009 -
0.008 o
2 0.007 -] 
•* ,r- 0.006 -
W V
Q. >»3 .g 0.005 H
8> 3 0.004 - 
o
_3 0.003 H 
0 0.002 
0.001 ^ 
0
8 10 12 
Time (days)
14
T 14
-- 12
-- 10
-- 8
-- 6
-- 4
c o
c o
81
0) 
(A 
O 
O
_D
O
0
16
Figure 3.3.4.2
Glucose uptake rate and residual glucose concentration in a semi-continuous culture 
of TEFLYRD/83 cells in monolayer at 32°C. The initial medium volume was 13.5ml. 
After 3 days the temperature was reduced from 37°C to 32°C and the medium volume 
was reduced to 9ml and then to 4.5ml after 5 days. The medium was changed daily 
from this point onwards. The GUR was used as an indirect measurement of viable cell 
number and to monitor cell growth. Error bars represent standard deviation, n = 4.
78
2.00E+06 i
1 .80E+06 -
•— »
^ 1 .60E+06 -
re
? 1.40E+06-
i
E 1.20E+06-
D
H 1 .OOE+06 -
o> 8.00E+05 -
4->
'•jj 6.00E+05 
.1 4.00E+05 -
^^
2.00E+05 -
n nnp-t-nn ——— 1_
1 1 Mean daily virus titre — o— Cumulative virus titre
1
I
- 1
i
im
^xx
— i—
?! 
^
i.
XX
IPi«;
^
/
i
•
1
i
I'; (•
I1'
fi
//cr
/
\
—
1
— 1_
T
-
i
/
1
tr^X^
- •
i
n
:f
— 1_
x>
t
r 5.00E+07
- 4.50E+07 ^
D
- 4.00E+07 H™^
- 3.50E+07 £
4->
h 3.00E+07 '^
3
- 2.50E+07 .t
- 2.00E+07 g
- 1.50E+07 S
3
1.00E+07 |
- 5.00E+06 °
n nnpj-nn
8 9 10 11 
Time (days)
12 13 14 15
Figure 3.3.4.3
Mean daily virus titre and cumulative virus titre for a semi-continuous culture of 
TEFLYRD/83 cells in monolayer at 32°C. A complete medium change was performed 
from day 6 onwards. 1ml of the harvested supernatant was stored in liquid nitrogen 
until the end of the experiment. The virus titre was then measured suing the LacZ 
titration assay. Error bars represent standard deviation, n = 4.
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3.3.5 Attachment and growth of TEFLYRD/83 on microcarriers
In order to facilitate the scale-up of retrovirus production, the available surface area 
for cell attachment and growth must be increased. Microcarriers offer the potential for 
high cell density cultures and can be used in a number of systems, such as stirred tank 
reactors, fluidised bed reactors and packed bed reactors.
Analysis of attachment kinetics
The rate of disappearance of cells from the supernatant follows an exponential decay 
curve, which is represented by:
where xt is the cell concentration at time t, XQ is the initial cell concentration and k is 
the attachment rate constant. This equation can be expressed logarithmically as:
- ln(*, /x0 ) = kt
Consequently, a first-order rate would be represented by a straight line from a plot of 
-ln(;t, I xQ ) vs. time with a gradient k. The value of A: was interpreted as the specific
attachment rate (hour" 1 ).
Evaluation of microcarriers for cell-bead attachment
In this study the rates of cell attachment to four different microcarriers, Cytoline 1 & 
2, Immobasil FS and Fibra-Cel™, were examined under intermittent stirring modes 
by monitoring the disappearance of cells from the supernatant. In all cases the rate of 
bead attachment was rapid with >80% of cells attaching after 1 hour and >90% 
attaching after 2 hours. The most rapid attachment was seen with Immobasil FS 
microcarriers. There was no significant difference in the rate of attachment between
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the other three carriers. The values of k were calculated from the data presented in 
Figure 3.3.5.1 by linear regression analysis and are given in Table 3.3.5.1. 
A control experiment was performed, under identical conditions, without any 
microcarriers. The number of cells in suspension did not change significantly during 
the attachment phase, showing that cell disappearance from the medium was due to 
attachment to carriers and not to attachment to the vessel walls or cell lysis. 
Furthermore, the results from the MTT assay performed 4 hours post inoculation 
confirmed that cells had attached to the microcarriers. Cell attachment was observed 
by fluorescent microscopy and the results are depicted in Figure 3.3.5.2. 
Cellular attachment occurs through electrostatic interactions (Ginsburg 1987) and 
charged surfaces support better cell attachment than carriers coated with an 
extracellular adhesion component such as collagen or fibronectin (Ng et al. 1996, 
Varani et al. 1998).The rapid attachment of cells to macroporous microcarriers is 
consistent with previous reports. It has been shown that the FLYRD18 cell line 
efficiently attaches to a variety of microcarriers within a few hours, and >80% of cells 
were able to attach to Immobasil FS carriers within 1 hour (Gerin et al. 1999a, 
McTaggart 2000). In contrast, it was reported by Merten et al. (2001) that TEFLY 
producer cells did not easily attach to solid microcarriers and had a tendency to form 
aggregates. The differences may be due to the surface properties of the carriers and 
the charge of the substrate; Cytodex solid microcarriers carry a high positive charge 
due to the N, N-diethylaminoethyl groups whereas the silica content of Cytoline and 
Immobasil carriers produces a slightly negative charge. Other factors that may effect 
cell attachment are the stirring mode (either continuous or intermittent), cell-bead 
ratio, bead concentration, culture pH or the concentration of serum (Mendon9a et al. 
1999, Ng et al. 1996, Shiragami et al. 1997).
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Table 3.3.5.1
The attachment rate constant, k, of TEFLYRD/83 cells to different microcarriers
under intermittent stirring modes in 100ml spinner flasks.
Microcarrier Attachment rate constant, k r
(hour' 1 )
Cytoline 1 1.3556 0.8898 
Cytoline2 1.3004 0.9730 
Immobasil FS 1.7945 0.9554 
Fibra-Cel™ 1.3353 0.9546
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Figure 3.3.5.1
The rate of attachment of TEFLYRD/83 cells to different microcarriers. Cells were 
inoculated at a density of 2 x 106 cells ml" 1 carrier in 10ml of culture medium. Culture 
vessels were 100ml spinner flasks containing 2ml of carriers. Cultures were stirred 
intermittently at 40rpm at 37°C and 5%CO2 . The number of attached cells was 
determined by counting the number of cells remaining in suspension and deducting 
this from the initial cell density. In a control study where no microcarriers were used, 
attachment of cells to the vessel walls, and no significant cell death was observed 
(results not shown). This implies that the disappearance of cells from suspension is 
due to attachment to the microcarriers. Error bars represent standard deviation, n = 4.
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Figure 3.3.5.2
Observation of cell attachment to Cytoline 1 (A), Cytoline (B) and Fibra-Cel™ (C) 
microcarriers Samples were stained with acridine orange and viewed under a 
fluorescent microscope 4 hours after inoculation.
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Cell growth
Cell growth was observed under static and agitated conditions to determine whether 
or not cells could withstand the effects of hydrodynamic forces within stirrer flasks. In 
Kolmogorov's theory of isotropic turbulence it is hypothesised that the energy in large 
systems cascades down through ever decreasing eddies until it reaches such small 
scales that the energy is dissipated (Thomas and Zhang 1998). The scale is usually 
characterised by a wave number, K, which is inversely proportional to the eddy size. 
Hence, the largest wave number will give rise to the smallest eddies and this is 
determined by the effects of viscous dissipation. The Kolmogorov microscale of 
turbulence, 77, is given by
where v is the kinematic viscosity of the liquid and e is the local energy dissipation 
rate. Therefore, the smallest eddy size is a function of the kinematic viscosity of the 
liquid and the local energy dissipation rate. A fluid-particle interaction is dependant 
on the relative sizes of the particles and eddies. If the eddies are larger than the 
particles they will simply entrain them and if the particle density is similar to the fluid 
there will be little relative motion and no damage. However, if the eddies are smaller 
than the particles they will be unable to entrain them resulting in a shear stress at the 
particle surface, possibly resulting in damage. This is an important consideration 
when using microcarriers as the particles are relatively big, with a diameter that 
ranges between 1mm for Immobasil FS and 6mm for Fibra-Cel™. The problem can 
be overcome by the fact that the beads have a macroporous structure. The cells will 
grow into these pores and will be protected from the hydrodynamic forces. However, 
during the early stages of the culture, immediately after attachment, cells will not have
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had the chance to migrate into the pores and will be exposed to hydrodynamic forces 
on the microcarrier surface. For this reason, the length scale, 77, was calculated for 
100ml spinner flasks with 20ml of medium to assess the potential of using stirred 
vessels for production of retroviral vectors.
The culture medium was assumed to have the same kinematic viscosity and density as 
water. The kinematic viscosity of a microcarrier culture was estimated from(Croughan 
etal. 1987)
V =
where ju f is the fluid viscosity (10~3 kg m'V1 ), pf is the fluid density (103 kg m"3), 
ps is the solid (microcarrier) density, and (/) is the volume fraction of solids (0.10). 
The values obtained are shown in Table 3.3.5.2. 
The mean energy dissipation rate, £r was calculated from
— PoN3D5
Cr T ——T V
where Po is the power number, a function of impeller Reynolds number (Re = ND2/v) 
and impeller configuration, N is the impeller speed, D is the impeller diameter and V 
is the culture volume. For Re > 1000, Po for most tissue culture systems may be 
considered constant with value 0.5 without major error (Cherry and Papoutsakis 
1988). The values used to calculate the mean energy dissipation rate were Po = 0.5, N 
= 0.667rps, D = 0.051 m, and V = 2 x 10"5 m3 . The mean energy dissipation rate was
-\ *") *2 _therefore 2.56 x 10" m s" . Consequently, the Kolmogorov microscale of turbulence 
was calculated for each microcarrier and the results are given in
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Table 3.3.5.2. The typical size of cells is 10-20um and therefore the agitation will not 
cause any direct cellular damage. However, it is assumed that the interaction of eddies 
at the microcarrier surface will cause cell detachment, resulting in death. For this 
reason, the cultures were left for 24 hours post attachment to allow the cells to migrate 
into the microcarrier pores where they would be protected from surface detachment 
before stirring was started.
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Table 3.3.5.2
Physical parameters of microcarrier cultures in 100ml spinner flasks containing 20ml 
of culture medium.
Microcarrier Density, ps 
(g ml' 1 )
Kinematic 
viscosity, v 
(m2 s' 1 )
Microscale of 
turbulence, rj
Cytoline 1 
Cytoline 2 
Immobasil FS 
Fibra-Cel™
1.32
1.03
1.065
1.04
1.308 xlO'b 
1.346xlO'6
1.341 x 10-6
1.345x10-6
172
176
175
176
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TEFLYRD/83 cells were grown on Cytoline 1 microcarriers in spinner flask cultures 
under static and stirred conditions. As seen from Figure 3.3.5.3, cells did not appear to 
have a lag phase under either condition. As expected the cell number was identical 
after 1 day in both sets of cultures as agitation had not begun. After 2 days the cell 
number in stirred flasks was slightly lower than in static flasks, although the 
difference in cell density was relatively small. After 3 days the cell density had shown 
a sharp decrease in both cultures. This shows that cell death had not been caused by 
agitation but in both cases a limiting factor was present. Glucose concentrations were 
measured (results not shown) and had not been exhausted. Therefore, some other 
limiting factor that had not been measured was present, such as low dissolved oxygen 
or glutamine concentration, or a build up in toxic metabolites such as lactate or 
ammonia, or a substantial decrease in pH due to CC>2 production. 
Cell growth on Cytoline 2 carriers showed similar characteristics (see Figure 3.3.5.4). 
No lag phase was observed in the cultures and cell density was not significantly 
different after 1 day. The cell density in stirred cultures increased after 2 days but was 
not as great as in static cultures suggesting that agitation may have had an effect on 
cell growth. As with Cytoline 1 carriers, the cell density declined after 3 days in 
stirred cultures. However, cell density in static cultures did not change significantly 
during the following 2 days suggesting that cell growth was limited but the culture 
was able to maintain the cell density.
As with the Cytoline carriers, no lag phase was observed in cell growth on Immobasil 
FS microcarriers. Cell densities were similar after 1 day for stirred and static cultures. 
After 2 days the viable cell density in stirred cultures had fallen by approximately 
80%, as can be seen in Figure 3.3.5.5. The cell density in static cultures had continued 
to increase, though. This suggests that cells had largely remained on the outside of the
particles and had not grown into the pores. Hence, when agitation had begun a large
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proportion of the cells had been detached from the carriers resulting in the decline in 
viable cell density. After this initial drop in cell density the cells recovered slightly but 
after 4 days the density was only about 50% of the density 4 hours after inoculation. 
Cells in static culture did increase in number over the course of the experiment and 
did not show any decrease although their growth rate decreased after day 3. This 
shows that cells can attach and grow on Immobasil FS carriers but they may not be 
suited to stirred cultures.
Cell growth on Fibra-Cel™ discs was not as rapid as the other beads, as illustrated in 
Figure 3.3.5.6. There was no significant difference in cell density between stirred and 
static cultures after 2 days and this only increased by 2-fold. After 3 days the cell 
density under both culture conditions had increased. The increase was greatest in 
stirred cultures. This trend lasted to the end of the experiment. This implies that 
agitation was necessary for nutrients to diffuse into the structure of the discs. Under 
static conditions the mass transfer to cells was slower resulting in a reduction in 
growth rate.
The highest cell density achieved was 2.06 x 107 cells ml" 1 carrier, using Cytoline 2 
microcarriers under static conditions. This was a ten-fold increase in cell number 
achieved after 3 days and showed a maximum specific growth rate of 1.075 day" 1 . 
Under stirred conditions the maximum cell density achieved was 1.55 x 107 cells ml" 1 
carrier, using Cytoline 1 microcarriers. The specific growth rate was 0.820 day" 1 . 
Fibra-Cel™ discs and Cytoline 2 beads had similar maximum cell densities of 1.16 x 
107 cells ml" 1 carrier and 1.23 x 107 cells ml" 1 carrier, respectively, and their specific 
growth rates were 0.503 day" 1 and 0.743 day" 1 , respectively. Immobasil FS had the 
lowest cell density under stirred conditions, reaching 3.26 x 106 cells ml" 1 carrier after 
4 days.
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Figure 3.3.5.3
Mean viable cell number during a 5 day batch culture of TEFLYRD/83 cells in 100ml 
spinner flasks (working volume 20ml) on Cytoline 1 microcarriers under stirred 
(40rpm) and static conditions. The flask impeller had a diameter of 51mm. Error bars 
represent observed range, n = 2.
91
3.00E+07 -,
2.50E+07 -
>, Is 2.00E+07
±s -z
(/) ^
® Jf 1.50E+07
"55 «-
0 §. 1.OOE+07
5.00E+06 -
O.OOE+00
0 0.5
Stirred - —o— Static
1.5 2 2.5 3 
Time (days)
3.5 4.5
Figure 3.3.5.4
Mean viable cell number during a 5 day batch culture of TEFLYRD/83 cells in 100ml 
spinner flasks (working volume 20ml) on Cytoline 2 microcarriers under stirred 
(40rpm) and static conditions. The flask impeller had a diameter of 51mm. Error bars
represent observed range, n = 2.
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Figure 3.3.5.5
Mean viable cell number during a 5 day batch culture of TEFLYRD/83 cells in 100ml 
spinner flasks (working volume 20ml) on Immobasil FS microcarriers under stirred 
(40rpm) and static conditions. The flask impeller had a diameter of 51mm. Error bars 
represent observed range, n = 2.
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Figure 3.3.5.6
Mean viable cell number during a 5 day batch culture of TEFLYRD/83 cells in 100ml 
spinner flasks (working volume 20ml) on Fibra-Cel™ microcarriers under stirred 
(40rpm) and static conditions. The flask impeller had a diameter of 51mm. Error bars 
represent observed range, n = 2.
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Virus production
On the final day of the experiment, samples of the supernatant were taken from each 
spinner flask and the virus titre was measured using RT-PCR. The results are 
presented in Figure 3.3.5.7. No significant difference was seen between stirred and 
static cultures, which imply that agitation has no affect on virus production. As shown 
in, the microscale of turbulence in spinner flask cultures was -175 um. Therefore, 
there would be no interaction between the fluid and the cell surface during viral 
budding, and thus no damage or premature cleavage of virus particles. Once the virus 
particles were in suspension they would not be damaged by eddies but entrained by 
them.
The virus titres obtained from Cytoline 1 and 2 were much smaller than those 
obtained from Immobasil FS or Fibra-Cel™. This can be attributed to the fact that the 
cell number peaked after 2-3 days for these cultures. As can be seen from batch 
cultures of TEFLYRD/83 in section 3.3.2, when the cells enter the death phase the 
virus titre shows a significant decrease. After 4 days the level of virus production 
from these cultures would be greatly reduced and it is expected that the titres would 
be lower than for Immobasil FS or Fibra-Cel™ where the cells were actively growing. 
This is reflected in the apparent specific production rate.
The apparent specific production rate was calculated based on final cell number and 
the virus titre. The results are presented in Table 3.3.5.3. The results obtained are 
higher than those reported by Cruz et al. (2000), who produced retrovirus from PA317 
cells, using Cultisphere-S macroporous microcarriers in 125ml stirred cultures. The 
virus titres are also higher than those recorded by Gerin et al. (1999a), where the 
FLYRD18 cell line was cultivated under similar conditions but using Cultisphere-G 
and Cytopore 1 microcarriers. This suggests that the TEFLYRD packaging cell line is
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well suited to microcarrier culture. The productivity was higher in stirred cultures 
than static cultures for all microcarriers. A common problem with macroporous 
microcarriers is that virus particles are unable to enter the free supernatant to be 
harvested. Instead they remain within the matrix where they decay, leading to an 
overall reduction in productivity. Hence, virus production may be higher from solid 
microcarrier cultures even though cell densities are lower than in macroporous 
cultures (Berry et al 1999, Wu et al 2002). The higher productivity observed in 
agitated cultures may not be due to increased cell specific production but an 
improvement in product transport into the free supernatant. Therefore, intraparticle 
fluid flow is an important factor in the design of any virus production system.
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Table 3.3.5.3
The apparent specific production rate for TEFLYRD/83 cells in different microcarrier 
cultures under static and stirred conditions.
Microcarrier Specific production rate Specific production rate
under static conditions
(LTU cell' 1 )
under stirred conditions
(LTU cell' 1 )
Cytoline 1 
Cytoline 2 
Immobasil FS 
Fibra-Cel™
0.601
0.098
3.683
4.589
0.686
0.434
8.670
4.726
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Figure 3.3.5.7
Mean final virus titres a batch culture of TEFLYRD/83 cells in 100ml spinner flasks 
(20ml working volume) using different microcarriers. Cells were attached to carriers 
(2ml carrier volume) and cultivated for 4 days under either static or stirred conditions 
(40rpm). Supernatant was harvested on the 5 th day and the virus titre was measured 
using RT-PCR. Error bars represent observed range, n = 2.
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3.4 Conclusions
hi this chapter the fundamental characteristics of the TEFLYRD/83 cell line have 
been studied to facilitate the optimisation of viral vector production. Monolayer 
cultures were carried out to determine the optimal mode of operation. From these 
experiments it is apparent that semi-continuous cultures offer the ability to produce 
infectious virus particles over long periods of time. The total virus production is less 
than that observed in batch cultures; however, a reduction in temperature to 32°C 
during virus production resulted in far superior titres being obtained. Therefore, the 
ideal mode of operation for alternative culture systems would be a semi-continuous 
culture with a cell growth phase at 37°C, followed by a production phase at 32°C, 
once cells had reached maximum density.
Porous microcarriers offer great potential for high density, long term cultivation of 
anchorage dependent cells. It has been shown that TEFLYRD/83 cells rapidly attach 
to various types of carrier and can be successfully cultivated in static and stirred 
cultures. Virus production is enhanced by agitation within the vessel, as this allows 
for effective transport between the internal and external environments. Of the four 
microcarriers that were tested, Fibra-Cel™ offered the greatest potential with regard 
to virus titre and specific cell productivity. However, this microcarrier may not be 
suitable for all applications due to its geometry. In the case of stirred tank and 
fluidised bed reactors, Cytoline 1 microcarriers should be used. In these experiments, 
this carrier supported rapid cell growth, which became limited after 3 days. This 
unfortunately led to a sub-optimal final virus titre. It is thought that this microcarrier 
is capable of sustaining high virus productivity under the correct culture conditions.
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Chapter 4: Alternative Bioreactor Systems for Retroviral Vector
Production
4.1 Introduction
Recombinant retro viruses are currently used in the majority of gene therapy trials 
(Kang et al. 2000; McTaggart and Al Rubeai 2001 ;Wu and Ataai 2000; Wu et al. 
2002). The advantages of these vectors are that they can be easily manipulated in 
vitro, the vector integrates stably into the host chromosome without any apparent 
pathogenicity, a wide range of target cells can be infected, and reasonably large genes 
can be inserted into the vector (Kirn et al. 2000). However, the disadvantages of this 
system are that target cells must be actively dividing for vectors to enter them (Smith 
1995) and their titres are relatively low, usually in the region of 107 particles ml" 1 for 
roller bottle cultures. Another limiting factor is the short half life, which is in the 
range of 2-8 hours at 37°C (Higashikawa and Chang 2001; Kaptein et al. 1997; Le 
Doux et al. 1999; Merten et al. 2001). For these reasons it is necessary to have a 
system capable of supporting a high cell density and a high specific productivity. Cell 
immobilisation within macroporous microcarriers has proved to be an effective 
method for cultivation of anchorage dependent and suspension cell lines, and of 
intensifying production of a number of biologies. In particular, packed bed bioreactors 
have shown great promise for the production of retroviral vectors (Kang et al. 2000; 
Merten et al. 2001). It has also been shown that virus titres can be greatly improved 
by reducing the culture temperature to 32°C (Cruz et al. 2000; McTaggart and Al 
Rubeai 2000). The reduction in temperature influences virus titre in two ways; firstly 
it is able to influence the specific production rate, although this is a weak function of 
temperature. Secondly, virus particles are more stable at lower temperatures so they
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will not decay as rapidly at 32°C as they do at 37°C, enabling higher titres to be 
attained (Le Doux et al. 1999).
In this chapter, the potential of three alternative culture systems have been compared 
with roller bottles; the spinner basket packed bed bioreactor, a packed bed bioreactor 
with internal silicone tubing to allow efficient oxygen transfer within the bed, and a 
microcarrier culture in spinner flasks. To overcome the problem of the short vector 
half-life a two-stage culture method was used. The first stage is a cell propagation 
phase where the culture temperature is 37°C. Once cells were considered to be 
confluent, based on glucose consumption, the temperature was reduced to 32°C for 
the production of virus particles.
Alternatively, high virus titres may be attainable by using perfusion culture. Cells are 
retained in the culture vessel at 37°C while active virus particles are constantly 
removed and transferred to a harvest vessel at a lower temperature to reduce virus 
decay. This has the advantage that cells will remain at their optimal temperature and 
metabolism will not be hindered, leading to a higher production rate, and virus 
particles will not be affected by medium components that may be present at 32°C, 
such as proteoglycans, and have an adverse affect on their transduction efficiency. 
Therefore, four systems were tested in perfusion mode; a stirred tank bioreactor, a 
packed bed bioreactor with internal silicone tubing, a fixed bed bioreactor, and a 
fluidised bed bioreactor.
4.2 Materials & Methods
4.2.1 Semi-continuous culture at 32°C
In the previous chapter it was concluded that the most efficient mode of producing 
infectious virus particles was semi-continuous culture, with a cell growth phase at
37°C and a production phase at 32°C. This method was used to compare three
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scaleable systems to roller bottle culture and assess their potential for large-scale 
production. The systems that were evaluated were microcarrier culture in spinner 
flask, a packed bed bioreactor, and a spinner basket culture.
Roller Bottle Culture
Cells were harvested from T-150 culture flasks for seeding into roller bottles (Falcon). 
Each roller bottle was inoculated with a total of 6.8 x 107 cells in 150ml of pre- 
warmed culture medium. The bottles were incubated at 37°C on a roller bottle rack, 
running at 0.25 rpm. After 24 hours the roller bottle rotation speed was increased to 
0.5 rpm. The cells were incubated for a total of 3 days at 37°C to allow them to grow 
to confluence. On the fourth day a complete medium change was performed and the 
volume was reduced to 100ml. The temperature was reduced to 32°C. The cells were 
incubated for 2 days to acclimatise to this temperature. A complete medium change 
was performed on the fifth day and the volume was reduced further to 50ml. A daily 
medium change was performed for the following 10 days. Virus-containing culture 
supernatant was harvested daily and stored in liquid nitrogen for later measurement of 
the virus titre by RT-PCR. The glucose concentration in the supernatant was measured 
daily in order to monitor cell viability and growth. At the end of the experiment cells 
were washed with PBS and detached from the roller bottles using trypsin, and counted 
using a heamocytometer under a microscope to determine the final cell number.
Microcarrier culture in 100ml Spinner Flasks
The producer cells were cultured on 10ml Immobasil FS microcarriers (Ashby 
Scientific, UK) in 100ml spinner flasks (Bellco™, USA) with 90ml of culture 
medium. Microcarriers were prepared as described in 2. The flasks were inoculated 
with 50ml of culture medium containing 2 x 106 cells ml" 1 of microcarrier of
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exponentially growing cells. The flasks were placed in an incubator during the 
attachment phase and gently shaken every 30 minutes to obtain uniform distribution 
of cells on the carriers. A sample of supernatant was taken every hour and the number 
of cells in suspension was counted under a microscope, using a haemocytometer, to 
estimate the number of attached cells. After 4 hours, culture media was added to give 
a total final volume of 100ml. A sample of microcarriers was taken and the cell 
density was estimated using MTT (see chapter 2) to ensure that the disappearance of 
cells from the supernatant was due to attachment to the carriers. The flasks remained 
under static conditions overnight in a humidified incubator with 5% COi at 37°C. 
Duplicate flasks were stirred at 40 rpm using a magnetic stirrer. Samples of 
microcarriers were taken at regular intervals and the cell density was estimated using 
MTT. The residual glucose concentration was measured daily and medium was 
changed when required to maintain the glucose concentration above Ig/L. The 
cultures were incubated at 37°C until the cells reached the stationary phase. A 
complete medium change was performed and the temperature was lowered to 32°C. 
Cells were incubated for 2 days to acclimatise. A daily medium change was 
performed for the following 10 days. Virus-containing culture supernatant was 
harvested at regular intervals and stored in liquid nitrogen for later measurement of 
the virus titre by RT-PCR.
Packed bed bioreactor
The packed bed bioreactor (PER) was filled with 5g of Fibra-Cel™ discs (Bibby 
Sterilin, UK). The vessel was assembled as a closed system with a 250ml Duran bottle 
(Figure 4.2.1.1). The discs were prepared by circulating PBS through the bed, using a 
peristaltic pump, to hydrate them for several hours before the complete system was 
autoclaved at 121V, 1 bar pressure for 30 minutes. Under sterile conditions the PBS
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was completely removed and replaced with 200ml of culture medium. The vessel was 
placed in an incubator at 37°C and air + 5% CC>2 gas was used to aerate the bed. The 
medium was circulated through the packed bed for a minimum of 24 hours to 
equilibrate the Fibra-Cel™ discs. The PER was inoculated with 2.5 x 107 cells via the 
top port. Cells attached within 2 hours, after which medium re-circulation was 
commenced. The vessel was incubated at 37°C and aerated with air + 5% 
Glucose was measured on a regular basis and the medium was changed every few 
days in order to maintain the glucose concentration >lg/L. Once the cells had reached 
steady state a complete medium change was performed and the temperature was 
reduced to 32°C. The cells were incubated for two days to acclimatise before the 
production phase was started. During retrovirus production medium was changed 
daily over a period of 10 days, and the supernatant was stored in liquid nitrogen 
before measuring the virus titre by RT-PCR. The cell number was determined at the 
end of the culture by using an MTT assay.
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Figure 4.2.1.1
Photograph of the packed bed bioreactor system (A) and schematic of the 
experimental set-up (B). Medium contained in the reservoir bottle was circulated 
through the packed bed by means of a peristaltic pump. An internal silicone tube was 
used to supply air + 5% CO2 to cells immobilised within 5g (50ml) Fibra-Cel ™ discs 
in the packed bed.
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Spinner basket culture
The spinner basket (New Brunswick Scientific, USA) was assembled for bubble-free 
aeration according to the manufacturer's instructions, with lOg (equivalent to 100ml 
bed volume) of Fibra-Cel™ discs packed in the basket (Figure 4.2.1.2). Prior to 
autoclaving at 121°C, 1 bar pressure for 30 minutes, 400ml of PBS was added to the 
vessel. All following procedures were performed within a laminar flow cabinet to 
maintain sterility. The PBS was removed and replaced with 400ml of culture medium 
to equilibrate the carriers. The spinner basket was incubated overnight at 37°C and 
aerated with air + 5% CC>2. The total cell number required for inoculation was 5 x 107 
cells. After removing the equilibration medium the cell suspension was added to the 
vessel and fresh medium was added as required to give a total working volume of 
500ml. The flask was placed on a magnetic stirrer within an incubator at 37°C and 
aerated with air + 5% €62- Residual glucose was monitored and the medium was 
changed as necessary to ensure the concentration was >lg L"1 . Once the cells had 
reached steady state (typically 7-8 days) a complete medium change was performed 
and the temperature was reduced to 32°C. The cells were acclimatised for two days 
before the production phase was started. During the production phase, medium was 
changed daily for a period of 10 days, and the supernatant was stored in liquid 
nitrogen before quantifying the virus titre with RT-PCR. Spent medium was also 
analysed for glucose consumption and lactate production. The cell number was 
determined at the end of the experiment by using an MTT assay.
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Figure 4.2.1.2
Photograph of the spinner basket (A) and schematic of the experimental set-up (B). 
Cells were immobilised on Fibra-Cel™ discs within the basket. Virus particles were 
secreted into the culture medium as it was circulated through the bed by an up- 
pumping impeller
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4.2.2 Comparison of Perfusion Culture Systems
An alternative method, and possibly a more effective approach for producing high 
titre virus stocks, might be to develop perfusion culture systems that rapidly remove 
newly formed virus particles from the high temperature cell culture vessel, where 
particles rapidly lose their activity, to a low-temperature vessel where viruses are 
more stable (Le Doux et al. 1999).
Stirred Tank Bioreactor Perfusion Culture
Cytoline 1 microcarriers were prepared as previously described and 100ml were 
added to a 1 litre (working volume) stirred tank bioreactor (LSL Biolafitte, France) 
with 900ml of PBS. The complete system (see Figure 4.2.2.1) was autoclaved at 
121°C, 1 bar for 30 minutes. Following sterilisation the PBS was drained into the 
waste bottle and 900ml of culture medium was added to the vessel to equilibrate the 
microcarriers for a minimum of 24 hours. The culture set points were: temperature 
37°C; DO2 50%; pH 7.0; agitation speed lOOrpm.
Prior to inoculation the medium was removed from the vessel. The vessel was 
inoculated with 1-2 x 106 cells ml" 1 microcarrier. Cells were prepared in T-flask 
cultures. When the required numbers of cells were available, the cells were detached 
by trypsin digestion and suspended in culture medium. Medium was added to give a 
final volume of 1 L. The culture was agitated at lOOrpm for 3 minutes every 30 
minutes for 4 hours to allow uniform distribution of cells on the microcarriers. The 
system was left under static conditions for 24 hours before stirring was commenced at 
lOOrpm.
Samples were taken at regular intervals and the glucose was measured to check cell 
viability. The perfusion rate was adjusted to maintain the glucose concentration above
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-11 g L" in the bioreactor. Samples of the supernatant were stored in liquid nitrogen and
the virus titre was measured at a later time using the LacZ titration assay.
Medium in
Probes; pH, DO2 , Temp Gas out
Gas blender
Figure 4.2.2.1
Schematic diagram of the experimental set up of the stirred tank perfusion culture. 
100ml of Cytoline 1 microcarriers were suspended on 900ml of culture medium. The 
stirred tank was fitted with a six-bladed Rushton turbine. The culture set pints were: 
temperature 37°C; pH 7.0; DO2 50%; agitation speed lOOrpm.
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Packed Bed Bioreactor Open Perfusion Culture
The packed bed bioreactor was prepared as described in section 4.2.1 with the 
exception that the downstream tube from the bioreactor vessel was connected to a 
separate harvest bottle outside of the incubator. The medium reservoir was connected 
to a bioreactor control system to control the upstream culture conditions as shown in 
Figure 4.2.2.2. The culture set points were as follows: temperature 37°C; DO2 75%; 
pH 7.0. These were assumed to stay constant between the medium reservoir and the 
vessel inlet.
Samples were collected downstream of the packed bed and the glucose was measured 
at regular intervals to monitor cell growth and determine the perfusion rate. 
Supernatant was periodically collected and stored in liquid nitrogen for virus 
measurement using the LacZ titration assay at a later stage.
Fixed Bed Bioreactor Perfusion Culture
The fixed bed bioreactor system (BioEngineering, Germany) consists of the fixed bed 
compartment, containing 1.5g Fibra-Cel™ discs, within a vessel for conditioning the 
medium (see Figure 4.2.2.3). Following sterilisation at 121°C at 1 bar for 30 minutes, 
culture medium was added to the vessel and recirculated through the fixed bed to 
allow the discs to equilibrate for at least 24 hours. This medium was drained and the 
vessel was inoculated with 2 x 105 cells ml" 1 medium of exponentially growing cells. 
Medium recirculation was initiated after 3 hours at a rate of 1ml min' 1 . This was 
gradually increased to 5 ml min" 1 over the next 5 days.
The medium in the conditioning vessel was sampled at regular intervals and the 
residual glucose concentration was measured. Samples of the supernatant were stored 
in liquid nitrogen and the virus titre was measured at a later time using the LacZ
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titration assay. The perfusion rate was set according to the demand of the cells and 
glucose was maintained above Ig I" 1 .
Fluidised Bed Bioreactor Perfusion Culture
Prior to the start of the experiment, 300 ml of Cytoline 1 microcarriers (Amersham 
Pharmacia Biotech) were prepared as described in chapter 2. The carriers were 
transferred to the fluidised bed bioreactor (Cytopilot mini; Amersham Pharmacia 
Biotech) and 1 litre of distilled water was added. The complete system was sterilised 
for 30 minutes at 121°C, 1 bar pressure in an autoclave. Using sterile technique, the 
medium tank and the harvest vessel were connected to the fluidised bed bioreactor. 
The water was removed from the bioreactor via the sampling port and replaced with 2 
litres of pre-warmed culture medium. The pH was adjusted to 7.0 and the dOi to 40- 
50% saturation. The microcarriers were left overnight to equilibrate. 
The culture was inoculated with 2 x 106 cells ml" 1 microcarrier. Cells were prepared in 
T-flask cultures. When the required numbers of cells were available, the cells were 
detached by trypsin digestion and suspended in culture medium. Cells were required 
to be in the exponential phase. The fluidised bed bioreactor was drained of the 
equilibrium medium and the inoculum bottle was connected to transfer the cells to the 
vessel. The bioreactor was filled to the working volume (2 litres) with fresh culture 
medium. To enable a uniform distribution of cells on the carriers, the fluidised bed 
bioreactor was run in packed bed mode at 100 rpm with fluidisation of the bed for 10 
seconds every 30 minutes at 150 rpm. This was repeated for 3 hours. After 3 hours a 
sample of supernatant was taken and the cells in suspension were counted using 
trypan blue exclusion test and a heamocytometer under a microscope. This was used 
to determine the number of cells that had attached to the carriers. The carriers were
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fluidised at 350rpm to give 100% fluidisation. The perfusion rate was adjusted to 
maintain the glucose concentration above 1.5g L" 1 .
Samples were taken at regular intervals and the glucose concentration was measured 
to determine the perfusion rate. Cell growth was monitored by calculation of the 
glucose uptake rate. Samples of the supernatant were stored in at -80°C before virus 
titration using the LacZ titration assay.
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Figure 4.2.2.2
Schematic diagram of the experimental set-up of the open perfusion packed bed 
culture system. The packed bed was filled with 5g Fibra-Cel™ discs and placed in a 
37°C incubator. The culture set points for the conditioning vessel were: temperature 
27°C; pH 7.0; DO2 75%.
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Figure 4.2.2.3
Schematic diagram of the experimental set up of the fixed bed perfusion bioreactor. 
The fixed bed was filled with 15ml of Fibra-Cel™ discs. Medium was circulated 
between the conditioning vessel and the fixed bed at a maximum flow rate of 5 ml 
min"1 . The set points were: temperature 37°C; DO2 50%, pH 7.0. The temperature of 
the vessel was control by circulating water through an external jacket from a water 
bath.
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Figure 4.2.2.4
The schematic diagram of the experimental set up of the fluidised bed bioreactor. 
Medium was circulated through the bed by a magnetically driven axial flow impeller. 
The culture set points were: temperature 37°C; pH 7.0; DC>2 50%; impeller speed 
350rpm.
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4.3 Results and Discussion
4.3.1 Comparison of semi-continuous culture systems at 32°C
The three systems tested, the spinner flask with Immobasil FS microcarriers, the 
spinner basket from New Brunswick Scientific and the packed bed bioreactor (PER) 
with Fibra-Cel™ discs, were compared to roller bottle production. From these it could 
be clearly shown that the TEFLYRD producer cells responded differently to the 
environmental conditions in each system. In the PER and the Spinner basket, the ratio 
of medium:discs was kept the same. The performance of these reactors was evaluated 
with regard to final cell density, maximum virus titre, daily vector production, and 
average specific production rate. As it was not possible to determine the cell number 
in immobilised cultures directly, the cell growth and viability during the experiment 
was determined by the Glucose Uptake Rate (GUR). The GUR (g day" 1 ) was 
calculated as follows:
where [S]o and [S] t are the glucose concentration (g I" 1 ) at time, 0 and time, t, 
respectively, and V is the medium volume (litres). From this it was possible to 
estimate the specific production rate in each system. Each system was run as a semi- 
continuous culture with a complete medium change performed every day during the 
production phase. The culture parameters are summarised in Table 4.3.1.1.
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Table 4.3.1.1
Cell growth and retrovirus production parameters for semi-continuous cultures at 
32°C in various culture systems.
Roller Spinner
bottle basket
Packed bed Spinner flask
Bioreactor
Type of carrier
Initial cell number
(xlO6 cells)
Final cell number
(xlO6 cells)
Medium volume
(ml)
Carrier volume
(ml)
Maximum virus titre
None
68
Fibra-Cel™ Fibra-Cel™ Immobasil-FS
50 25
239 680 550
50 400 200
N/A 100 50
(LTUmr'day 1 )
Average daily virus 1.48 x 107 3.44 x 106 9.24 x 106
production rate
(LTU ml'1 day'1 )
Total virus production 7.4 xlO9 1.38 x 1010 1.8 x 1010
20
41.1
90
10
1.95x 107 6.92 x 106 1.21 x 107 5.25 x 10e
4.56 x 1(T
4.56 x 10s
Specific virus 
production rate
4.09 0.778
(LTU cell' 1 day")
3.23 0.867
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4.3.2 Cell growth and metabolic trends
Roller bottle culture is currently the preferred method for the production of clinical 
grade retrovirus particles. From these experiments, it was possible to achieve a final 
cell density of 4.8 x 106 cells ml" 1 . For 850cm2 roller bottles with 50ml of culture 
medium, this is equivalent to 2.8 x 105 cell cm"2 . This density is consistent with 
monolayer cultures in T-flasks. During the production phase the glucose uptake rate 
was calculated as being 0.167 - 0.183 g day" 1 (see Figure 4.3.2.1) and the residual 
glucose concentration after 24 hours was ~0 mM. This demonstrates that glucose was 
the limiting factor, not surface area, as can be seen from Figure 4.3.2.2, and that the 
cell number achieved was the maximum that could be supported by 50ml of culture 
medium.
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Figure 4.3.2.1
Mean glucose uptake rate (GUR) for TEFLYRD/83 cells in roller bottle culture. Cells 
were cultured at 37°C for the first 3 days before the temperature was reduced to 32°C. 
The culture medium was changed daily from day 5 onwards. Error bars represent 
observed range, n = 2.
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Figure 4.3.2.2
The residual glucose concentration for TEFLYRD/83 cells in roller bottle culture. A 
complete medium change was performed during the virus production phase (day 5 - 
15) when the culture temperature was at 32°C. The figure shows that glucose was 
completely utilised by the cells and limiting from day 8 forwards. Error bars represent 
observed range, n = 2.
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Of the three alternative systems that were tested, the highest final cell number was 
achieved in the spinner basket. This system was capable of supporting 6.8 x 108 cells. 
This is equivalent to a cell density of 6.8 xlO6 cells ml" 1 carrier. However, the PER
o
produced 5.5 x 10 cells but its total bed volume was half that of the spinner basket. 
Therefore, the cell density in this system was 1.1 x 107 cells ml" 1 carrier. In the 
spinner basket and PER, an equal ratio between medium volume and bed volume was 
used. During the production phase the maximum GUR in these systems was 0.684g 
day" 1 and 0.686g day" 1 , respectively (see Figure 4.3.2.3 and Figure 4.3.2.5). The yield 
coefficient for these systems was calculated as follows:
_ cell number
x/s ~ GUR
Q 1 fiBased on the final cell density and the relative GUR, Y / was 10 cells g" and 8x10
7s
cells g" 1 for the spinner basket and the PER, respectively. The GUR is determined 
from the change in glucose, which is considered to be the primary energy source for 
the culture, and is represented by AS. As glucose serves as both carbon and energy 
source its utilisation can be fully written as:
\L^ ) \f-^J )assimiiation \/-**J /growth energy y-^J Jmaintenance energy
While the change in substrate due to assimilation is relatively constant the overall 
yield coefficient is not. Cells that are in the exponential phase will consume glucose 
for assimilation and growth energy, whereas cells in the stationary phase will 
consume glucose for maintenance energy as growth rate is essentially zero (Bailey 
and Ollis 1986). It was assumed that during the production phase the cells had reached 
the stationary phase and glucose was therefore consumed for maintenance. The higher 
yield coefficient in the spinner basket implies that more maintenance energy was 
required to sustain cell viability. This is caused by an increase in environmental stress
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to cells. In a bioreactor this is commonly due to deprivation of glucose, serum, 
glutamine, essential amino acids and exposure to toxic metabolites such as ammonia 
and lactate. It may also be a reaction to changes in pH or oxygen limitation. In more 
severe cases this will lead to the cell engaging in a biochemical pathway comprising 
of a protease cascade, which leads to the induction of a range of enzymes which are 
responsible for the death and destruction of the cell (Fassnacht et al. 1999). This form 
of programmed cell death is known as apoptosis and is a common cause of cell 
density restrictions in industrial processes.
A common characteristic of packed bed bioreactors is the limitation of either nutrient 
or oxygen transfer rate. Over the 24 hour period between medium changes, the 
amount of residual glucose in the spinner basket did not fall below 5.5mM as 
illustrated in Figure 4.3.2.4. Therefore, a limitation in the supply of nutrients was not 
believed to be the reason for the increased maintenance energy. The dominant 
mechanism for supply of oxygen to immobilised cells in packed beds is intraparticle 
convective flow (Park and Stephanopoulos 1993). The extent of this is controlled by 
(i) the bead size, which determines the fraction of the fluid flow rate passing through 
the particle pores and (ii) the medium flow rate through the packed bed. Hence, a 
linear relationship exists between the flow rate through the packed bed and the total 
number of viable cells in the packed bed. Fluid flow through the spinner basket 
packed bed was achieved with a magnetically driven down-pumping axial flow 
impeller, with a stirring speed of SOrpm. Thus, it can be concluded that the type of 
impeller and/or the agitation speed were the cause of the relatively low cell number. 
The parameters used were unable to provide an oxygen transfer rate capable of 
supporting cell densities higher than 6.8 x 106 cells ml" 1 , which is only 35% of the 
density achievable according to the manufacturer's reports and other published data
(Merten et al. 2001; Shi ct al. 1992; Wu and Ataai 2000). The oxygen transfer rate
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was also believed to be the cause of the increase in maintenance energy compared to 
the PER. Hence, cell number could be significantly improved by modifications in 
mixing regime.
In contrast, the PER was believed to offer a more conducive environment for cell 
growth, resulting in a lower level of required maintenance energy. Fluid flow through 
the packed bed was achieved using a peristaltic pump. Hence the flow rate was 
sufficiently high enough to provide good transfer rates of nutrients to the cells by 
convective flow. Efficient oxygenation was also achieved by the internal silicone 
tubing in the bed. This prevented the appearance of gradients in the bed and helped to 
maintain a homogenous environment. The limitation in cell number was attributed to 
complete glucose consumption. The residual glucose in the medium reservoir fell as 
low as 1.4mM between medium changes as can be seen in Figure 4.3.2.6. There are 
two ways in which this limitation could be overcome. The first is to increase the 
frequency of the medium changes as suggested for the spinner basket. The alternative 
is to increase the volume of the medium reservoir. This is an option that is not 
available for the spinner basket as the packed bed is contained within the medium 
reservoir. Alternatively, these systems could be operated as continuous perfusion 
cultures where the medium feed rate could be adjusted according to the GUR of the 
cell population.
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Figure 4.3.2.3
Glucose uptake rate (GUR) for TEFLYRD/83 cells in the Spinner basket packed bed 
bioreactor (New Brunswick Scientific). Cells were cultivated at 37°C for 7 days 
before the temperature was reduced to 32°C. Culture medium was changed daily 
thereafter and virus containing supernatant was stored in liquid nitrogen.
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Figure 4.3.2.4
The residual glucose concentration in duplicate cultures of TEFLYRD/83 cells in 
spinner basket culture. Medium was changed after 4 days, 7days and daily after 9 
days in order to prevent glucose from limiting cell growth.
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Figure 4.3.2.5
Mean glucose uptake rate (GUR) for TEFLYRD/83 cells in a packed bed bioreactor 
with internal aeration (see Figure 4.2.1.1). Cells were cultivated at 37°C for 7 days 
before the temperature was lowered to 32°C for virus production. Error bars represent 
observed range, n = 2.
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Figure 4.3.2.6
The residual glucose concentration for TEFLYED/83 cells grown in a packed bed 
bioreactor with internal aeration. The total working volume was 200ml. Medium was 
changed after 4 days, 6 days and daily after 9 days. Error bars represent observed 
range, n = 2.
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In addition to the packed bed systems, cells were cultivated on Immobasil FS 
microcarriers in 100ml spinner flasks. Immobasil has previously been shown to be a 
suitable substrate for human packaging cell lines producing retrovirus particles 
(McTaggart and Al Rubeai 2000). The ability of stirred cultures to efficiently produce 
virus particles is doubtful (Gerin et al. 1999). In this study, the cell number showed a 
dramatic increase during the initial 24 hours, prior to the onset of agitation. The cell 
number fell to -50% of the inoculum within 24 hours of the commencement of 
stirring but recovered during the following 6 days to reach a maximum number of 7.1 
x 107 cells. This is equal to a cell density of 7.1 x 106 cells ml" 1 carrier. During the 
production phase the cell number gradually decreased, with a final cell number of 
4.14 x 107 cells (see Figure 4.3.2.7). This suggests that stirred cultures are unable to 
support long-term cultivation of TEFLYRD/83 cells at 32°C.
Cell attachment and growth on microcarriers is dependent on several parameters 
including agitation speed, culture pH, inoculum ratio, bead concentration and serum 
concentration (Forestell et al. 1992; Hu et al. 1999; Mendon9a et al. 1999; Ng et al. 
1996; Shigami et al. 1997). The inoculum ratio and bead concentration used were 
those recommended by the manufacturer. The culture medium was supplemented with 
10% serum. This did not have any adverse affect on cell attachment kinetics and 89% 
of cells had disappeared from suspension after 1 hour.
The initial 24 hours of static conditions allowed cells to grow and expand into the 
matrix. The majority of the cells remained on the outer surface of the carriers. Hence, 
when agitation was started these cells were subjected to mechanical stress, which 
eventually led to cell death. The remaining cells were able to colonise the internal 
surface of the particles and reach a maximum cell density of 7.1 x 106 cells ml" 1 
carrier. However, this was considerably lower than densities reported for the
cultivation of other cell lines and reiterated the limited potential of stirred cultures for
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the cultivation of this cell line. Cell growth was not limited by glucose utilisation, as 
shown in Figure 4.3.2.8.
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Figure 4.3.2.7
Mean cell density for TEFLYRD/83 cells in 100ml spinner flask culture on 
Immobasil FS beads. Agitation was initiated after 24 hours. The culture temperature 
was reduced from 37°C to 32°C after 10 days. Error bars represent observed range, n
= 2.
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4.3.3 Retrovirus production
The retro virus titre from duplicate experiments was measured on day 1, day 5 and day 
10 of the production phase (after cells had been acclimatised to 32°C) using RT-PCR. 
The average daily retrovirus production in roller bottles was calculated to be 1.48 x 
107 LacZ Transforming Units (LTU) ml" 1 day" 1 . The maximum virus titre was 1.95 x 
107 LTU ml" 1 and the total production during the course of the culture was estimated 
to be 7.4 x 109 LTU. The cell specific production rate was calculated as 4.09 LTU
cell" day" . Hence, roller bottles provide a favourable environment for high titre virus 
production.
The most promising alternative to roller bottle culture was the PER. The average daily 
vector production was 9.24 x 106 LTU ml" 1 day" 1 , and was significantly higher than 
production from the spinner basket or spinner flask cultures. However, productivity in 
the roller bottle culture was 60% higher than in the PER. The advantage of the PER is 
that it can produce a large amount of virus supernatant in a relatively small space. 
During the course of the culture the PER produced a total of 1.8 x 1010 LTU. This is 
equivalent to 2.4 roller bottles. Another promising feature of this system is the 
specific production rate was 3.23 LTU cell" 1 day" 1 . While this is still lower than the 
specific production rate in roller bottles, it is higher than the other production systems 
evaluated in this study. It is believed that optimising the culture conditions as 
described in the above section can further increase this production rate. 
The level of productivity in the spinner basket was not satisfactory, when compared to 
roller bottle culture or the PER. The average productivity rate was calculated as 3.44 
x 106 LTU ml" 1 day" 1 , which produced a cumulative virus titre of 1.38 x 10 10 LTU. 
From the three different methods that were evaluated and compared to roller bottle 
culture, it was anticipated that the spinner basket would produce the highest amount
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of total virus due to the fact that it had the largest culture volume and the potential to 
support the highest number of cells. Unfortunately, this was not the case as the 
specific production rate of the cells was 0.778 LTU cell" 1 day" 1 . Despite having the 
largest total cell number at the end of the culture, the cells were unable to produce 
high titre virus supernatant.
The daily virus titres measured from the spinner flask culture showed a decrease 
during the course of the production phase.
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Figure 4.3.3.1
Virus titre at 32°C for TEFLYRD/83 cells cultured in roller bottles. The virus titre 
was measured from harvested supernatant from the respective days using RT-PCR. 
The samples were stored in liquid nitrogen prior to analysis. Error bars represent 
observed range, n = 2.
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Figure 4.3.3.2
Virus titre at 32°C for TEFLYRD/83 cells in a spinner basket packed bed bioreactor. 
Following the reduction of the temperature from 37°C to 32°C, a complete medium 
change was performed daily and 1ml of virus containing supernatant was stored in 
liquid nitrogen for later analysis. Virus titre was determined by RT-PCR from 
duplicate samples. Error bars represent observed range, n = 2.
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Figure 4.3.3.3
Virus titre for TEFLYRD/83 cells in a packed bed bioreactor with internal aeration at 
32°C. A daily medium change was performed from day 10 onwards, after the culture 
temperature had been reduced from 37°C to 32°C. 1ml of the harvested medium was 
stored in liquid nitrogen and the virus titre was measured upon completion of the 
experiment using RT-PCR. Error bars represent standard error.
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Figure 4.3.3.4
Virus titre for TEFLYRD/83 cells in 100 ml spinner flask culture with Immobasil FS 
microcarriers at 32°C. 10ml of carriers were cultured in 90ml of culture medium. 
Once cells had reached the stationary phase the culture temperature was reduced from 
37°C to 32°C. The medium was changed at regular intervals to prevent glucose 
limitation and 1ml of virus containing supernatant was periodically collected and 
stored in liquid nitrogen. The virus titre was measured using RT-PCR. Error bars 
represent standard error.
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It is thought that there are multiple factors that account the differences in retroviral 
litres and the specific productivity. A common feature of roller bottles and PBR is that 
over the 24 hour period between medium changes, the residual glucose fell below 
5.5mM. Nutrient deprivation or metabolite accumulation does not have a direct 
limitation on virus production (Gerin et al. 1999a). It will, however, have an indirect 
affect on virus production, as cell propagation and nutritional state will be effected. 
It is well reported that virus production is dependent on cell proliferation. Although 
virus assembly is not predominant in any particular phase of the cell cycle it is 
essential that cells progress through the cycle (McTaggart and Al Rubeai 2001). Viral 
replication requires the 5' and 3' long terminal repeats (LTRs) as these contain 
promoter and enhancer sequences (Kim et al 2000; Smith 1995). LTRs are most 
active in cycling cells (Merten et al. 2001), therefore, virus productivity will be 
enhanced in cultures where cells are continuously dividing. It was observed that the 
supernatant from roller bottle cultures contained noticeable amounts of cell debris. 
This demonstrates that although the viable cell number remained constant throughout 
the production phase, cell death was prevalent with dividing cells replacing those that 
were lost. This active cell division is one factor that accounts for the increased 
specific production rate. Similarly, in the PBR the GUR increased throughout the 
course of the production phase, which may be explained by an increasing cell number. 
Hence, cells were actively dividing in the PBR during production. The lower specific 
production rates observed in the spinner basket may have been the result of a reduced 
cell proliferation rate. We have deduced that cells were in sub-optimal conditions by 
their enhanced requirement for glucose and that this was primarily used for 
maintenance energy, as oppose to growth energy. This would result in a reduction in 
the expression of LTRs, which leads to lower specific virus production. In the spinner
flask, the cell number gradually decreased over the course of the production phase,
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showing that cell death was the dominant feature in these cultures, and the death rate 
was greater than the growth rate.
Another factor that may affect virus production is the type of microcarrier used. Fibra- 
Cel™ has proved to be a more favourable substrate than Immobasil for the 
production of retrovirus particles (see chapter 3). This is due to the microenvironment 
surrounding cells immobilised within the particles. The carriers are constructed of 
different materials which will determine cell spreading/aggregation behaviour and the 
geometric arrangements in the matrix. This will influence the transport of nutrients to 
the cells and the release of virus particles into the culture supernatant. The restriction 
of nutrients to cells in the centre of the carriers will result in a poor nutritional state, 
where cells are unable to produce virus, and may lead to a necrotic core in the beads. 
Necrotic cells release proteases, DNA and other cellular components (Fassnacht et al. 
1999) which will affect the surrounding cell population and may have a negative 
effect on the stability of virus particles. Immobasil FS carriers have a spherical 
geometry, which means that any cells that spread into the internal structure will be 
susceptible to nutritional gradients. As mentioned earlier, cells are unable to occupy 
the external surface of the carrier due to hydrodynamic forces. Therefore, it is 
hypothesised that cells only remain viable in a thin shell close to the surface of the 
carrier, thus only low cell densities are attained and productivity is relatively low. In 
contrast, the disc shape of Fibra-Cel™ allows cells to propagate the entire structure as 
the distance for nutrient diffusion is relatively small through the cross-sectional plane. 
In addition to the favourable geometry of disc microcarriers, diffusion of nutrients 
through packed bed bioreactors is enhanced by intraparticle convective flow. In 
monolayer culture the virus particles are assembled and released into the supernatant 
without any resistance. In microcarrier culture the particles have to diffuse to the
exterior. The increased residence time within the matrix will have a negative effect on
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virus harvest due to the short half-life of the retro virus. The intra-p articular convective 
flow through a packed bed not only allows greater nutrient transport but also for 
vector release. The inefficient fluid flow through the bed of the spinner basket may be 
insufficient to effectively transport virus particles from the basket into free 
supernatant. However, the fluid flow through the PER was capable of not only 
providing adequate amounts of nutrients to cells but also of carrying virus particles to 
the medium reservoir.
In the spinner flask and spinner basket hydrodynamic forces were present due to the 
agitation within the culture vessel. The shear stress generated from the impellers was 
not deemed to be a cause of virus damage. Retrovirus particles have on average a 
diameter of lOOnm (Andreadis et al. 1999), whereas the smallest eddies present in a 
spinner flask culture are in the range of 170-200um. Therefore, virus particles would 
simply be entrained by eddies and would not suffer any adverse effects from particle- 
eddy interactions.
Once virus particles have been released into the culture medium they are subject to 
several environmental factors that may have an effect on their stability. Viral vector 
stability can be influenced by factors such as temperature, pH and incubation 
conditions such as growth medium and serum components (Higashikawa and Chang 
2001). In order to allow a pragmatic comparison between culture systems, conditions 
were kept constant i.e. the temperature was maintained at 32°C and identical culture 
medium and serum was used. However, it was not possible to regulate the pH or 
dissolved oxygen in these systems. COi is a product of respiration and glucose 
metabolism which affects the pH of the culture medium causing it to become more 
acidic. The medium did contain sodium bicarbonate but this was not considered an 
effective buffer. Therefore, differences in pH between systems may have affected the
amount of virus harvested as a dramatic decrease in vector half-life is observed at pH
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levels below 7.0. Although pH was not measured in this study, it has been reported 
that it can drop to 6.5 over a 24 hour period in high density cultures (Higashikawa and 
Chang 2001; McTaggart and Al Rubeai 2000).
4.3.4 Comparison of perfusion culture systems
Continuous perfusion culture systems offer many advantages for the long-term 
production of virus particles when compared to semi-continuous cultures. The 
continually feeding of medium to the culture vessel will eradicate the problem of 
nutrient limitation whilst continual removal of waste products prevents the 
accumulation of toxic metabolites. Virus particles can be efficiently removed from the 
culture vessel to a harvest vessel at lower temperature to increase the stability of 
particles. In the systems tested the bioreactor conditions could be controlled, ensuring 
that pH and dissolved oxygen levels were maintained at acceptable levels. The four 
systems tested were the stirred tank bioreactor, the packed bed bioreactor with internal 
aeration, a fixed bed bioreactor and a fluidised bed bioreactor. Due to the different 
method used to determine the virus titre it was not possible to directly compare these 
results with those obtained for semi-continuous cultures at 32°C.
4.3.5 Cell growth and metabolic trends
The standard stirred tank bioreactor is the technology of choice for the industrial 
production of the majority of biopharmaceutical products (Chu and Robinson 2001). 
This makes it an attractive option in process development as many issues pertaining to 
regulation and licensing are more easily overcome than with other methods. In this 
study, Cytoline 1 microcarriers were used in the stirred tank bioreactor partly because 
of the unsatisfactory results obtained with Immobasil FS microcarriers in spinner flask 
culture and also to allow a better comparison with the fluidised bed bioreactor, which
used Cytoline 1 carriers.
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The cell density in stirred tank bioreactors showed no definite increase during the 
course of the experiments as depicted by the GUR in Figure 4.3.5.1. In the first run no 
viable cells were detected after 5 days and a constant glucose concentration indicated 
that there was no evidence of cell growth. During the second run cells were 
maintained for 12 days. After this time the increase in glucose concentration 
indicated a complete loss in cell viability. In both cases the residual glucose 
concentration never fell below lOmM and therefore perfusion was not initiated (see 
Figure 4.3.5.2).
The loss of cell viability was attributed to the stirring regime employed in the 
bioreactor and the type of microcarrier used. In previous experiments Cytoline 1 
carriers have proved very effective for the growth of TEFLYRD/83 cells. However, as 
these carriers were originally designed for use in fluidised bed reactors their density is 
greater than other macroporous carriers designed for use in stirred tank reactors. This 
higher density requires greater agitation to fully suspend the beads and obtain a 
homogenous environment. As stated by the Kolmogorov theory, the microscale of 
turbulence is a function of energy dissipation and kinematic viscosity. Amongst the 
parameters used to calculate the energy dissipation are the agitation speed and the 
power number of the impeller. The STR was fitted with a 6-bladed rushton turbine 
with a power number of 5 (c.f. power number of the spinner flask was 0.5). These two 
factors are thought to account for the difference in performance observed between 
spinner flask culture and the stirred tank bioreactor. Another consideration are the 
relatively large pores of Cytoline 1 microcarriers (10-400 urn), which may not offer 
adequate protection of cells from these mechanical forces, especially as the eddy sizes 
would be less than some of the pores.
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Figure 4.3.5.1
The glucose uptake rate in a perfusion culture of TEFLYRD/83 cells, cultured in a 
stirred tank bioreactor. Cells were attached to Cytoline 1 microcamers (100ml) in 
900ml of culture medium. The bioreactor set points were: temperature 37°C; DO2 
50%; pH 7.0; agitation speed 100 rpm. Medium samples were collected at regular 
intervals and the glucose concentration was measured off line using a 
GLUCOTREND® glucose test kit. The GUR was calculated from the change in 
residual glucose concentration.
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Figure 4.3.5.2
Residual glucose concentration for a perfusion culture of TEFLYRD/83 cells cultured 
in a stirred tank bioreactor. Medium samples were collected at regular intervals and 
the glucose concentration was measured off line using a GLUCOTREND® glucose 
test kit. Perfusion of culture medium was not started as the residual level didn't fall 
below lOmM.
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The packed bed bioreactor (PER) has shown a great deal of promise in semi- 
continuous cultures. In order to improve performance the feed medium was 
conditioned in a stirred tank bioreactor and the virus containing supernatant was 
harvested in a separate vessel at a lower temperature. The difference in cell numbers 
obtained between duplicate experiments highlights the difficulties in obtaining 
reproducible results with this culture system. In the initial run cells were able to grow 
steadily over the course of 16 days. The maximum cell number achieved was ~1 xlO8 
cells which equates to 2 x 106 cells ml" 1 carrier. In the second run cell growth was 
extremely rapid during the initial stages and a cell number of >4 x 108 cells was 
reached within 4 days (see Figure 4.3.5.3). However, this cell number was not 
maintained as the perfusion rate was increased and after 21 days there was no 
evidence of cell viability.
In both experiments the perfusion rate was determined by the concentration of 
residual glucose. Where the concentration of glucose increases the perfusion rate is 
higher than the nutritional demand of the cells. This is expected immediately after an 
increase in perfusion rate but it was anticipated that the concentration would gradually 
decrease as cell numbers increased. As cells did not continue to multiply the glucose 
concentration remained unchanged as illustrated in Figure 4.3.5.4.
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Figure 4.3.5.3
The viable cell number of an open perfusion culture of TEFLYRD/83 cells in a 
packed bed bioreactor with internal aeration. Cell numbers were calculated at the end 
of the experiment using the MTT assay. Intermediate cell numbers were estimated 
from the GUR due to the inaccessibility of cells immobilised within the vessel. 
Medium samples were collected at regular intervals and the glucose concentration was 
measured off line using a GLUCOTREND® glucose test kit. The GUR was 
calculated from the change in residual glucose concentration.
Medium was circulated through the packed bed using a peristaltic pump. The culture 
set points were temperature 37°C; DOi 75%; pH 7.0.
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The fixed bed bioreactor proved an effective method for the long term cultivation of 
TEFLTRD/83 cells. The first run was ended after 16 days due to complete 
consumption of the feed medium. During the second run it was possible to maintain 
the culture for 28 days as can be seen from Figure 4.3.5.5. Although long-term 
cultivation was possible, the cell density did not increase to anticipated levels. For the 
majority of the experiment the cell density was -3.3 x 106 cells ml" 1 microcarrier and 
the maximum density reached during run #2 was 4.8 x 106 cells ml" 1 microcarrier. 
As with previous perfusion cultures, the glucose concentration was used as a 
parameter for determining the perfusion rate. The residual glucose concentrations and 
perfusion rates for each run are shown in Figure 4.3.5.6. The constant medium 
recirculation between the fixed bed compartment and the conditioning vessel allowed 
effective uptake of glucose and oxygen, as demonstrated from the changes in residual 
glucose concentration and the requirement for constant sparging. As the glucose was 
depleted in the conditioning vessel, so the perfusion rate was increased. It was only 
towards the end of the second run that glucose concentration began to increase within 
the vessel, and this was attributed to a gradual decline in cell number, caused by the 
longevity of the culture.
Despite the disappointing cell densities the fixed bed bioreactor has shown good 
potential for the cultivation of TEFLYRD/83 cells and warrants further investigation 
and optimisation to enhance cell growth.
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Figure 4.3.5.5
The viable cell number of an open perfusion culture of TEFLYRD/83 cells in a fixed 
bed bioreactor. Medium was circulated between the conditioning vessel and the fixed 
bed. Cell numbers were measured at the end of the experiment using the MTT assay. 
Intermediate cell numbers were estimated from the GUR due to the inaccessibility of 
cells immobilised within the vessel. The culture set points were temperature 37°C; 
DO2 50%; pH 7.0. Medium circulation between the fixed bed and the conditioning 
vessel was started 3 hours after inoculation at a rate of 1ml min" 1 . This was increased
to 5ml min during the following 5 days.
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Due to the potential problems of scalability with packed bed reactors, the feasibility of 
cell growth and retro virus production was examined in a fluidised bed bioreactor. This 
system is manufactured up to a scale of 400L by Vogelbusch (Germany). 
The culture was run over a period of 19 days. During this time a total cell number was 
reached of 1.58 ± 0.25 x 109 cells (see Figure 4.3.5.7). This shows an overall increase 
of 3-4 fold. Interestingly, the initial cell number used in run #2 was considerably 
lower than that used in run #1, yet the final cell numbers were similar. This suggests 
that cell division will be more rapid at lower densities and that the total cell number is 
controlled by the residual glucose concentration.
During the course of the experimental runs the glucose concentration was maintained 
above 8.5mM by adjusting the perfusion rate according to the residual concentration 
as shown in Figure 4.3.5.8. This ensured that cell growth was not limited at any point 
during the culture.
The final cell numbers were disappointing, though. The cell density was 5.27 x 106 
cells ml" 1 microcarrier. In the manufacturer's literature it is stated that cell densities of 
2 x 10s cells ml" 1 microcarrier are achievable, yet this was not found to be the case 
with TEFLYRD/83 cells. This problem is believed to be the result of poor oxygen 
transfer to cells entrapped within microcarriers. The GUR and the glucose 
concentration within the vessel do not suggest that any nutritional limitations were 
present. Alternatively, poor cell density may be because the cell line does not like to 
maintain cell division on such material. However, a recent study on the poor 
performance and productivity of a fluidised bed bioreactor under similar conditions, 
were attributed to oxygen limitations (Preissmann et al. 1997). They reported that the 
maximum penetration depth of oxygen was 300um and that 40% air saturation could 
not provide efficient oxygenation of the surface biofilm during the exponential phase.
Whilst oxygen uptake rate or oxygen transfers were not examined in our study the
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results appear to conform to the findings of Preissmann et al. (1997). Therefore, 
oxygen supply is believed to be the limiting factor for cell growth and explains the 
poor performance.
Another draw back of this system, and the reason why the culture was halted after 19 
days, was that microcarriers began clumping. This had a detrimental effect on the 
level of fluidisation and agitation speed had to be increased to maintain 100% 
fluidisation of the bed. There are two possible reasons why clumping occurred. The 
first is that the serum in the medium bound to the surface of the carriers and caused 
them to stick together. The problem could be overcome by gradually reducing the 
serum concentration in the culture during the course of the experiment. Serum is 
required by the cells for growth and attachment and so a reduction in the initial serum 
concentration may not be practicable, nor would a complete removal of serum 
towards the latter stages of the culture, although these need further investigation. The 
second explanation for microcarrier clumping is the bridging of cells. This 
phenomenon occurs when cells attach to more than one microcarrier, forming an 
aggregate. It is more commonly observed with solid microcarriers as cells tend to 
grow within the structure of macroporous carriers. However, if due to oxygen transfer 
limitations cells could only grow on the external surface of the carriers then it is 
conceivable that bridging would occur.
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Figure 4.3.5.7
The viable cell number of a perfusion culture of TEFLYRD/83 cells in a fluidised bed 
bioreactor. Cell numbers were estimated from the GUR. The GUR was calculated 
from the change in glucose concentration and the perfusion rate. The culture set points 
were temperature 37°C; DO2 50%; pH 7.0; fluidisation 100%. The initial impeller 
speed was 350rpm. During the course of the experiments this was increased to 
maintain 100% fluidisation.
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4.3.6 Retrovirus production in perfusion cultures
On the basis of the cell numbers it was expected that the highest virus titres would be 
obtained from the fluidised bed bioreactor, followed by the packed bed bioreactor, the 
fixed bed bioreactor and the lowest titres being from the stirred tank bioreactor. In 
practice this was found to be true with the exception that higher titres were found in 
the fixed bed compared to the packed bed bioreactor as can be seen from the data 
presented in Table 4.3.6.1. No significant amounts of virus particles were detected 
from the stirred tank bioreactor. It was also presumed that the virus titres would 
increase over the course of the experiments as the cell number increased, as was the 
case. This is illustrated for the packed bed bioreactor, the fixed bed bioreactor and the 
fluidised bed bioreactor in Figure 4.3.6.1, Figure 4.3.6.2, and Figure 4.3.6.3, 
respectively. This reiterates the fact that virus titre is a function of cell number and 
high titre vector systems must be able to support high cell numbers. 
A direct comparison of vector concentrations between different production systems is 
complicated due to variations in bed fraction, total working volume and the time of 
culture. Thus, a more dependable parameter is the specific production rate, assuming 
that this is constant during the course of the experiment. The highest specific 
production rate was in the fixed bed bioreactor, which had the lowest cell density and 
the smallest bed fraction. This system may, therefore, have the greatest potential for 
effective vector production. The system could easily be intensified by doubling the 
bed fraction, giving a ratio of carriers:volume equal to that of the fluidised bed 
bioreactor. Its performance could be further improved by increasing the cell density 
through optimising the culture parameters.
The increased specific production rate in the fixed bed bioreactor was believed to be 
due to two factors. In the first instance the specific production rate in the packed bed
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bioreactor was thought to be a direct result of the fluid flow rate through the vessel. 
As mentioned in 4.3.2, fluid flow through a packed bed is a function of bead geometry 
and flow rate. Effective transport of nutrients to cells and products from the cells is 
dependent on the level of intraparticle flow. In semi-continuous cultures a relatively 
high flow rate was used to recirculate medium through the vessel and this resulted in 
high virus titres. In open perfusion cultures the flow rate was much lower and this 
may have caused virus particles to get trapped within the immobilisation matrices 
instead of being transported into the effluent stream. Similarly, the high recirculation 
rate in the fixed bed bioreactor between the conditioning vessel and the fixed bed 
would have led to good intraparticle flow, enabling virus particles to be efficiently 
transported into the supernatant.
The differences in specific production rate between the fixed bed bioreactor and the 
fluidised bed bioreactor can be attributed to differences in specific growth rates. 
Through simple kinetic analysis, product formation can be shown to be connected 
with specific growth rate (Cruz et al. 2000). The growth rate in the fixed bed 
bioreactor and the fluidised bed bioreactor were estimated to be 1.40 day" 1 and 1.09 
day" 1 , respectively. This accounts for the improved production rate in the fixed bed. 
The lower growth rate observed in the fluidised bed is due to oxygen limitations as 
discussed in 4.3.5.
While the specific production rate is of more scientific value for comparison of 
production systems, bioreactor productivity is of more industrial importance as this 
parameter serves as the basis for scale-up studies and calculating production plant size 
(Merten et al. 2001). From this viewpoint, the fluidised bed bioreactor was the most 
favourable system as it was capable of producing virus titres up to 1 x 107LTU ml" 1 
(see Figure 4.3.6.3). This is a 11-fold higher than the fixed bed bioreactor. The
fluidised bed bioreactor has the added advantage that scale-up is relatively straight
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forward compared to packed/fixed bed bioreactors, making it more commercially 
attractive.
Table 4.3.6.1
Cell growth and retro virus production parameters in perfusion culture at 37°C in 
various production systems.
Stirred Packed bed Fixed bed Fluidised 
tank bioreactor bioreactor bed 
bioreactor bioreactor
Bed fraction 61 0.625 0.075 oT5
(bead volume/total
volume)
Initial cell number 67.1 ± 32.9 20.65 ± 7.05 20.7 ± 13.54 524.5 ± 76
(xlO6 cells)
Maximum cell number - 2.565 ± 1.55 0.490 ± 0.23 15.8 ± 2.5
(xlO8 cells)
Maximum cell density - 5.13xl06 3.26xl06 5.26xl06
(cells ml" 1 jicarrier)
Maximum virus titre - 8.1 x 104 8.9 x 105 1 x 107
(LTUml^day 1 )
Specific virus - 0.0028 0.237 0.0045
production rate
(LTU cell' 1 day" 1 )
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Figure 4.3.6.1
Mean daily virus titres for an open perfusion culture of TEFLYRD/83 cells cultured in 
a packed bed bioreactor with internal aeration. The supernatant was collected 
immediately downstream of the culture compartment. The infectious virus titre was 
measured with the LacZ titration assay. Error bars represent observed range, n = 2.
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Figure 4.3.6.2
Mean daily virus titres for a perfusion culture of TEFLYRD/83 cells cultured in a 
fixed bed bioreactor with continuous recirculation of medium between the fixed bed 
compartment and the conditioning vessel. The supernatant was collected from the 
conditioning vessel. The infectious virus titre was measured with the LacZ titration 
assay. Error bars represent observed range, n = 2.
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Figure 4.3.6.3
Mean daily virus titres for a perfusion culture of TEFLYRD/83 cells cultured in a 
fluidised bed bioreactor. The infectious virus titre was measured with the LacZ
titration assay.
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4.4 Conclusions
A major concern in the production of retrovirus vector stocks is the ability to produce 
infectious particles efficiently and economically. At the present time clinical grade 
retrovirus vectors are produced in roller bottle cultures. These are beset with process 
limitations such as an inability to control important cultural parameters such as pH 
and dissolved oxygen and scale-up relies on an increase in unit number. Due to these 
limitations we have evaluated several alternative systems for the production of 
retrovirus particles.
In the first instance, semi-continuous culture systems, with a production phase at 
32°C, were compared to roller bottle culture. Of the three alternative systems that 
were tested none were able to produce the same volumetric productivities found in the 
roller bottle, which also had the highest specific production rate. However, the packed 
bed reactor with internal aeration offers an acceptable alternative. This vessel is still 
in the developmental stage but through effective reactor design and improvement it 
could provide a suitable means for virus production. It was proposed that production 
in this system and in the spinner basket reactor could be enhanced by implementing a 
continuous perfusion mode instead of semi-continuous feeding.
It has been suggested that perfusion culture at 37°C may be a more efficient means of 
virus production, with active virus particles being removed from the high temperature 
compartment and transported to a low temperature harvest vessel, than semi- 
continuous culture at 32°C. Therefore, four perfusion culture systems were evaluated 
for long-term virus production. To allow a meaningful comparison to be made the 
specific production rate was determined based on the final cell number and virus titre. 
The highest specific productivity was found in the fixed bed reactor and this was 
attributed to its specific growth rate and the intraparticle convective flow through the
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bed of microcarriers. It was hypothesised that its overall productivity could be 
improved by increasing the ratio of carriers to medium and by improving the cell 
density by optimisation of the culture conditions. The highest reactor production was 
observed in the fluidised bed bioreactor. It was thought that this would be the 
industrial choice of system due to its overall performance and the ease of scale-up. 
It was not possible to make a direct comparison between the virus titres in semi- 
continuous and perfusion cultures. This was due to the different methods used to 
measure the particles. RT-PCR, used to measure titres in semi-continuous cultures, is 
a rapid and reliable method. However, the results it produces are based on relative 
amounts of the fluorescence of the reporter dye. Quantitation is only possible by 
comparing results to a relative calibration curve. The virus titres for perfusion cultures 
were measured by the LacZ titration assay. A major drawback of this method, as with 
any biological assay, is the inherent variability in the number of LacZ transforming 
units. The ability of virus particles to successfully infect a target cell is dependent on a 
number of parameters, including the metabolic state of the target cells, target cell 
density, ratio of target cells to vector particles, concentration of the vector stock, 
infection medium, exposure time of target cells to vector and the type of target cells 
(McTaggart and Al Rubeai 2000). Therefore, the virus titres in this study can not be 
taken as absolute values but as an indication of an increase or decrease in virus 
number. Comparison between culture systems was possible as virus titres were 
measured with the same assay and therefore under identical conditions.
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CHAPTER 5: INFLUENCE OF SERUM CONCENTRATION ON 
CELL GROWTH AND RETROVIRUS PRODUCTION AND
DECAY KINETICS
5.1 Introduction
To optimize a bioreaction process for retrovirus production, the biological potential of 
the cell must be optimally exploited and the virus stability maximized. Previous 
reports on process optimization have looked at the effect of environmental conditions, 
especially temperature, on virus production (Kaptein et al. 1997; Le Doux et al. 1999; 
McTaggart and Al Rubeai 2000), bioreaction mode (Cruz et al. 2000) and different 
bioreactor systems (Merten et al. 2001). Previous studies on the effects of serum on 
retrovirus production have been varied. This may be the result of different cell lines 
being used in each of the studies. It has been known for almost a decade that product 
production kinetics depend on both cell line and cell culture method 
(Leelavatcharamas et al. 1994). It has been demonstrated that serum has a negative 
dose dependent effect on retrovirus production in the FLYRD18 cell line (Gerin et al. 
1999a; Gerin et al. 1999b; McTaggart and Al Rubeai 2000). McTaggart and Al- 
Rubeai (2000) reported an 11-fold increase in virus titre in cultures containing 1% 
PCS compared to 5% PCS. The negative effect of serum was determined to be at the 
virus assembly/maturation stage and not at the extra-cellular stage. This suggested a 
possible role of protease inhibitors present in serum. In this chapter, the effect of 
serum concentration on cell growth, virus stability and virus production has been 
examined. The ability of cells to grow under serum free conditions has also been 
assessed.
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5.2 Materials and Methods
5.2.1 Measurement of retrovirus decay
Packaging cells were grown to confluence in 850cm2 roller bottles at 37°C in DMEM 
+ 10% PCS. The culture medium was removed and replaced with 50ml of fresh 
medium. After 24 hours the supernatant containing retrovirus particles was harvested 
and centrifuged at 1500 rpm for 10 minutes to remove any cell debris. The 
supernatant was then filtered through a 0.22fim syringe filter to ensure sterility. The 
samples were centrifuged over night (-18 hours) at a speed of 6000g at 4°C to 
separate the virus particles. The supernatant was removed and discarded and the pellet 
was resuspended in 5ml DMEM supplemented with either 1% or 10% PCS in sterile 
bijoux tubes and incubated at 37°C. Samples were taken from the tubes at regular 
intervals and frozen in liquid N2 for later analysis by the LacZ virus titration assay.
5.2.2 Measurement of cell growth and retrovirus production in 
batch culture
Retrovirus producing cells, TEFLYRD/83, were inoculated at a density of ~6 xlO4 
cells ml" 1 medium in several 25cm2 T-flasks containing 10ml DMEM, supplemented 
with 10%, 5%, 2.5% and 1% PCS and incubated at 37°C in a 5% CO2 atmosphere. At 
regular intervals, the medium from duplicate flasks of each serum concentration was 
harvested and samples were stored in liquid N2 for later analysis by the LacZ virus 
titration assay and the glucose and lactate concentrations were measured as described 
in chapter 2. After the medium was removed the cells were trypsinised and counted 
under a microscope using the trypan blue exclusion test and a haemocytometer. The 
number of cells per flask was assumed to be constant and equal to the mean number 
of cells per flask observed for each serum concentration.
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5.2.3 Long-term monolayer culture and virus production
TEFLYRD/83 human packaging cells were seeded into several 25cm2 T-flasks at a 
density of 106 cells per flask. 4.5ml of culture medium supplemented with 2.5% or 
10% PCS was added to equal numbers of flasks and the cells were grown to 
confluence over 3 days at 37°C, 5% CO2 . Following this the medium was replaced 
with fresh medium and the volume was reduced to 1.5ml. Subsequent medium 
changes were performed at daily intervals. The medium volume was increased as 
required to prevent glucose limitation. Glucose concentration was measured daily 
using a "Gluco-Trend" glucose test meter (Roche, France) and virus samples were 
collected three times per week for later titration. The cell number per flask could only 
be determined at the end of the experiment by standard trypsinisation methods and 
counting the number of viable cells using the trypan blue exclusion test. Intermediate 
cell numbers were estimated from the daily glucose consumption rate.
5.2.4 Retrovirus production in a packed bed bioreactor
Packed bed reactors have previously been shown to be an effective method for the 
production of retroviral vectors (Kang et al. 2000; McTaggart and Al Rubeai 2000; 
Merten et al. 2001). The packed bed used in this study is described in chapter 4, 
section 4.2.1. The vessel was packed with 5g (50ml) Fibra-Cel™ discs, which were 
prepared as described in chapter 2.
The bed was inoculated with ~1.7 x 107 cells suspended in fresh medium. After 2 
hours >90% of cells had attached to the carriers and medium recirculation was started 
with a medium reservoir of 200ml. The medium reservoir was changed after 4 days 
and daily thereafter to prevent substrate limitation. Supernatant samples were taken at 
regular intervals for virus titre and glucose measurements. The cell number was
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estimated at the end of the experiment by an MTT assay (see chapter 2). Intermediate 
cell numbers were estimated from daily glucose consumption rate as described by 
(Rodrigues et al 1999).
5.2.5 Adaptation to serum-free media
VP-SFM
To determine the ability of cells to grow in a commercially available serum-free, 
protein-free medium, adaptation to VP-SFM (Gibco Life Technologies, UK) was 
performed. Cells that had been cultivated in standard culture medium (i.e. DMEM + 
10% PCS) were inoculated into T75 culture flasks at a concentration of 105 cells ml" 1 , 
with 20ml of medium containing VP-SFM and standard culture medium in a ratio of 
1:1. Cells were sub-cultured after 3-4 days and the specific growth rate was calculated. 
When the specific growth rate was >0.35 day" 1 the concentration of VP-SFM was 
increased by changing the ratio to 2:1, 4:1, 9:1, 19:1, and 39:1 before cells were 
grown in 100% VP-SFM. At each stage of the dilution cells were sub-cultured every 
3-4 days. A cell bank of cells was prepared as described in chapter 2.
SF-DMEM:F12
Serum-free DMEM:F12 medium was prepared by adding the ingredients listed in 
Table 5.2.1 to 990ml of double distilled water. The medium was sterilised by filtration 
through a 0.22um filter.
Unadapted cells were grown to confluence in a T75 flask with standard culture 
medium. The medium was removed and replaced with 20ml of SF-DMEM:F12 
medium. After 3-4 days cells were passaged and the viability, cell density and specific 
growth rate were determined. Once cell viability remained above 85% for two
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consecutive passages a batch culture was initiated to assess the virus production, as 
described in 5.2.2.
Table 5.2.1
Ingredients and their concentrations used to prepare SF-DMEM:F12
Ingredient Supplier Concentration
DMEM:F12 Gibco Life Technologies 7.88g I/ 1
NaHCO3 1.125gL-1
ITS-S Gibco Life Technologies lOmlL"1
0.27% BSA Sigma 2.7g L' 1
0.05% Pluronic F-68 Sigma 0.5g U1
5.2.6 Kinetic analysis
Previous studies have shown that the production of retrovirus vectors can be described 
by a mathematical model including differential equations relating to cell growth, virus 
production and virus decay (Cruz et al. 2000; Le Doux et al. 1999; Merten et al. 
2001). Therefore, the following set of equations can be applied. Cell growth is 
described by:
dxT
v dt (1)
The specific growth rate is the most suitable parameter for measuring cell growth in 
given culture conditions (Bailey and Ollis 1986). As growth proceeds it becomes 
limited by cell or substrate concentration. Limitation of growth and production can 
generally be regarded as being of two types, stoichiometric and kinetic. A 
stoichiometric limitation refers to the limitation on product yield, either cell mass or
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retrovirus particle production, caused by the complete utilization of a certain nutrient 
(substrate). A kinetic limitation implies the lessening of a rate, either the growth rate 
or the production rate, due to a reduction in the amount of the kinetically limiting 
substrate. Therefore, according to the Monod model
__/fmax_^0_
(Ks + S
Where j^max is the maximum specific growth rate of the cell line used, So is the initial 
substrate concentration and Ks is the substrate concentration at half jumax . As cell 
growth is exponential, the above equation can be integrated and the specific growth 
rate, ju for each culture can be calculated using the expression:
xt =
where xt is the cell concentration at time /, x0 is the initial cell concentration, and t is 
the time period to the end of the exponential phase.
Retrovirus vectors are particles not molecules and will therefore decay with time. 
Their level of stability is dependent on several environmental factors including 
temperature, pH, and serum (Higashikawa and Chang 2001). The rate of decay is 
proportional to the concentration of active virus and the change in concentration of 
active virus with time can be described by
V A =V0A exp(-kd t) (4)
where VA is the concentration of active virus at time t, V0A is the initial concentration
of active virus and kj is the virus decay rate constant (Le Doux et al. 1999). 
The packaging cells were designed to constantly produce retro viral vectors. Assuming 
that virus production is directly proportional to the concentration of viable cells the 
concentration of viruses as a function of time can be given by:
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dVT
—- = ajux + /]x (5) at
TWhere V is the total concentration of virus particles in the culture medium, a. and /5 
are production parameters characteristic of the cell line and culture conditions, jc is the 
viable cell density, and t is the time. In batch cultures, virus production and virus 
decay occur simultaneously. Therefore, the concentration of active particles is a 
function of both production and decay rates:
dV A
—— = a]iiX + /]X -kd y A (6)
The virus decay rate was assumed to be constant and the virus concentration at t = 0 
was given as 0. By simple rearrangement of equation 6, the specific production rate, 
kp, can be calculated and is described as:
kp =aju + p (7)
By definition, the specific production rate (virus cell" 1 hour"1 ) is therefore associated 
with specific growth rate.
5.3 Results and discussion 
5.3.1 Retrovirus decay
Incubation of retroviral vectors at 37°C in medium supplemented with 10% or 1% 
PCS showed an exponential decrease in infectious virus particles with time. The 
decay rate was determined by fitting an exponential curve to the experimental data. 
For medium supplemented with 1% PCS this was calculated as 0.15 hour" 1 with a 
corresponding virus half-life of 4.6 hours. In medium supplemented with 10% PCS 
the decay rate was 0.114 hour" 1 which equates to a virus half-life of 6 hours as seen in 
Figure 5.3.1.1.
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Extra-cellular virus particle stability has been shown to decrease with increasing 
concentrations of human or mouse serum. This is due to the presence of certain sugars 
on their envelope which activate complement via natural antibodies present in the 
serum (Takeuchi et al. 1996). The packaging cell line and the envelope proteins have 
been established as the factors that determine which sugars are present (Takeuchi et 
al. 1994). The increased stability of virus particles with an increase in foetal calf 
serum concentration may be due to two mechanisms. Firstly, the packaging cell line 
used and the envelope protein used for the vector do not activate complement in FCS. 
This validates the use of this production system for the generation of clinical grade 
vectors. Secondly, FCS contains particular components that can enhance the stability 
of virus particles. Previous reports using packaging cells derived from HT1080 cells, 
expressing vectors carrying the RD114 envelope protein have reported that FCS 
concentration has no affect on virus stability (Gerin et al 1999a; McTaggart and Al 
Rubeai 2000). While this confirms that complement is not activated in FCS, it also 
demonstrates that the increased stability conveyed by FCS in these experiments is 
dependent on the packaging cell line, not the envelope protein.
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Figure 5.3.1.1
The rate of virus decay in medium supplemented with 10% PCS and 1% PCS at 37°C. 
Virus particles were produced in roller bottle cultures at 37°C. The supernatant was 
harvested after 24 hours and the virus was filtered and then concentrated using low 
speed centrifugation (6000g for -18 hours). The supernatant was discarded and the 
pellet resuspended in DMEM supplemented with 1% or 10% (v/v) PCS. The virus 
suspensions were incubated at 37°C and 5% CO2 . Samples were taken at regular 
intervals and stored in liquid nitrogen. The amount of infectious particles remaining in 
the medium was measured using the LacZ titration assay after completion of the 
experiment. Error bars represent the 95% confidence interval.
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5.3.2 Cell growth and virus production in batch culture
The growth of TEFLYRD/83 cells in batch culture at various initial serum 
concentrations is shown in Figure 5.3.2.1. The maximum cell number achieved was in 
the range 8.24 x 105 cells ml' 1 to 8.73 x 105 cells ml' 1 at 5% PCS and 2.5% PCS, 
respectively. The specific growth rate was calculated by fitting the experimental data 
from the exponential growth phase (between 24 and 144 hours) to equation (3) and 
the values are presented in Table 5.3.1. There was no significant difference over the 
range of serum concentrations examined, which shows that serum does not have a 
kinetic limitation on cell growth. However, the rate of cell death was greater in 
cultures containing less serum. The reduction in viable cell density, between 192 and 
240 hours, was 64%, 41%, 21% and 14% for cultures supplemented with 1%, 2.5%, 
5% and 10% PCS, respectively. This supports the hypothesis that serum starvation is 
an inducer of cell death of a part of the cell population (Kessler et al. 1997). Hence, 
serum exerts a stoichiometric limitation on a cell population.
The residual concentrations of glucose and lactate were measured and are presented in 
Figure 5.3.2.2. Glucose utilization was essentially linear for all concentrations of 
serum up to the late exponential phase (144 hours). The rate of consumption was 
highest in 10% PCS and lowest in 1% PCS. No significant difference was seen 
between 5% PCS and 2.5% PCS. With the exception of cultures with 1% PCS, the 
glucose was completely exhausted after 8 days. In cultures containing 1% PCS the 
growth was limited after 6 days. This corresponds with a glucose concentration of 
9.9mMol I" 1 , suggesting that growth was limited by a factor other than glucose. The 
production of lactate was consistent with glucose utilisation.
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Figure 5.3.2.1
Mean viable cell number during a batch culture of TEFLYRD/83 cells in monolayer 
at various serum concentrations. At each time point duplicate flasks were sacrificed 
and the cells were counted after trypsinisation. Cells numbers were assumed to be 
constant under identical culture conditions. Error bars represent observed range, n = 2.
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Table 5.3.1
Cell growth and retrovirus production parameters for batch cultures of TEFLYRD/83 
at different initial serum concentrations. 
FCS concentration Specific growth Max viable cell Production rate
rate, ju 
(hour' 1 )
density constant, kp 
(x 105 cells ml" 1 ) (virus cell" 1 hour" 1 )
1
2.5
5
10
0.0204 ± 0.0009
0.0195 ±0.0004
0.0199 ±0.0005
0.0194 ±0.0009
8.27 ± 0.27
8.73 ± 0.97
8.24 ± 0.66
8.57 ±0.69
0.122
0.126
0.098
0.049
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Figure 5.3.2.2
Mean glucose and lactate concentrations in a batch culture of TEFLYRD/83 cells in 
monolayer culture at various serum concentrations. Duplicate flasks were sacrificed at 
regular intervals and the residual glucose and lactate concentrations were measured 
using the GLUCOTREND® glucose test kit and the biolyser rapid analysis system, 
respectively. Glucose consumption and lactate production were assumed to be 
constant for all cultures under identical conditions. Error bars represent observed 
range, n = 2.
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The mean daily virus titre was assessed using the LacZ titration assay, and the results 
are shown in Figure 5.3.2.3. The data presented in Figure 5.3.2.1 and Figure 5.3.2.3 
was fitted to equations 6 and 7 in order to determine the specific production rate, kp, 
during the exponential phase (see Table 5.3.1). The highest specific production rate 
was observed in 2.5% PCS, while the lowest was seen with 10% FCS. Hence, there is 
a direct, negative dose dependent relationship between serum concentration and virus 
production, as previously reported (Gerin et al. 1999a; Gerin et al. 1999b; McTaggart 
and Al Rubeai 2000).
The negative effect of serum on virus production has been attributed to the presence 
of protease inhibitors (Gerin et al. 1999a). During virus replication, the env gene is 
synthesised as a polyprotein that is cleaved by a cellular protease to yield the gp70 
(surface protein, SU) and the p!5E (transmembrane protein, TM)(Morgan 1995). The 
presence of protease inhibitors in serum causes a deficiency of env proteins, which 
has an adverse effect on virus assembly. Therefore, the reduction of serum 
concentration also reduces the presence of protease inhibitors and enables more active 
virus particles to be produced. The increase in specific production rate was 
proportional to the initial serum concentration between 1% FCS and 10% FCS. 
Therefore, the change in specific production rate with serum concentration could be 
described as:
(8)
Where So is the initial serum concentration and c' and c" are experimentally 
determined constants. For TEFLYRD/83 cells grown in monolayer batch culture, 
these were 0.1529 and 0.1082, respectively (r2 = 0.95).
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Figure 5.3.2.3
Mean virus titre in a batch culture of TEFLYRD/83 cells in monolayer culture at 
various serum concentrations. Duplicate flasks were sacrificed at regular intervals and 
1ml of supernatant from each flask was stored in liquid nitrogen. The virus titre was 
measured after completion of the experiment using the LacZ titration assay. Error bars 
represent the 95% confidence interval, n = 2.
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Figure 5.3.2.4
Specific production rate and half-life for OB83 retrovirus vectors produced from 
TEFLYRD/83 cells grown in monolayer cultures at different serum concentrations. 
The virus half life was calculated determining the gradient of an exponential curve 
fitted to the results shown in Figure 5.3.1.1. The specific production rate was 
calculated by fitting equations 6 and 7 to the experimental data presented in Figure 
5.3.2.3. Error bars represent 95% confidence interval.
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The highest virus litres were obtained in medium supplemented with 2.5% PCS. This 
is due to the combination of the specific production rate and the virus decay rate. The 
virus production rate and the virus half-life were plotted against initial serum 
concentration, shown in Figure 5.3.2.4. The point at which the lines cross indicates 
the optimal serum concentration for virus production and stability. Therefore, culture 
medium supplemented with 2.5% (v/v) PCS offers the most desirable environment for 
virus production. In addition, the reduction in serum proteins allows more efficient 
and simplified downstream processing of vector supernatants. A reduction in 
purification time will further increase the final product yield, making the overall 
process more economical.
5.3.3 Long-term monolayer culture and virus production
Having determined from batch cultures that culture medium supplemented with 2.5% 
PCS offered the best environment for virus production, it was necessary to assess the 
long-term cultivation of cells under reduced serum conditions, in semi-continuous 
monolayer culture. While the amount of active virus is a function of kp and fa, it is 
also dependent on cell concentration and time, as depicted in equation 6. Therefore, 
for a constant cell number the virus titre will increase until the specific production rate 
and decay rate reach equilibrium and a constant virus titre is achieved. By assuming a 
constant cell density at 10% PCS and 2.5% PCS and applying the constants 
determined from batch cultures, the optimal residence time was determined to be 24 
hours. After 24 hours the increase in virus titre at either serum concentration was 
inconsequential. For that reason, it was decided to change the culture medium and 
harvest the virus every 24 hours, once cells had reached confluence. 
The cell growth was monitored in monolayer cultures by the glucose uptake rate 
(GUR). This is a reliable method for the estimation of cell numbers in immobilised
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cultures where direct measurement of cell density is not possible (Former et al. 1994; 
Rodrigues et al. 1999). There was no significant difference between the GUR for cells 
cultured in medium supplemented with 2.5% (v/v) PCS and control cultures, 
supplemented with 10% (v/v) PCS (Figure 5.3.3.1). The fact that low serum 
concentration does not affect long term cell density, with daily medium replacement, 
was confirmed by measuring the final viable cell number, which showed no 
significant difference. The final viable cell number for 2.5% PCS and 10% PCS was 
1.04 ± 0.03 x 107 cells and 9.94 ± 0.77 x 106 cells, respectively. The final cell number 
and the virus titres are presented in Figure 5.3.3.2.
An average 42% increase in virus titre was observed in 2.5% PCS cultures compared 
to 10% PCS over the 21 day period. In batch culture, the average daily increase in 
virus titre was over 2-fold higher in 2.5% PCS compared to 10% PCS. This indicated 
that virus production was effected by a parameter other than serum concentration. As 
all culture conditions were consistent with batch cultures it was suggested that cell 
growth rate has an effect on virus production. In a previous study on the relationship 
between cell proliferation, cell cycle and virus production it was proposed that 
without significant cell proliferation virus particles are not produced (McTaggart and 
Al Rubeai 2001). During batch culture the specific growth rate was high as cells were 
in the exponential growth phase. However, once cells have reached confluence the 
total cell number remains comparatively constant as cell population cannot increase 
due to a limiting factor such as surface area or substrate exhaustion. Thus, the specific 
growth rate, //, is essentially zero. Therefore, the Leudeking and Piret equation for 
product formation, as described in equation 6, will become:
dV A
(9)
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And kp is now equal to /5. The significantly lower production rates in semi-continuous 
culture imply that a. is the dominant parameter in cell specific production and cell 
proliferation is important for achieving high virus titres.
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Figure 5.3.3.1
Mean glucose uptake rate (GUR) and residual glucose concentration in a semi- 
continuous culture of TEFLYRD/83 cells in triplicate monolayer cultures. Medium 
was supplemented with 2.5% (v/v) PCS and 10% (v/v) PCS.
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Figure 5.3.3.2
Mean daily virus titre and cell density in a semi-continuous culture ofTEFLYED/83 
cells in monolayer containing medium supplemented with 2.5% and 10% PCS. The 
virus titre was measured from harvested supernatant by the LacZ titration assay. The 
final cell number was obtained by trypsinising cells and counting under a microscope 
using a haemocytometer counting chamber. Error bars represent 95% confidence 
interval, n = 3.
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5.3.4 Retrovirus production in a Packed-bed reactor
Although the results from long-term monolayer cultures were not as promising as 
hoped for, they still showed that a reduction in serum concentration could enhance 
virus production and appreciably improve the final yield. However, monolayer 
cultures are undesirable for large-scale production as scale-up relies on multiple flasks 
or bottles as oppose to a single high volume, high surface area unit process. Packed 
bed reactors have previously been shown to offer a suitable means of immobilising 
packaging cells and producing virus vectors (Kang. et al. 2000; McTaggart and Al 
Rubeai 2000; Merten et al. 2001).
The cell growth was monitored through the residual glucose concentration and the 
GUR (Figure 5.3.4.1). The medium was changed after 4 days when glucose began to 
limit cell growth. At this point the GUR showed no difference between cultures 
supplemented with 2.5% (v/v) PCS and control cultures (10% (v/v) PCS). After the 
first medium change the GUR between control cultures and test cultures began to 
diverge, indicating that cell growth in 2.5% PCS was constrained. Loss of cell 
viability in immobilised cultures can be due to numerous factors that include nutrient 
limitation, toxic metabolite accumulation, changes in pH or mass transfer limitations. 
As the test culture was under identical conditions to the control culture, the decrease 
in cell growth and premature loss in viability could only be attributed to the reduction 
in serum concentration. This phenomenon had not been previously observed in 
monolayer cultures. Serum is essential for certain cell lines to maintain function, 
growth and attachment. In static monolayer cultures, cell attachment occurs as a 
function of gravity, as cells have a higher density than the culture medium. Once cells 
have attached they are not exposed to any hydrodynamic forces that may result in 
their detachment as the culture medium is motionless. In contrast, culture medium
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constantly flows through the packed bed in order to supply the cells with nutrients and 
remove toxic metabolites. Fluid flow through a packed bed can be regarded as flow 
through a collection of entangled, tortuitous tubes (Park and Stephanopoulos 1993). A 
pressure gradient exists that is proportional to fluid velocity and this will exert a 
friction factor on the external and internal surface of the carriers, as described by the 
Ergun and Carmen-Kozeny equations (Rhodes 1998). The reduced serum 
concentration results in a reduction of attachment factors and the effect of the friction 
factor cause cell detachment and loss of viability. This force is relatively small 
compared to those found in stirred cultures and detachment is not observed 
immediately after the start of medium circulation. Therefore, the fluid flow through 
the packed bed is a key parameter in determining optimal performance. If the fluid 
flow is too low diffusion gradients will appear resulting in dead zones within the 
vessel due to mass transfer limitations, which will confine cell number. Conversely, 
high flow rates will increase the friction factor resulting in cell detachment. 
In contrast to monolayer cultures the virus titre was lower at 2.5% PCS compared to 
10% PCS, as was expected from the cell density (see Figure 5.3.4.2). The specific 
production rate was also lower at both serum concentrations when compared to semi- 
continuous monolayer cultures. At 10% FCS /5 was calculated to be 0.001 LTU cell" 1 
hour" 1 in the PER, compared to 0.005 LTU cell" 1 hour" 1 in monolayer, and in 2.5% 
FCS )8 was calculate as 0.0001 LTU cell" 1 hour" 1 in the PER compared to 0.008 LTU 
cell" 1 hour" 1 in monolayer. This demonstrates that /3 is not constant and will vary 
according to the culture conditions. The change in environment, and the difference in 
serum concentration, almost certainly has an affect on cell function. As a consequence 
the translational and transcriptional machinery of the cells may be altered, which 
contribute to reduced virus levels.
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Figure 5.3.4.1
Glucose uptake rate in a semi-continuous culture of TEFLYED/83 cells on Fibra- 
Cel™ discs in a packed bed bioreactor with medium containing 2.5% or 10% PCS. 
Medium was changed after 4 days and 6 days, then every subsequent day. Error bars 
for medium supplemented with 10% PCS represent the observed range, n = 2.
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Figure 5.3.4.2
Mean daily virus titres in a semi-continuous culture of TEFLYRD/83 cells on Fibra- 
Cel™ discs in a packed bed bioreactor with medium supplemented with 2.5% PCS or 
10% PCS. The virus titre was measured from harvested supernatant using the LacZ 
titration assay. Error bars represent 95% confidence interval, n = 2.
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5.3.5 Adaptation to serum-free media
VP-SFM
Adaptation of TEFLYRD/83 cells to VP-SFM serum-free, protein-free medium was 
performed over a period of 38 days. Cells were adapted to grow in medium containing 
0.25% PCS with a specific growth rate of 0.25 day" 1 . The specific growth rates and 
doubling times at different serum concentrations during the adaptation process are 
shown in Figure 5.3.5.1.
A cell bank was created before complete removal of serum from the culture medium. 
However, cells revived from the cell bank lost their ability to grow in medium 
containing less than 5% PCS, although growth characteristics appeared normal in 
medium containing 10% PCS. In addition to this, when cells were cultivated in 
DMEM supplemented with 10% PCS it was observed that virus production was 
negligible. Therefore, it can be deduced that the freezing solution had an adverse 
affect on cell function following their adaptation to low-serum medium. 
Development of a suitable freezing medium is now required to fulfil the potential of 
this work. Successful adaptation to serum-free, protein-free medium will offer a wide 
range of benefits to the production of retrovirus production such as reducing the risk 
of contamination by foreign viruses, mycoplasma, and bacteria, elimination of 
protease inhibitors, and simplification of downstream processing. The absence of 
components of animal origin will also make the production process more attractive to 
regulating authorities.
Successful adaptation to VP-SFM may also allow cells to be adapted to suspension 
cultures. Although it is not possible to achieve the same cell densities in suspension 
culture as with immobilisation methods, it is advantageous with regard to scale-up
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and is a method commonly used in industry. This is an important consideration if 
large-scale production is to be undertaken by a contract manufacturer as their facilities 
would most likely be designed for suspension cultures.
Another advantage of suspension cultures are that a continuous process could be used. 
This would allow the removal of cells and virus and by doing so would encourage the 
division of cells retained in the bioreactor vessel. As virus production has been proved 
to be linked with cell growth rate it is proposed that this method would enhance the 
productivity of the system.
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Figure 5.3.5.1
Specific growth rate and doubling time of TEFLYRD/83 cells during adaptation to 
VP-SFM serum-free medium. Cells were cultivated in 75cm2 T-flasks at the 
respective serum concentrations. They were passaged every 3-4 days and the specific 
growth rate was calculated using equation 3. The doubling time was determined from 
the corresponding growth rate.
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SF-DMEM:F12
Following the successful survival of cells in SF-DMEM:F12 medium over a period of 
21 days, a batch culture was performed to establish the growth characteristics of cells 
and the virus production in relation to cells cultured in DMEM + 10% FCS. This 
medium composition has previously been used to grow a variety of cells lines under 
serum-free conditions including CHO cells (Sakai et al 1999), and hybridoma cells 
(Murakami et al 1982).
The growth of cells is shown in Figure 5.3.5.2. No increase in cell number was 
observed in the serum-free medium and after 7 days the viable cell number had fallen 
to zero. Cell death was ascribed to the absence of serum in the medium as the control 
culture, supplemented with 10% FCS, displayed typical growth characteristics of the 
cell line. Serum is a complex medium component that promotes cell replication 
(Bailey and Ollis 1986). It was anticipated that the addition of albumin and ITS-S 
would be able to replace this capability. However, in light of these results it is 
apparent that TEFLYRD/83 cells were unable to replicate in SF-DMEM:F12 medium. 
The inability of cells to survive in this culture was possibly due to a loss of cell 
function. During the initial 24 hours of the culture the glucose concentration was 
dramatically reduced (see Figure 5.3.5.3). A reduction on glucose concentration is 
usually associated with cell growth but this was not the case. It is more likely that 
glucose was required by the cells for maintenance energy as a result of being 
inoculated at a low density into serum-free medium. Prior to this study, cells had been 
cultivated in serum-containing medium and this was only substituted by serum-free 
medium when cells were at a high density. After the first day no significant change in 
glucose concentration was observed suggesting that cell metabolism had completely
ceased.
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Figure 5.3.5.2
Mean viable cell number in a batch culture of TEFLYRD/83 cells in monolayer 
culture with DMEM + 10% PCS or SF-DMEM:F12 media. Cells were inoculated at a 
density of 106 cells flasks" 1 in to several 25cm2 T-flasks with 10ml of medium. 
Duplicate flasks were sacrificed at regular intervals and the cell number was 
determined by trypsinising cells and counting under a microscope using a 
haemocytometer. Viability was determined by the trypan blue exclusion test. Error 
bars represent observed range, n = 2.
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Figure 5.3.5.3
Residual glucose concentration in a batch culture of TEFLYRD/83 cells in monolayer 
with DMEM + 10% FCS and SF-DMEM:F12. The glucose concentration was 
measured from the supernatant collected from sacrificed flasks using the 
GLUCOTREND® glucose test kit. Error bars represent observed range, n = 2.
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Despite the diminishing cell numbers and a lack of glucose uptake, the cells retained 
their ability to produce infectious virus particles, as seen in Figure 5.3.5.4. The titres 
obtained were lower than in control cultures, as expected from the cell densities. 
However, this does show that cells were able to maintain genetic functionality under 
serum-free conditions.
The implications of this study are that cells could be grown in serum containing 
medium before the serum concentration is gradually reduced to allow production of 
virus vectors under serum-free conditions. Cells would not necessarily have to be 
cultivated in high concentrations of serum during the initial stages as it has been 
demonstrated that growth rate is not affected at initial serum concentrations of 1% in 
monolayer cultures. This method has been successfully used to increase production of 
rabies virus in microcarrier cultures (Frazzati-Gallina et al. 2001). However, the effect 
of reducing serum concentration in packed bed bioreactor cultures requires further 
investigation to determine how cells will respond.
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Figure 5.3.5.4
Mean virus titre in a batch culture of TEFLYRD/83 cells in monolayer with DMEM + 
10% PCS and SF-DMEM:F12. Flasks were sacrificed at regular intervals for 
enumeration of cells. 1ml of virus containing supernatant was collected from these 
flasks and stored in liquid nitrogen. After completion of the experiment the virus titre 
was analysed using the LacZ titration assay. Error bars represent observed range, n = 
2.
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5.4 Conclusions
In this work it has been confirmed that serum concentration has a direct negative 
influence on virus production in human packaging cell lines. The presence of 
antiproteases in serum inhibits the assembly of virus particles at the intracellular level. 
However, certain components of serum can increase the stability of extra-cellular 
virus particles, justifying the use of low concentrations of PCS. 
Kinetic analysis shows that two parameters, a. and /?, influence the specific virus 
production rate. Of these, a is the dominant parameter and is related to the specific 
growth rate. Therefore, the specific production rate is higher in batch cultures where 
the cells are in the exponential growth phase and the growth rate is relatively high, 
compared to semi-continuous cultures, where the growth rate is essentially zero. /? is a 
weak function of production rate and is influenced by the culture environment and its 
affect on cell function. This has been proved by the difference in production rate 
observed between monolayer cultures and the packed bed reactor. 
A reduction in initial serum concentration may offer some benefit to the production of 
retroviral vectors for use in production. However, it is essential that a culture system 
that allows cells to be kept in a highly proliferative state is used to fully exploit the 
benefits of the increased virus production rate.
Complete adaptation of cells to grow in serum-free medium has not been achieved. 
However, promising results have been produced. Successful adaptation to VP-SFM is 
perfectly feasible if a suitable freezing solution can be developed. This may then lead 
to the adaptation of cells to grow in suspension. Cells were able to survive and 
produce virus particles in SF-DMEM:F12, although cell replication was not observed. 
Therefore, this medium may be useful in developing a process where serum 
concentration is gradually reduced during the course of the culture.
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Chapter 6: General discussion and conclusions
As gene therapy products progress through clinical trials and become closer to being 
fully licensed products, the need for efficient and economical methods of manufacture 
grow in ever increasing importance. To see the realisation of such processes a number 
of key issues have to be overcome. The two major concerns are with the stability of 
the virus particles and the low productivity of the packaging cell lines. The stability of 
viruses is affected by a number of external factors. These include temperature, pH of 
the culture supernatant and the concentration of serum (Higashikawa and Chang 2001; 
McTaggart and Al Rubeai 2000). While increasing the stability of virus particles can 
significantly improve virus litres, there is still a need for enhanced virus production. 
Cells do respond differently to the substrate to which they are attached to, the feeding 
strategy, the type of bioreactor in which they are grown and the type of medium used 
to feed them. These factors all have an influence on specific growth rate, death rate 
and production rate and an understanding of the cellular reaction to all these features 
is essential for process optimisation. It is hoped that in this study the problems that 
face the gene therapy industry have been addressed through the alternative systems 
that have been presented.
6.1 Mode of bioreaction
Batch culture systems are the most popular production system because of their 
simplicity in design and operation and the fact that they are well used and validated. 
Any alternative mode of bioreaction has to maintain these characteristics and be 
economically advantageous (Griffiths 1992). In monolayer culture, batch operations 
were shown to be very effective for the production of virus particles and it was 
possible to obtain relatively high virus litres, providing the particles were harvested at
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the end of the exponential growth phase. Previous studies have alluded to the fact that 
a direct correlation exists between the specific virus production rate and the specific 
growth rate (Cruz et al. 2000; McTaggart and Al Rubeai 2001; Merten et al. 2001). 
This was subsequently confirmed through kinetic analysis (see chapter 5). Therefore, 
it is not surprising that in semi-continuous culture the virus titres were considerably 
lower than the maximum titre achieved in batch. The advantage of semi-continuous 
operation is that virus particles can be produced over long cultivation periods and it is 
envisaged that the accumulated titre will be higher than the equivalent titres achieved 
from a corresponding number of batch operations over the same time period. It is also 
proposed that the volume of medium can be reduced from batch cultures as nutrients 
are only required for multiple 24 hour periods as opposed to 144+ hours in batch. 
However, in practice the batch cultures remained superior to semi-continuous 
production. The total number of virus vectors was not higher than the equivalent titres 
produced in batch and the anticipated advantages in volume of medium used were 
unfounded.
In semi-continuous cultures the cells are grown to maximum density and then virus 
containing medium is harvested every day. Cells can survive over extended periods 
because nutrients are replenished every day and toxic waste products are removed 
before their presence becomes detrimental. In this system, though, the cell number 
remains constant, once the maximum density is achieved as dead cells are 
immediately replaced and the density is limited by either surface area availability or 
nutrient exhaustion. This has a negative effect on virus production because it is related 
to specific growth rate. Cells retain their ability to produce infectious particles but 
their productivity is greatly reduced by the fact that the specific growth rate is 
essentially zero i.e. there is no change in the cell number.
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In order to improve the semi-continuous process the temperature during production 
was reduced from 37°C to 32°C. At lower temperatures the cell productivity has been 
shown to decrease. However, the virus stability is a stronger function of temperature 
and is enhanced at 32°C, resulting in a significant improvement in the virus titre (Le 
Doux et al. 1999; McTaggart and Al Rubeai 2000). When the temperature was 
reduced in monolayer semi-continuous cultures a marked increase in the virus titre 
was observed and the total amount of virus produced was far superior to that obtained 
from batch cultures. Batch culture at 32°C was not deemed to be a viable production 
method as the decrease in temperature would have a unfavourable effect on cell 
growth.
The disadvantage of semi-continuous culture is that it is difficult to implement in 
large-scale processes. The constant removal and replenishment of medium may also 
increase the risk of contamination. Hence, continuous perfusion cultures at 37°C were 
examined. At 37°C cell metabolism will be able to operate under optimal conditions 
and the specific production rate is presumed to be at its highest with regard to cell 
function. Virus particles are continuously removed from the culture vessel, 
overcoming the problem of rapid viral inactivation at 37°C. In addition the perfusion 
rate can be set to meet the nutritional requirements of the cells, resulting in a more 
efficient feeding strategy. Perfusion cultures can be applied to large-scale processes 
and their use in existing manufacturing processes demonstrates their regulatory 
acceptance. Direct comparison of virus titres between semi-continuous and perfusion 
cultures was not possible due to the different methods used to measure infectious 
virus particles; RT-PCR was used to measure the virus titre from semi-continuous 
cultures and the LacZ titration assay was used for perfusion cultures. Perfusion 
cultures were shown to offer a viable alternative to semi-continuous production in
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roller bottles, with virus litres up to 1 x 107LTU ml" 1 being achieved in a fluidised bed 
reactor.
Due to the relationship between cell growth and virus production an alternative mode 
of operation may be a chemostat. In this system the cells are not retained in the 
bioreactor but are continuously removed. The cell number in the reactor remains 
constant, though, as cells continue to actively divide. This method would maintain 
cells in a highly proliferative state, whilst maintained a constant high cell density and 
virus particles would be continuously removed from the high temperature vessel. 
However, prior to evaluation of this system it is necessary to adapt cells to grow in 
suspension cultures. This has not been possible to date.
6.2 Selection of a suitable microcarrier
The suitability of a microcarrier as an immobilisation matrix for cultivation of cells 
can be evaluated with regard to rate of attachment, cell growth and survival and virus 
production. The carriers studied were chosen on the basis that previous research had 
demonstrated their suitability for cell propagation and production of a range of 
biopharmaceutical products in a variety of culture systems. None of the four 
microcarriers evaluated in this study were solid beads, as this type has an inferior 
surface area to volume ratio, when compared to macroporous carriers, and cells are 
exposed to hydrodynamic forces in stirred vessels.
The rate of attachment was rapid for all microcarriers (Cytoline 1, Cytoline 2, 
Immobasil FS and Fibra-Cel™) with >90% of cells attaching to the microcarriers 
within 2 hours. In stirred cultures, agitation was started after 24 hours. There was no 
reduction in cell number after the start of stirring in Cytoline 1 & 2 cultures. This 
shows a strong cell attachment was achieved or that cells were able to colonise the 
interior pores of the matrix where they were protected from hydrodynamic forces. In
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contrast a significant reduction in cell number was observed in cultures containing 
Immobasil FS carriers. Despite rapid attachment, a sharp drop in viable cell number 
after the onset of mixing proves that a weak cell attachment was present or that cells 
were unable to rapidly proliferate into the porous structure. Cells did recover and were 
able to grow. However, cells were unable to reach a high cell density or maintain 
viability over an extended period of time. This shows that this type of carrier is 
unsuitable for the cultivation of TEFLYRD/83 cells.
Fibra-Cel™ discs were able to sustain cell viability and growth under both static and 
stirred conditions. In addition to this, a high virus titre was achieved in batch culture. 
Successful cell growth on a microcarrier requires that medium be efficiently supplied 
to the cells. A major problem with macroporous carriers is that nutrients, such as 
glucose or oxygen, cannot be efficiently transported to cells that colonise the interior 
of the particle. At the same time metabolic products accumulate and are unable to 
diffuse into the free supernatant resulting in cell death in the centre of the bead 
(Yamaji and Fukuda 1992). As the cells in this necrotic core lyse their cellular 
components are released and will adversely affect the surrounding cell population 
(Fassnacht et al. 1999). Virus particles may also be trapped within the particle, 
increasing their residence time in the vessel, leading to lower titres. These problems 
can be overcome by (i) decreasing the size of the particle and thus reducing the 
distance for the transport of nutrients and products, and (ii) increasing the pore size. 
Smaller macroporous beads, such as Cytopore, are commercially available. The 
problem with these microcarriers is that they are difficult to handle, because of their 
size, and they are only suitable for use in stirred bioreactors. One of the purposes of 
porous structures is to protect cells from mechanical forces. An increase in pore size 
would be counter productive as eddies would exist that were smaller than the pores
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and the level of protection would be reduced. Fibra-Cel™ discs have partially 
overcome these drawbacks by modifying the geometry and structure of the carrier. A 
disc shape allows a short diffusion pathway, allowing efficient transport of nutrients 
and products to and from the cells. The woven structure offers a macroporous 
environment that has a large surface area and protects cells from shear stresses. 
However, these carriers are only suitable for production in packed bed bioreactors. 
Therefore, these systems must be optimised in order to fully exploit the advantages 
presented by Fibra-Cel™ discs.
6.3 Choice of bioreactor
It is apparent from this work that the most suitable system for the production of 
infectious virus particles is either the fixed bed bioreactor or the fluidised bed 
bioreactor. The use of packed bed bioreactors, incorporating Fibra-Cel™ discs for cell 
immobilisation, has been previously reported and shown to offer great potential for 
large-scale processing of vectors (Kang et al. 2000; Merten et al. 2001). The 
Cytopilot fluidised bed bioreactor is a novel method for retrovirus production and its 
appropriateness has not been previously reported.
An important consideration in choosing a production system is its capability for 
industrial scale manufacture. The fixed bed bioreactor had a higher cell specific 
production rate but the overall reactor productivity was poorer than the fluidised bed 
bioreactor, due to a lower cell number. The reactor productivity may be improved by 
intensifying the culture system, by increasing the bed volume in relation to the 
conditioning vessel volume, and by optimising the culture conditions to improve the 
cell density. Another drawback in the use of the fixed bed bioreactor is its scalability. 
It has been reported that the maximum length of the fixed bed is 15cm. However, this 
apparent disadvantage can be overcome by the use of a radial flow fixed bed (Portner
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et al. 1999). This has shown good scale-up potential and a 5 litre fixed bed within a 
10 litre glass conditioning vessel can achieve an equivalent cell density to a 100 litre 
suspension culture. However, unless the overall productivity of the fixed bed 
bioreactor can be improved, the fluidised bed reactor remains the industrial choice for 
virus production. Additionally, the fluidised bed bioreactor is favourable because it is 
a scalable system, with vessels up to 400 litres commercially available. 
There are a number of problems associated with the fluidised bed bioreactor. Of 
greatest significance is the poor cell densities achieved. These have been attributed to 
oxygen transfer limitations, which prevent the cells from completely utilising the 
porous structure of the microcarriers. Cell densities between 2 x 107 and 3 x 107 cells 
ml"1 have been reported for this system using CHO cells (Goldman et al. 1998; Kong 
et al. 1999; Wang et al. 2002), and it is believed that through process development 
similar cell densities could be achieved with the TEFLYRD/83 cell line. Another 
drawback observed in the fluidised bed bioreactor was the clumping of microcarriers 
approximately 18 days into the culture. This led to the termination of the experiment 
after 19 days, whereas the fixed bed bioreactor was successfully run for 28 days. The 
clumping of carriers was mainly attributed to the high serum concentration in the 
medium and it was thought that reducing this would result in improved performance. 
The production in either of these systems could be enhanced by modifications in the 
process. As with semi-continuous cultures the temperature could be reduced to 32°C. 
Originally the culture temperature was set at 37°C and a low residence time was 
expected in order to prevent excessive virus deactivation. However, in practice the 
perfusion rates in these systems was not as high as anticipated and the residence time 
of the virus particles was greater than 24 hours. Therefore, a significant amount of 
particles would loose their infectivity before they could be harvested from the vessel.
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Hence, a reduction in culture temperature is expected to improve the infectious virus 
titres. A further consideration is to reduce the serum concentration over the course of 
the experiment. In the fluidised bed reactor this would prevent microcarrier clumping, 
as mentioned above, but it would also increase the specific cell production rate (see 
chapter 5). An initial serum concentration of 10% (v/v) would be required for 
adequate cell attachment but it is proposed that this could be reduced in a step-wise 
fashion until the concentration was 1% (v/v). These suggested improvements require 
thorough validation but it is anticipated that they will be able to enhance the overall 
productivity of perfusion culture systems.
6.4 Medium development
The standard culture medium used for the production of retro virus vectors (as 
stipulated by Oxford BioMedica) is DMEM supplemented with 1% (v/v) non- 
essential amino acids and 10% (v/v) foetal calf serum. The kinetic analysis of batch 
cultures has proved that the initial serum concentration has a direct negative effect on 
the specific production rate. This is due to the presence of protease inhibitors in the 
serum which hinder the assembly of infectious virus particles. The virus stability was 
also affected by the serum concentration. The half-life was reduced at lower 
concentrations suggesting that certain serum proteins are able to enhance the vector 
stability. The cell specific growth rate showed no significant difference between 
serum concentrations above 1% (v/v). Therefore, the optimal serum concentration was 
determined to be 2.5% (v/v). This was verified in semi-continuous culture, although 
the difference in virus titre between 2.5% and 10% was not as great as in batch culture. 
This was due to the fact that the specific growth rate in semi-continuous culture was 
essentially zero, which influenced that specific production rate. The advantages of 
reduced serum concentrations could not be emulated in packed bed bioreactor cultures.
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This is thought to be due to the reduced levels of certain serum components that are 
required for the attachment of cells to the microcarriers. This problem could be 
overcome by the addition of attachment enhancing supplements to the medium as a 
substitute to the serum components. Alternatively, the cells could be grown in an 
initial concentration of 10% PCS and weaned off this over the duration of the culture, 
as discussed in the previous section.
Two serum-free media were tested to ascertain their suitability for cell cultivation and 
virus production. Cells were adapted to grow in VP-SFM supplemented with 0.25% 
PCS. However, they were unable to retain this capability after a single freeze-thaw 
cycle. This highlights the need to develop a suitable freezing medium that will permit 
cells to preserve the ability to proliferate under near serum-free conditions, and 
hopefully enable a completely serum-free culture to be accomplished. 
Cells also demonstrated an ability to survive in SF-DMEM:F12 medium. However, 
they were unable to proliferate when inoculated into a batch culture. Cell function was 
retained and virus particles were produced, albeit at lower concentrations, for the 
duration of the experiment. This may be a suitable alternative medium in semi- 
continuous cultures or perfusion cultures once cells have reached confluence and 
virus production has begun.
Modifications in the medium composition are a very important aspect of process 
design. Traditionally, animal cell culture has used serum as it contains proteins 
necessary for cell growth, function and attachment. In recent years, though, 
alternatives have been sought in order to dispose of all components of animal origin 
due to the safety concerns that have been raised. This is especially true for products 
used in human therapy. It represents a major source of contamination from viruses, 
mycoplasma and bacteria and the introduction of pyrogenic contaminants by serum
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complicates product recovery (Bailey and Ollis 1986). The albumin protein 
background also complicates the downstream processing of protein products present 
in low concentrations. Aside from the safety issues, lot-to-lot variation can result in a 
lack of reproducibility of a process. The approval of a human gene therapy product 
may be expedited if it is produced under serum-free, protein-free conditions. 
The use of serum-free medium often results in cells becoming adapted to suspension 
culture. The cells densities reached in suspension culture are often inferior to 
immobilised culture but there are still several advantages. Firstly, scale-up is 
relatively simple as with bacterial or yeast cultures. Secondly, cells can be grown in 
traditional fermenters. This does away with the need to validate new processes or 
reactors and may reduce capital costs. Thirdly, suspension cultures can be grown in a 
chemostat, which, due to the continual cell division, is anticipated to yield high virus 
titres (see 6.1).
6.5 Conclusions
On the basis of the work carried out, the recommended method for the large-scale 
production of retrovirus vectors for gene therapy applications is a perfusion culture 
using the fluidised bed bioreactor. Cytoline 1 microcarriers have proved to be a 
suitable substrate for cell growth. It is anticipated that virus titres can be further 
enhanced by reducing the culture temperature to 32°C and decreasing the serum 
concentration in the culture medium over the duration of the production run.
6.6 Recommendations for future work
Further work is required to evaluate the ability of TEFLYRD/83 cells to grow under 
serum-free conditions and the effect that this may have on virus production. 
Validation of suspension cultures is also required and a chemostat is suggested as an
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alternative system for virus production. The ease and simplicity of suspension cultures 
has made them an attractive option in the large-scale production of biopharmaceutical 
products. Failure of these cells to grow in suspension may indicate the need for an 
alternative packaging cell line to be used in the production of OB83 retrovirus 
particles. HEK293 cells or PER.C6 cells are eligible candidates as they are proven 
cell lines for the production of recombinant retro viruses and can be grown in serum- 
free suspension cultures.
In this study, none of the immobilised culture systems examined were able to perform 
better than the roller bottle cultures. This may be due to the inability of virus particles 
to escape from the matrices and subsequently being denatured due to the prolonged 
time at culture temperature. The microenvironment within the particles may also be 
detrimental to virus particles as the pH would be lower than in the free supernatant, 
due to cell respiration. This again would have a negative affect on virus stability. 
Therefore, if cells could be grown in suspension, virus particles would be immediately 
released into the supernatant and would avoid the problems mentioned above. This 
also suggests that solid microcarriers may be more amenable to virus production, if 
cells are unable to grow in suspension, even though the cell densities may not be as 
high as those obtained with macroporous carriers.
If macroporous carriers are to be used in the future production of virus particles then 
more examination of the physical aspects pertaining to fluid flow and mass transport 
is required. An in depth analysis of packed bed reactors is required in order to 
understand the mechanisms that limit cell growth and inhibit the virus production rate, 
such as characterisation of fluid flow, the effect of channelling and the emergence of 
dead zones. Characterisation of cell growth, the particle microenvironment and the 
possibility of cell bridging is also required to fully understand these systems.
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